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Abstract
The human discoidin domain receptors (DDRs), DDR1 and DDR2, are a unique 
subfamily of receptor tyrosine kinase as they bind to and are activated by the 
extracellular matrix protein collagen. The DDRs are expressed widely and play 
an important role in cell-matrix interaction, cell adhesion, motility and 
proliferation. Several different collagen types activate the DDRs, and both DDRs 
bind only native, triple-helical collagen and not denatured collagen. The DDRs 
need to be dimerised in order to bind collagen, as shown by studies using 
soluble extracellular domain (ECD) constructs of DDR1 and DDR2. However, 
the oligomerisation state of the full-length receptors on the cell surface has not 
been investigated. In this study, chemical cross-linking analysis and co- 
immunoprecipitation of FLAG- and MYC-tagged receptors show that full-length 
DDRs, expressed on the cell surface, exist as preformed oligomers in the 
absence of ligand. The DDR domains involved in dimerisation were investigated. 
Both DDR1 and DDR2 are composed of an N-terminal discoidin domain 
followed by a region of no known sequence homology that is predicted to be 
folded, named domain X in this study. A transmembrane (TM) domain ensues, 
followed by a juxtamembrane domain and a C-terminal catalytic tyrosine kinase 
domain (KD). DDR1 contains an additional region rich in proline and glycine 
situated between the domain X and the TM domain. Chemical cross-linking
analysis and co-immunoprecipitation studies of DDR1 and DDR2 deletion
mutants indicate that more than one receptor domain is involved in receptor
dimerisation, as the deletion of any one of the above mentioned receptor
domains was not sufficient to abolish oligomerisation. Furthermore, the role of 
the TM domain in DDR dimerisation was investigated. DDR mutants containing 
mutations to disrupt two potential TM dimerisation motifs, a leucine zipper and a 
GxxxG motif, were studied. Neither motif was required for DDR dimerisation in 
the absence of ligand. However, the leucine zipper, but not the GxxxG motif, 
was found to be required for DDR activation in the presence of collagen I, 
indicating that upon collagen binding, the DDR TM domains self-assemble, and 
this interaction occurs via the leucine zipper motif.
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Chapter 1 
General Introduction
Chapter 1
1.1. Receptor Tyrosine Kinases
Receptor Tyrosine Kinases (RTKs) play an important role in the control of cell 
growth, differentiation, metabolism and cell migration (reviewed in Hunter, 2000; 
Schlessinger, 2000). RTKs exist as membrane-spanning cell surface receptors; 
they function as mediators to relay signals from the extracellular environment to 
the inside of the cell. So far more than 16 structural subfamilies of these 
receptors have been identified (reviewed in Heldin, 1996). Structurally, RTKs are 
characterized by an extracellular ligand binding domain, a single 
transmembrane (TM) region, and a cytoplasmic region which contains a 
conserved catalytic protein tyrosine kinase domain (KD) (reviewed in Hubbard et 
a i, 1998). The structures of seven subfamilies, which are present in mammals, 
are depicted in Figure 1.1. The extracellular domains (ECDs) of these receptors 
are composed of diverse protein modules, including fibronectin-like and 
immunoglobulin-like domains, leucine-rich and cysteine-rich domains (Heldin, 
1995). These receptors are activated by extracellular signal proteins, ligands, 
which include a wide variety of growth factors and hormones. Usually these are 
soluble proteins found in blood or other body fluids, for example, the platelet- 
derived growth factor, PDGF, and epidermal growth factor, EGF (Carpenter and 
Cohen, 1990; Yu et a i, 2003), or, as has been recently discovered, membrane 
bound ligands. For example, the fibroblast growth factor, FGF, needs the 
membrane bound heparin sulphate proteoglycan receptor in order to activate its 
receptor (Yayon et a i, 1991). For all RTKs, the binding of ligand to the 
extracellular ligand binding domain activates the intracellular tyrosine KD. Once 
activated, the KD catalyzes transfer of the y-phosphate group from ATP to 
selected tyrosine side-chains on the receptor and on intracellular signalling 
proteins which bind to the phosphorylated receptors (reviewed in Hunter, 1998).
Receptor dimerisation is thought to be an important step in the activation 
process leading to tyrosine kinase autophosphorylation. In addition, it has been 
suggested that receptor oligomerisation allows for generation of signal diversity,
16
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Figure 1.1: Seven subfamilies of RTKs. All RTKs contain an 
extracellular ligand binding domain, TM domain and a cytosolic 
conserved catalytic KD. The extracellular domain characterises the 
individual subfamilies and determines ligand specificity. (Figure taken 
from Alberts et a/., 2001, Molecular Biology of the Cell, 4th ed., page 
872)
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as each monomer within a dimer can recruit a different set of signalling proteins 
(Lemon and Schlessinger, 1994). The classical model of RTK activation 
describes that ligand binding induces dimerisation and activation of receptors 
(Weiss and Schlessinger, 1998). In this model, ligand binding to the ECD of 
monomeric receptors induces receptor dimerisation. The mechanism by which 
RTK dimerisation stimulates catalytic activity is not fully understood. Available 
data suggests that dimerisation is followed by the re-arrangement of receptor 
cytosolic tails, enabling the adjacent KDs to cross phosphorylate one another 
(known as autophosphorylation). A schematic diagram of this model is shown in 
Figure 1.2. Autophosphorylation contributes to the activation process in two 
ways. Firstly, phosphorylation of tyrosines within the activation loop (A-loop) of 
the catalytic domain maintains and increases the catalytic kinase activity. 
Secondly, autophosphorylation of additional tyrosines in the non-catalytic region 
serve as docking sites for intracellular signalling molecules containing SH2 (Src 
Homology 2) and PTB (phosphotyrosine binding) domains (reviewed in Pawson, 
1995). The binding of signalling molecules to phosphorylated tyrosines leads to 
the assembly of an intracellular signalling complex and signal transduction. The 
classical model of RTK activation proposes that dimerisation stabilizes the 
conformation of the A-loop is an ‘open conformation’ allowing ATP and substrate 
binding, thus enabling transphosphorylation of the A-loop and stabilizing the 
catalytic domain in an active conformation. An alternative mechanism is that 
receptor dimerisation increases the local concentration of the KD leading to 
more efficient transphosphorylation of the A-loop (Weiss and Schlessinger, 
1998).
Recently, a different model for receptor activation has been described. Certain 
cytokine receptors, such as the erythropoetin (Epo) receptor (Constantinescu et 
al., 2001;) and growth hormone (GH) receptor (Brown et al., 2005), and the RTK 
epidermal growth factor receptor (EGFR) (Moriki et al., 2001), are able to 
dimerise in the absence of ligand and are activated by a ligand-induced 
conformational change. In this model, receptors exist as inactive,
18
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Figure 1.2: The classical model of RTK activation. Receptors exist as 
monomers on the cell surface. Ligand binding to the extracellular 
domain induces receptor dimerisation and re-arrangement of the 
receptor cytosolic region leading to activation of the catalytic tyrosine 
kinase and receptor autophosphorylation.
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preformed dimers on the cell surface. Ligand binding causes a re-orientation of 
the receptor domains leading to re-arrangement of the cytosolic tails followed by 
activation of the tyrosine kinase catalytic activity (Figure 1.3).
1.1.1 The Epidermal Growth Factor Receptor
The Epidermal Growth Factor Receptor (EGFR) was the first RTK to be 
discovered (Carpenter et al., 1978). EGFR belongs to the Erb family of RTKs 
which consists of four members, EGFR (ErbB1), ErbB2, ErbB3 and ErbB4 
receptors (reviewed in Olayioye et al., 2000). Together they function to control 
cell proliferation, differentiation and survival. Activating mutations and over­
expression of these receptors have been shown to result in a variety of cancers 
(reviewed in Blume-Jensen and Hunter, 2001). These receptors were found to 
be activated by the epidermal growth factor (EGF), transforming growth factor a 
(TGFa) and an additional ten potential ligands. The large ECD of these 
receptors are composed of four subdomains, denoted as I, II, III, and IV (Figure 
1.4). Domains I and III form the ligand binding domain of EGFR while other parts 
of the ECD are involved in receptor dimerisation (Schlessinger, 2002). The 
prevailing model for the mechanism of activation of EGFR is thought to be that 
ligand binding induces receptor dimerisation (Schlessinger, 2000). This concept 
is supported by a number of biochemical, biophysical and crytallographic 
studies. Biophysical studies have demonstrated that two EGF molecules bind to 
two EGFR molecules simultaneously forming a 2:2 EGF-EGFR complex formed 
from stable 1:1 EGF-EGFR complexes (Lemmon et al., 1997). Crystallographic 
studies of ligand:receptor complexes have given insight into the details of how 
ligand binding induces EGFR dimerisation (Garrett et al., 2002; Ogiso et al., 
2002). The crystal structures are consistent with a ‘receptor mediated’ 
mechanism of receptor dimerisation (Lemmon et al., 1997). The binding of EGF 
to EGFR induces a conformational change which exposes a site in the ECD. 
This site consists of a specific loop which projects from domain II, called the
20
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signalling pathways
Figure 1.3: An alternative model of RTK activation. Receptors exist as 
inactive, preformed dimers on the cell surface in the absence of ligand. 
Ligand binding leads to re-orientation of receptor domains. This 
conformational change is transmitted into the cytosolic region, resulting 
in the activation of the catalytic tyrosine kinase and receptor 
autophosphorylation.
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‘dimerisation loop’. This finding suggests that two EGFR monomers would be 
able to dimerise only when occupied by EGF (Burgess et al., 2003).
Based on the crystal structures, a model was proposed for the process by which 
ligand binding drives receptor dimerisation. By comparing active and inactive 
EGFR crystal structures, it was proposed that EGFR exists in equilibrium 
between a tethered (inactive) conformation and an extended (active) one. In 
order to switch from this inactive conformation to the active one, a domain re­
arrangement is required. It seems that by ligand binding simultaneously to both 
domains I and III, the relative orientation of the two domains are altered. This 
could change the conformation of domain II so that its ability to dimerise is 
enhanced. As seen in Figure 1.4, there is a direct intermolecular interaction 
between domain II and IV, which buries the dimerisation loop of domain II, thus 
the receptor is unable to form dimers. For a ligand to bind both domains I and III 
simultaneously, the receptor needs to adopt the ‘extended conformation’. It is 
proposed that ligand binding actually ‘traps’ the extended configuration, shifting 
the equilibrium to the right and thus the majority of receptor molecules will be in 
the extended state, and will be able to dimerise (Figure 1.4). Thus the crystal 
structure provides good evidence for ligand-induced dimerisation and activation 
of EGFR (Burgess et al., 2003).
A contradiction to this classical model has been proposed by several 
independent groups, who provide evidence for a proportion of EGFR molecules 
existing as preformed dimers on the cell surface (Gadella and Jovin, 1995; Chu 
et al., 1997; Sako et al., 2000; Moriki et al., 2001; Martin-Fernandez et al., 2002; 
Yu et al., 2002). A series of biochemical studies involving chemical cross-linking 
analysis of cell surface EGFRs, co-immunoprecipitation and sucrose density 
gradient centrifugation experiments in vitro, showed that EGFR has the ability to 
form dimers in the absence of bound ligand (Chu et al., 1997; Moriki et al., 2001; 
Yu et al., 2002). Biophysical studies using single molecule tracking of EGFR 
dimerisation (Gadella and Jovin, 1995) and Fluorescence Resonance Energy
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Figure 1.4: A model for EGFR activation by ligand-induced dimerisation 
and conformational change*The inactive receptor is shown on the left as 
a monomer. Domains II and IV interact thus burying the dimerisation arm 
of domain II and the receptor is unable to dimerise (tethered 
conformation). Upon EGF binding, a conformational change occurs 
resulting in an extended conformation of the two receptors allowing 
receptor dimerisation as shown on the right. (Figure taken from Burgess 
et al., 2003).
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Transfer (FRET) analysis (Sako et al., 2000) in live cells, indicate the presence 
of preformed EGFR dimers. FRET between fluorescently labelled monoclonal 
anti-EGFR Fab fragments, EGF and TGFa bound to live A431 cells, show that 
14% of EGFRs in these cells exists as preformed oligomers (Martin-Fernandez 
et al., 2002). Furthermore, a recent study (Moriki et a/., 2001) proposed a 
‘rotation twist model’, in which ligand binding to predimerised, inactive EGFRs 
induces rotation of the juxtamembrane region, leading to rotation of the TM 
domain. This results in the cytoplasmic domains dissociating from an inactive 
conformation to form an active conformation, leading to the activation of the KD.
1.2. The Extracellular Matrix
The extracellular matrix (ECM) is the extracellular space surrounding cells in 
tissues. The matrix is composed of a variety of proteins and polysaccharides 
that are secreted by the cells within the matrix and assembled by these cells into 
an organized meshwork.
There are two main types of ECM molecules: first, polysaccharide chains of 
glycosaminoglycans and proteoglycans and second, fibrous proteins such as 
collagen, elastin, fibronectin and laminin. The proteoglycan molecules form a 
hydrated gel-like base in which the fibrous proteins are embedded. The gel 
resists compressive forces on the matrix and allows rapid diffusion of nutrients, 
metabolites and hormones between blood and cells. The collagen fibres 
strengthen and help organize the matrix and rubber-like elastin fibres give it 
resilience. Most of the matrix proteins help cell attachment. Thus the ECM 
functions as a scaffold for cells, provides a substrate for cell anchorage, guides 
cell migration and contributes to the mechanical strength of the tissues 
(reviewed in Katz et al., 2000). Figure 1.5 shows a schematic diagram of 
connective tissue underlying an epithelium, containing a variety of matrix 
molecules which are secreted mainly by fibroblasts within the tissue. In addition
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Figure 1.5: Connective tissue underlying an epithelium. Fibroblasts in 
the connective tissue secrete the extracellular matrix consisting of 
collagen fibres, elastic fibres and proteoglycans. (Figure taken from 
Alberts et al., 2001, Molecular Biology of the Cell, 4th ed., page 972).
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to these scaffolding functions, the ECM is also responsible for transmitting 
environmental signals to cells, thus controlling fundamental cellular processes 
such as cell proliferation, differentiation and survival. Altering the matrix 
composition can lead to certain pathological diseases such as restinosis and 
artherosclerosis (Gumbiner, 1996).
1.2.1. Collagens
Collagens are a family of fibrous proteins known to be one of the most abundant 
proteins in vetebrates and the major proteins of the ECM. Around 27 different 
collagen types have been discovered (Boot-Handford et al., 2003). These 
include the fibrillar collagens (for example types I, II, III, V, XI and XXVII), which 
are found in abundance in connective tissue like tendon, skin, bone and blood 
vessel walls, where they provide tensile strength (reviewed in van der Rest and 
Garrone, 1991). Collagen types IX, XII, XIV, XVI and XIX are fibril-associated 
collagens as they decorate the surface of collagen fibrils and link the fibrils to 
one another and to other ECM components. Type IV, VIII and X are non-fibrillar, 
network-forming collagens. Type IV collagens, found in basal laminae, form a 
meshwork, while type VII collagens form dimers which assemble into anchoring 
fibrils. There are also collagens that form beaded filaments (type VI), and 
collagens with a TM domain (types XIII and XVII) (reviewed in Prockop and 
Kivirikko, 1995).
Mutations in collagen genes cause a variety of human diseases (reviewed in 
Myllyharju and Kivirikko, 2001). For example, mutations in type I collagen genes 
cause bone defects such as osteogenesis imperfecta and osteoporosis. 
Mutations in the gene for type II collagen can produce cartilage disorders such 
as chondrodysplasias and certain forms of osteoarthritis. The renal disease 
called Alport syndrome results from mutations in type IV collagen. Epidermolysis 
bullosa, a disease characterised by severe blistering and scarring of the skin, is 
thought to be caused by mutations in type VII collagen, which form anchoring
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fibrils for basement membranes. Transgenic mice with mutated collagen genes 
have proved useful for defining the functions of various collagens and studying 
collagen-related diseases (reviewed in Myllyharju and Kivirikko, 2001).
Structurally all collagens are long, stiff triple-helices made up of three 
polypeptides chains (a-chains) which are wound around each other to form a 
triple-helix (reviewed in Brodsky and Ramshaw, 1997). An a-chain consists of 
Gly-X-Y triple repeats, in which X and Y are often proline and hydroxyproline, 
respectively. Collagens are synthesised as precursor pro-a-chains, which 
contain short amino acid sequences at the N- and C-terminal ends called pro­
peptides. In the ER lumen, selected prolines and lysines get hydroxylated to 
form hydroxyproline and hydroxylysine, at the same time some hydroxylysines 
are glycosylated. Each pro-a-chain gets H-bonded to two other a-chains to form 
a triple-stranded, helical molecule called pro-collagen. The soluble pro-collagen 
molecules are secreted and further processed by cleavage of the N- and C- 
terminal pro-peptides by specific proteinases. The monomers self-assemble 
spontaneously to form large collagen fibrils (10-300 nm in diameter). Formation 
of covalent cross-links between lysine residues of collagen molecules greatly 
enhances the strength of the collagen fibrils. Collagen fibrils then aggregate to 
form larger collagen fibres of several micrometers in diameter (reviewed in 
Prockop and Kivirikko, 2001).
The three a-chains are non-identical in type I collagen, unlike those of type II 
and type III. A type I molecule consists of two identical al- and one a2-chain. 
Each a-chain has, at both ends, a short sequence of residues in which glycine 
no longer occupies every third position. These ends, called ‘telopeptides’, adopt 
less regular conformations. The presence of glycine at every third position 
enables close packing of the a-chains. The abundance of the imino acids, 
proline and hydroxyproline, allows for hydrogen bonding between the three a- 
chains and stabilizes helix-helix interactions, thus enabling the formation of a
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right-handed super-helix. Clusters of charged residues, which are important for 
triple-helix self-association and ligand binding, are interrupted with imino-rich 
regions. Molecular modelling of collagen containing adjacent charged residues 
Glu and Arg, suggest that the side-chains of these charged residues can be 
involved in the formation of intra-chain and intra-helix ion pairs (Katz and David, 
1990; Katz and David, 1992). Details on the molecular structure of collagen 
have been discovered by X-ray crystallography of different collagen peptides 
(Bella etal., 1994; Kramer et al., 1998; Kramer etal., 1999).
Fibrillar collagens are the most abundant matrix component (Kucharz, 1992). 
The triple-helical domain of fibrillar collagens are around 300 nm long, and each 
of the three collagen a-chains consists of approximately 1000 amino acids. The 
structure of a triple-helical collagen monomer and a schematic representation of 
the assembly of monomers to form a collagen fibril are shown in Figure 1.6 (a). 
Electron microscopy images of collagen fibers reveal a regular, transverse 
banding of the long fibrils (shown in Figure 1.6, b). This banding is pattern 
results when adjacent, parallel triple-helical monomers are staggered axially by 
67 nm (or 244 amino acids), thus forming a 67 nm wide repeat structure known 
as the ‘D period’ (Kadler et al., 1996).
1.3. Collagen Receptors
In addition to providing mechanical strength for the ECM and structural support 
in tissues, collagens act as an adhesive substrate for cell attachment and 
migration. They also mediate signalling events by binding to cell surface 
receptors such as integrins. Apart from the a1 p1, a2p1, a10p1, a 1 1 p1 and aVp3 
integrins, other collagen receptors identified are the proteoglycans (Clemetson 
et al., 1999) and syndecans (San Antonio et al., 1994), the discoidin domain 
receptors DDR1 and DDR2 (Shrivastava et al., 1997; Vogel et al., 1997), 
glycoprotein VI (Clemetson et al., 1999) and Endo 180 (East et al., 2003).
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Figure 1.6: Collagen structure and assembly, (a, upper panel) Triple­
helical structure of a collagen monomer. The proline and hydroxyproline 
rings are oriented away from the axis of the helix (black arrows), and 
glycine occupies the axial core of the triple-helix, (a, lower panel) 
Schematic representation of the self-assembly of collagen monomers, in 
a quarter staggered array, to form the collagen fibril, (b) Transmission 
electron micrograph of large collagen fibres which are formed by 
collagen fibrils. (Figure taken from Siljander and Farndale, 2002).
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1.3.1. Integrins
Integrins mainly function as cell-matrix adhesion receptors (as well as cell-cell 
adhesion molecules in blood cells) and bind to a variety of ECM proteins such 
as collagen, fibronectin and laminin. In addition, integrins activate intracellular 
signalling pathways which relay information about the ECM to the cell (Hynes,
1992). Integrins bind ligand at low affinity and are present at ten to hundred fold 
higher concentration on the cell surface, compared to cell surface receptors for 
soluble signal molecules.
Integrins are heterodimers composed of two TM glycoprotein subunits, a and p. 
All integrins contain an extracellular globular head approximately 70 A in 
diameter, consisting of the N-terminal regions of both a- and (3-chains, 
connected via a long rigid stalk (approximately 100 A long) to a pair of 
membrane-spanning helices and short C-terminal cytoplasmic tails (Erb et al., 
1997). The recently determined crystal structure of the ECD of integrin av(33, 
revealed a ‘bent’ conformation of the ECD, in the absence of ligand (Xiong et al., 
2001; Xiong et al., 2002). Integrin activation leads to the straightening of the 
integrin ECD (Kim et al., 2003). Both a- and p-subunits contain divalent cation 
binding sites. It has been shown that ligand binding is dependent on the 
presence of extracellular divalent cations, calcium or magnesium and the type of 
divalent cation can influence the affinity and the specificity of ligand binding 
(Tuckwell et al., 1995; Dickeson et al., 1997). Different types of integrins bind 
different ligands and multiple integrins can recognise a single type of ECM 
protein. In mammals, 24 distinct integrins can be formed by a combination of 8 
types of a-subunits and 18 types of p-subunits and further diversity is introduced 
by alternative splicing of mRNA (Humphries, 2000).
By binding to matrix proteins outside the cell and the cytoskeleton inside the cell, 
integrins link the cells to the ECM. This cell-matrix interaction allows the cells to 
grip the matrix. Interaction with the actin cytoskeleton occurs via other
30
Chapter 1
intracellular proteins such as talin, a-actinin, filamin and vinculin (Zamir and 
Geiger, 2001). Upon ligand binding, the cytoplasmic tail of the a-subunit 
interacts with these proteins which link to actin filaments. This leads to clustering 
of the integrins and formation of focal adhesions. If the cytoplasmic tail of the a- 
subunit is deleted, ligand binding still occurs but cell adhesion is greatly 
reduced, and clustering at focal adhesions does not occur. This indicates that 
integrins must link to the cytoskeleton in order to bind cells to the matrix. This 
cytoskeleton-integrin attachment may help cluster the integrins, thus resulting in 
a stronger bond or alternatively, lock the integrin in a conformation which allows 
it to bind its ligand more tightly (Calderwood et al., 2000). Integrins also function 
as signal transducers, activating intracellular signalling pathways by recruiting 
cytoplasmic tyrosine kinases and adaptor proteins to focal adhesions (Schwartz, 
2001). Integrins and conventional signalling receptors often co-operate to 
promote cell growth, survival and differentiation. Signalling via integrins relies on 
focal adhesion kinase (FAK), a cytoplasmic, tyrosine phosphorylated kinase 
found abundantly in focal adhesions. Upon integrin clustering FAK is recruited to 
focal adhesions by intracellular anchor proteins which bind to integrin a-subunit 
(talin) or p-subunit (paxillin). Here cross phosphorylation of FAK occurs which 
enables docking of Src kinases onto phosphorylated tyrosines, leading to 
additional tyrosine phosphorylation of FAK and recruitment of a variety of 
intracellular signalling proteins (Parsons et al., 2000).
Integrins and other cell surface receptors such as G-protein coupled receptors 
(GPCRs) or RTKs act in concert, synergistically activating a multitude of 
signalling pathways which enable cell proliferation, differentiation, cell shape and 
migration. Integrin signalling and signalling via growth factor receptors can 
interact and re-enforce one another (Assoian and Schwartz, 2001). For 
example, signalling via integrins and growth factor receptors act together to 
sustain activation of the Ras-Mitogen Activated Protein Kinase (MAPK) pathway 
long enough to induce cell proliferation. Integrins activate signalling pathways to 
promote cell survival: When cells in culture are attached, due to signalling via
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integrins, these cells can then respond to growth factors. Signalling via growth 
factor receptors then enables cell growth and proliferation. Also, signalling 
pathways activated by conventional receptors increase the expression of 
integrins or ECM molecules, while signalling by integrins can increase the 
expression of growth factor receptors or ligands (Giancotti and Ruoslahti, 1999; 
Miranti and Brugge, 2002).
Signals generated inside the cell can either enhance or inhibit the ability of 
integrins to bind ligand, known as ‘inside out signalling’. Regulation of integrin 
activity by the cells is important in leukocytes and platelets where integrins are 
required to be activated before being able to mediate adhesion (Harris et al., 
2000; Plow et al., 2000). The major platelet integrin, allbp3, is usually present in 
the inactive OFF state on the cell surface. Upon platelet activation the integrins 
are activated by signals from within the cell, leading to a conformational change 
in the ECD. The integrins can then bind fibrinogen, von Willebrand factor and 
fibronectin, thus adhering strongly to the walls of blood vessels. Cross-linking of 
integrins to fibrinogen molecules bound to the surface of adjacent platelets, 
induces platelet aggregation. Integrins also intercommunicate with each other, 
thus activating or inhibiting each other. For example collagen signalling through 
another platelet integrin, a2pi, triggers the activation of allb(33 on the platelet 
cell surface (Schwartz and Ginsberg, 2002).
The a1p1 and a2pi integrins are the major integrin collagen receptors; these 
integrins as well as two other p1 integrins, a io p i and a l ip i ,  recognise native, 
triple-helical collagen (reviewed in Heino, 2000). Another integrin collagen 
receptor, avp3, binds gelatine, the denatured form of collagen I (reviewed in 
Hemler, 1999). Integrin-collagen interactions are shown to be involved in many 
important physiological processes including cell adhesion, cell growth and 
differentiation and pathological states such as thrombosis and tumour 
metastasis.
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The integrin a1p1 is abundant on mesenchymal cells (Gardner et al., 1996), 
whilst a2(31 is an important collagen receptor on platelets, where it is required 
for platelet adhesion to collagens present in the vascular subendothelium 
(Siljander and Farndale, 2002). a1p1 and a2|31 have different binding affinities 
to collagen (reviewed in Heino, 2000). For example, a ip i  prefers network- 
forming collagen type IV over collagen type I, whilst a2p1 binds type I collagen 
more strongly than type IV collagen. In addition, the signalling pathways initiated 
by these two receptors are distinct. Activation of a1|31 integrin leads to 
downregulation of collagen I synthesis (Langohlz et al., 1995; Gardner et al.,
1999), and increased cell proliferation by stimulating signalling via the adaptor 
protein She and activation of Ras and extracellular-signal regulated kinase (Erk) 
(Pozzi et al., 1998). In contrast, a2(31 integrin increases type I collagen and 
matrix metalloproteinase (MMP) synthesis (Langholz et al., 1995) via p38 kinase 
signalling (Ravanti etal., 1999).
Early studies carried out to identify the integrin binding sites on collagen, 
involving the fragmentation of collagen I, resulted in the identification of several 
integrin a2(31 sites on the collagen molecule (Morton et al., 1994). 
Subsequently, based on the above findings, overlapping triple-helical collagen 
peptides were made and studied, resulting in the identification of a 15 residue 
triple-helical sequence of the collagen I a1(l)-chain (Knight et al., 1998). 
Experiments carried out by the same group then showed that the a2(31 as well 
as the a1|31 recognition site lies within just 6 residues, GFOGER, of this 15 
residue sequence (Knight et al., 2000). Since the above study, additional 
recognition motifs within collagen I a1-chain have been found with the motif 
Gxx’GER, such as GLOGER and GASGER (Xu et al., 2000). Recently, a 
peptide of collagen III containing the motif GMOGER, was shown to bind with 
moderate affinity to (31 integrins (Siljander et al., 2004). Following this study, a 
larger scale investigation sought to locate novel integrin a2|31 binding motifs in 
collagen III (Raynal et al., 2005). Using a set of synthetic peptides covering the
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whole triple-helical domain of collagen III, the investigators found that wild-type 
integrin a201 bound with high affinity to two motifs, GROGER and GLOGEN, 
and with intermediate affinity to a third motif, GLKGEN.
Nine integrin a-subunits contain a ~200 amino acid insert called the I (or A)- 
domain (Humphries, 2000). Integrins a1(31, a2p1, a io p i and a l i p i  interact 
with collagen via the l-domain of the a-subunit, as shown by studies using 
recombinant l-domains which exhibit ligand binding properties of intact integrin 
(Kamata and Takada, 1994; Tuckwell et al., 1995). The a-subunit contains a p- 
propeller structure into which the l-domain is inserted, between blades two and 
three. The l-domain contains a divalent cation binding site called MIDAS, for 
Metal Ion Dependant Adhesion Site (Lee et al., 1995). Mutagenesis studies 
have shown that the MIDAS motif plus surface side-chains are required for 
ligand binding (Kern et al., 1994; Kamata et al., 1999). Several studies have 
reported a conformational change of the integrin l-domain upon ligand binding 
(Lee etal., 1995; Qu and Leahy, 1995).
More detailed evidence comes from the crystal structure of the l-domain of a2  
with bound triple-helical collagen peptide GFOGER (Emsley et al., 2000). The 
crystal structure shows that three loops on the upper surface of the l-domain 
that co-ordinate the metal ion are also involved in binding to the collagen, with 
the collagen glutamate residue in turn completing the co-ordination of the metal 
ion (Figure 1.7). Upon comparison with the unliganded l-domain structure 
(Emsley et al., 1997) a model for allosteric activation of integrins was proposed, 
where ligand binding to the l-domain induces a conformational change within the 
l-domain, and this conformational change is propagated to the other parts of the 
integrin molecule. Recently the crystal structure of the isolated a2p1-binding 
collagen peptide (IBP) was solved (Emsley et al., 2004), enabling comparison of 
the GFOGER hexapeptide containing IBP in bound and unbound state. A direct, 
water mediated interaction between a Glu and Arg residue between two 
collagen strands is observed in the unbound sate; this interaction is disrupted in
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Figure 1.7: Structure of the integrin a2-l-domain:collagen complex, (a) 
Stereo diagram of the a2-l-domain in complex with the collagen peptide. 
The l-domain helices are shown as cylinders, /?-strands as arrows. The 
three strands of the collagen triple-helix are shown in green (leading 
strand), yellow (middle strand) and blue (trailing strand). The residues of 
the motif GFOGER, of both the green and yellow strands, make contacts 
with the l-domain. The blue strand does not make any contacts with the 
l-domain. (b) Stereo diagram of the MIDAS motif of integrin a2-l-domain. 
The glutamate residue (E) from the collagen middle strand co-ordinates 
the metal ion (blue ball). Residues from the three loops (L1, L2, and L3; 
gray ribbons) of the a2-l-domain co-ordinate the metal ion either directly 
or through water molecules (cu). (Both figures taken from Emsley et al., 
2000).
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the bound state. In addition, the region GFOGER is shown to be flexible, which 
could be important for integrin-collagen interaction.
Subsequently, the crystal structure of the entire ECD of the aV(33 integrin was 
obtained without and with bound ligand, an Arg-Gly-Asp (RGD) peptide (Xiong 
et al., 2001; Xiong et al., 2002). In the crystal structure of aV(33 with no ligand 
bound, the integrin molecule is bent over and the bent form is supposed to be 
inactive. The integrin aV[33 does not contain a a-l-domain and the location of the 
ligand binding pocket was found to be at the junction of the (3-propeller and [3-I- 
domain. Activation of integrin occurs by ligand binding or by changes in the 
cytoplasmic domain. A series of conformational changes then leads to the 
straightening of the integrin and the separation of the legs, followed by the 
separation of the TM and cytoplasmic domains (Kim et al., 2003). This results in 
conformational changes within the cytoplasmic domain which allows binding of 
intracellular proteins (see Figure 1.8 for the schematic representation of integrin 
activation).
1.3.2. Endo 180
Endo 180, a member of the mannose receptor family, is a collagen binding cell 
surface receptor expressed in a restricted range of cell types which include 
fibroblasts, macrophages and certain endothelial cells (Isacke et al., 1990; 
Sheikh et al., 2000; Schnack Nielson et al., 2002). Importantly, Endo 180 
expression is upregulated in tumour endothelium and breast cancer cells (St 
Croix et al., 2000; Schnack Nielson et al., 2002). The ECD of this receptor is 
characterized by an N-terminal cysteine rich domain (CRD) followed by a 
fibronectin type II (FNII) domain and 8 C-type lectin-like domains (CTLDs). The 
cytoplasmic tail is short, and contains a dihydrophobic endocytosis motif and 
PKC phosphorylation sites (East et al., 2002). Transglutaminase cross-linking 
studies revealed that Endo 180 forms a tri-molecular complex with urokinase- 
type plasminogen activator (uPA) and its GPI-anchored membrane receptor
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Figure 1.8: Schematic representation of integrin activation. In the bent 
conformation extensive interactions are present between the integrin 
headpiece and tailpiece. In addition, the juxtamembrane C-terminal 
segments of the a- and p-subunit ECDs are in proximity to one another. 
In the extended conformation (right), there is no interaction between the 
a- and p-subunits in the tailpiece. (Figure modified from Kim et al., 
2003).
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(uPAR). Endo 180 acts as a TM adaptor protein for uPAR during chemotaxis by 
linking uPAR with the small G-protein, Rho GTPase activation (Behrendt et al.,
2000).
Cells derived from mice with targeted deletion in Endo 180 gene, which results 
in a mutant protein lacking the CRD, FNII and CTLD1 domains, have a defect in 
collagen binding and internalisation (East etal., 2003, Engelholm et al., 2003). A 
recent study which looked at the ability of hepatic stellate cells to internalise and 
degrade denatured collagens, provided evidence for Endo 180 being the main 
receptor responsible for this process (Mousavi et al., 2005). Further proof comes 
from in vitro studies, tissue immunohistochemistry and cell-based assays which 
show that Endo 180 binds to both native collagens (types V, I, II, IV with 
decreasing affinity) and denatured collagen or gelatin (Wienke et al., 2003). 
Recently it was shown that Endo 180 bind to a defined region of collagen type I 
a-chain, namely the C-terminal glycine repeat and C-prodomain (Thomas et al., 
2005). Sequence analysis of the FNII domains of the mannose receptor family 
predicts that these receptors will bind collagen (East and Isaake, 2002). The 
FNII domain is found in other proteins such as fibronectin and MMP2 and MMP9 
gelatinases, and enables binding of these proteins to denatured collagen or 
gelatin (Steffenson et al., 1999; Pickford et al., 2001). The Endo 180 FNII 
domain shows sequence conservation with these other FNII domains, thus the 
Endo 180 FNII domain is responsible for mediating collagen binding. Binding to 
collagen by Endo 180 most probably involves CTLD1 domain in addition to the 
FNII domain. However Endo 180 contains only one FNII domain, whereas the 
other gelatin/collagen binding receptors contain multiple FNII domains. For 
example in MMP2 all three tandem FNII domains are needed to mediate high 
affinity collagen binding (Banyai et al., 1994). The three-dimensional structure of 
the N-terminal region of Endo 180 was obtained by single particle electron 
microscopy and revealed that the CRD contacts the second CTLD, bringing the 
FNII domain spatially close to the CTLD1 domain (Rivera-Calzada et al., 2003) 
thus indicating that these two domains likely interact to stabilize and enhance
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collagen binding. Also, clustering of Endo 180 in clathrin-coated pits might 
enhance collagen binding (Rivera-Calzada et al., 2003). Further studies would 
need to be carried out in order to prove that CTLD1 is also involved in collagen 
interaction and to gain insight into the FNII-mediated collagen binding.
Endo 180 constitutively recycles between the plasma membrane and the 
endosomal compartments (East et al., 2002). This enables internalisation of 
native and denatured collagens via clathrin-coated vesicles that are delivered to 
lysosomes for degradation, as shown by experiments using cell culture systems 
where expression of Endo 180 results in rapid uptake of gelatin by the cells 
(Wienke et al., 2003). Thus Endo 180 could have a role in extracellular matrix 
remodelling, which occurs during tissue development and homeostasis, by 
facilitating the uptake and degradation of collagens.
It has been shown that native collagen type IV is a principle ligand of Endo 180 
in murine kidney as collagen type IV and soluble Endo 180 protein show co­
localisation in these cells (Kjoller et al., 2004). In normal breast tissue, Endo 180 
is expressed by myoepithelial cells and intra/interlobular fibroblasts that align 
with collagen fibrils, whilst in breast tumour Endo 180 is expressed by cells 
within the remodelled collagen matrix as seen by immunohistochemistry. Thus, 
Endo 180 could play a role in remodelling of the ECM during tumour growth and 
progression (Howard et al., 2004). Endo 180 was identified as a key mediator of 
collagen turnover in mammary carcinogenesis, as genetic ablation of this 
receptor disrupted collagen turnover that is required for tumour progression 
(Curino et al., 2005).
1.3.3. Glycoprotein VI
Glycoprotein VI (GPVI) is an important signalling receptor for collagen that is 
expressed only on platelets (Miura et al., 2000). Studies using collagen and 
collagen related peptide (CRP), which mimics triple-helical collagen, showed
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that collagen acts as a ligand for this receptor. Upon collagen binding and 
activation of GPVI, tyrosine phosphorylation of a number of intracellular proteins 
occurs, leading to platelet activation (Nieswandt and Watson, 2003). It has been 
shown that GPVI binds only to fibrous collagens and not soluble collagens 
(Moroi etal., 1996).
The structure of this receptor was identified by cDNA cloning and revealed that 
GPVI belongs to the immunoglobulin superfamily as the extracellular region of 
this receptor contains two immunoglobulin C2-like domains (Clemetson et al.,
1999). It is thought that GPVI forms a complex with the Fc receptor (FcR) y- 
chain, a TM protein containing an immunoreceptor tyrosine activation motif 
(ITAM) (Gibbins et al., 1996). By site-directed mutagenesis studies, it was 
shown that this interaction occurs via an arginine residue in the GPVI TM 
domain which makes a salt bridge with an aspartic acid residue of FcR y-chain 
(Tsuji et al., 1997). Activation of platelets by collagen induces tyrosine 
phosphorylation of FcR y-chain ITAM motif, followed by assembly of various 
signalling molecules, leading to downstream signalling from GPVI (Poole et al., 
1997; Tsuji et al., 1997; Nieswandt et al., 2000). Associated Src-family tyrosine 
kinases, such as Fyn and Lyn have been suggested to be required for 
phosphorylation of FcRy, upon collagen binding to GPVI (Ezumi et al., 1998; 
Briddon etal., 1999)
It has been suggested that GPVI is present as preformed dimers on the platelet 
surface (Miura et al., 2002; Farndale et al., 2003). Using soluble ECDs of the 
receptor (a monomeric and a dimeric Fc-tagged form) Miura et al. showed that 
the dimeric Fc-tagged form binds fibrous collagen with high affinity, whilst the 
monomeric form does not. However, further studies would be needed to provide 
conclusive evidence for the existence of GPVI dimers on the cell surface. It has 
been shown, using a triple-helical CRP composed of ten repeated G-P-0 
triplets, that GPVI recognizes the sequence G-P-0 (O denotes hydroxyproline) 
within collagen (Kehrel et al., 1998). The hydroxyproline of the G-P-0 sequence
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is thought to be required for GPVI-collagen binding (Perret et al., 2003). A recent 
study using site-directed mutagenesis and blocking phage antibody, identifies 
the collagen binding region on GPVI to be at the apex of the junction between 
the two Ig-like domains (Smethurst et al., 2004).
1.4. Discoidin Domain Receptors
The Discoidin Domain Receptors (DDRs) are a novel subfamily of RTKs. Two 
members of this family exist, DDR1 {previously known as DDR (Johnson et al.,
1993), trkE (Di Marco et al., 1993), NEP (Zerlin et al., 1993), RTK6 (Laval et al., 
1994, Cak (Perez et al., 1994), Ptk-3 (Sanchez et al., 1994), MCK10 (Alves et 
al., 1995), EDDR1 (Shelling etal., 1995), and NTRK4 (Valent etal., 1996)} and 
DDR2 {also known as TKT (Karn et al., 1993), Tyro 10 (Lai and Lemke, 1994) 
CCK-2 (Alves et al., 1995)}. The DDRs were named as such due to the 
presence of a motif in the ECD, which is homologous to the Dictyostelium 
discoideum protein, discoidin 1 (Vogel etal., 1997).
Most RTKs bind soluble protein present in blood or other body fluids. DDR1 and 
DDR2 are an unusual class of RTKs, as they bind collagen in the ECM 
(Shrivastava et al., 1997; Vogel et al., 1997). Several different collagens act as 
physiological ligands that activate DDR1 and DDR2. Both are activated by 
fibrillar collagens I, II, III and V (and VIII in the case of DDR1), whereas only 
DDR1 responds to non-fibrillar collagen type IV (Shrivastava et al., 1997; Vogel, 
1999; Hou et al., 2001). Both DDR1 and DDR2 only bind native, triple-helical 
collagen and not collagen which has been heat denatured, nor do they bind to 
gelatine (Vogel et al., 1997). Furthermore, collagen treated with collagenase, 
which disrupts Gly-X-Y repeats, does not activate the DDRs, whereas treatment 
of collagen with pepsin, which digests only at the N- and C-terminal non-helical 
regions, has no effect on DDR activation. It has been suggested that 
carbohydrates bound to the collagen may be involved in DDR-collagen 
recognition and activation as periodate treatment of collagen, which results in
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partial deglycosylation of collagens, prevented full activation of DDR2 (Vogel et 
al., 1997). It has been demonstrated by using recombinant DDR ECDs that DDR 
binding to collagens is direct, occurs with high affinity and does not require a co­
receptor or accessory proteins (Leitinger, 2003). The kinetics of DDR activation 
by collagen is very slow, differing from the kinetics of growth factor activation of 
most RTKs. For example EGF and PDGF stimulate receptor activation within 
seconds, whereas DDR tyrosine phosphorylation is detected only after 30-60 
minutes of collagen stimulation and the phosphorylation is sustained for up to 18 
hours (Shrivastava et al., 1997; Vogel et al., 1997). The reason for such slow 
kinetics is unclear, however in a study which sought to look at the effect of 
adhesion on DDR1 activation, it was found that cells in suspension were able to 
activate DDR1 rapidly, when compared with adherent cells (L’hote et al, 2002). 
The authors proposed that in adherent cells, there may be a phosphatase which 
inhibits DDR1. Another possibility is that DDR1 may be involved in cell adhesion 
itself or bound to an inhibitory matrix protein and therefore not easily accessible 
to collagen in adherent cells. Further research is needed to prove these 
hypotheses and find the mechanism for slow phosphorylation kinetics of the 
DDRs.
1.4.1. DDR Structure
Both DDR1 and DDR2 contain an N-terminal ECD which contains a discoidin 
homology domain (DS) domain of about 150 amino acids. This domain is 
homologous to the discoidin 1 protein of Dictyostelium discoideum, which 
functions as a sugar-binding lectin (Springer etal., 1984). Mammalian examples 
of DS domain containing proteins are secreted proteins such as the blood 
coagulation factors V and VIII (reviewed in Baumgartner et al., 1998); and 
membrane-bound proteins such as neurexins, neuropillins (Lee et al., 2003) trkA 
receptor; and the matrix-binding proteins Del-1 and aortic carboxypeptidase-like 
protein (reviewed in Baumgartner etal., 1998; Vogel, 1999).
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In the DDRs, the DS domain is followed by a region of about 220 amino acids 
with no known sequence homology, which most likely folds into a domain 
(named domain X in this report), as suggested by findings with ECD constructs 
of varying lengths (E.Hohenester - personal communications). It was found that 
a construct containing the DS domain on its own is a monomer, while further 
constructs extending the DS domain by a stepwise addition of 20 amino acids 
did not express until a construct consisting of the DS domain and the following 
170 amino acids (up to Asp 354), showed expression and dimerisation. It is 
most likely, therefore, that the region after the DS domain folds into a domain 
and is not unstructured. In DDR1, a largely hydrophilic region rich in proline and 
glycine (P/G) residues follows the domain X. The TM domain region ensues, 
consisting of a single a helix of 23 amino acids. The amino acid sequence of the 
TM domain is greatly similar between DDR1 and DDR2. The TM domain is 
followed by a cytoplasmic juxtamembrane region, which is unusually long in both 
DDRs compared with other RTKs (176 and 147 amino acids in DDR1 and 
DDR2, respectively) and a C-terminal catalytic tyrosine KD, which is highly 
conserved among all RTKs studied so far and 45% homologous to the KD of 
NGF receptor, TrkA (Foehr et al., 2000). In addition, the G-X-G-X-X-G 
‘signature’ sequence, found in N-terminal region of most other RTK KDs, is 
displaced by 12 residues in the DDRs relative to other RTKs (Foehr et al.,
2000). Figure 1.9 shows a schematic diagram of DDR1 and DDR2 domain 
organisation.
DDR1 consists of three active isoforms a, b and c, as a result of alternative 
splicing in the cytoplasmic region (Alves et al., 2001). Compared to DDR1a, 
DDR1b has an insertion of 37 amino acids in the juxtamembrane region 
encoded by exon 11. DDR1c contains six additional amino acids inserted at the 
start of the KD. In addition, two kinase deficient DDR1 isoforms, DDR1d and 
DDR1e were identified (Alves et al., 2001). DDR1d protein lacks the KD domain 
altogether, while DDR1e has a deletion of exons 10a, 11, and 12 plus an altered
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DDR1 DDR2
Juxtamembrane
Figure 1.9: Schematic diagram of DDR1 and DDR2 domain 
architecture. Both DDR1 and DDR2 contain an N-terminal discoidin (DS) 
domain, followed by a region with no known homology or domain X, a 
transmembrane (TM) domain, a cytosolic juxtamembrane region and a 
C-terminal tyrosine KD. DDR1 contains a proline and glycine (P/G) rich 
region between the domain X and TM domain which is not present in 
DDR2.
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sequence in the juxtamembrane region, rendering it kinase dead. So far, only 
one isoform of DDR2 has been identified.
The N-terminal ectodomain of DDR1 undergoes limited proteolysis (-10%) upon 
tyrosine phosphorylation, which is shown by the appearance of a membrane 
anchored, tyrosine phosphorylated C-terminal fragment of 62 kDa (Alves et al., 
1995; Vogel, 2002). The particular protease or sheddase involved was 
suggested to belong to the membrane-bound metalloproteinase or disintegrin 
and metalloproteinase family of proteases (Vogel, 2002). Recently, Slack et al., 
found that DDR1 ectodomain shedding by collagen type I is dependent on the 
concentration of collagen and length of collagen stimulation as well as Src 
tyrosine kinase activity (Slack et al., 2006).
1.4.2. DDR Physiological Functions
Both DDRs are expressed widely in most human adult tissue and during 
development, but DDR1 and DDR2 are expressed in different cell types. DDR1 
is found mainly in epithelial cells (particularly in the skin epithelium, kidney, lung, 
gastrointestinal tract and brain), corneal and dermal fibroblasts, and leukocytes 
(Alves et al., 1995; Chin et al., 2001; Kamohara et al., 2001; Mohan et al., 2001; 
Sakamoto et al., 2001). DDR2 is expressed in mesenchymal cells such as 
skeletal muscle, heart, blood vessels and connective tissues (Vogel, 1999). In 
addition, DDR1 mRNA is upregulated in several human malignant tumours 
originating in the breast (Barker et al., 1995; Perez et al., 1996), ovaries (Laval 
et al., 1994), eosophagous (Nemoto et al., 1997), pediatric brain (Weiner et al., 
1996; Weiner et al., 2000). It has been found that DDR2 protein is present in 
stromal cells surrounding highly invasive, DDR1 positive tumours (Alves et al., 
1995).
The physiological functions of the DDRs are being discovered, but it is now clear 
that these receptors play an important role in cell adhesion, cell migration and
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motility, cell differentiation, proliferation, and matrix remodelling. Female DDR1 
knockout mice (DDR1-/-) were viable, but significantly smaller than control mice 
(Vogel et al., 2002). Figure 1.10 (a) shows X-rays of 10-week-old DDR1 
heterozygous (DDR1+/-) and DDR1-/- mice. Importantly, DDR1-/- contained 
severe mammary gland development defects and impaired blastocyst 
implantation. DDR1-/- mice were unable to lactate due to aberrant mammary 
gland ductal morphogenesis (Vogel etal., 2001). Most significantly, mice lacking 
the primary mammary collagen receptor, a2pi integrins, showed decreased 
branching morphogenesis but no lactational defect (Chen et al., 2002) -  
therefore a more severe mammary gland defect is seen in DDR1-/- mice when 
compared with integrin a2(31-/- mice. Insight into the role of DDR1 in mammary 
gland function and lactogenesis (Faraci-Orf et al., 2006), showed that DDR1 
signalling is essential to maintain Stat5 activation, a downstream signal 
transducer of the prolactin pathway, the signalling pathway which is required for 
the transcription of milk proteins. DDR2 deficient mice (DDR2-/-) exhibit 
dwarfism and shortening of long bones, due to reduced chondrocyte proliferation 
(Labrador et al., 2001). Figure 1.10 (b) compares images of Alizarin red-stained 
tibia and humerus bones from DDR2-/- and WT DDR2 mice.
The DDRs are associated with a variety of human diseases. Both DDRs are 
linked with different types of cancers (Laval et al., 1994; Barker et al., 1995 
Nemoto et al., 1997; Perez et al., 1996; Weiner et al., 1996; Weiner et al., 2000; 
Heinzelmann-Schwarz et al., 2004; Dejmek et al., 2005; Ram et al., 2005; Wall 
et al., 2005). The DDRs are suggested to play a role in artherosclerosis (Ferri et 
al., 2004) and osteoarthritis (Xu et al., 2004). The DDRs are implicated in fibrotic 
diseases of the liver (Olaso et al., 2001; Olaso et al., 2002) and lung 
(Matsuyama et al., 2005; Matsuyama et al., 2006a; Matsuyama et al., 2006b). 
The roles played by the DDRs in these diseases will be described in more detail.
Recently, DDR1a was shown to be involved in glioblastoma multiforme, a 
malignant astrocytic glioma (Ram etal., 2005). Both DDR1a and DDR1b protein
46
Chapter 1
+ /+  • / •  + / +  -A
Tibia Humerus
Figure 1.10: DDR1 and DDR2 null mice, (a) X-rays of 10-week-old 
heterozygous DDR1+/- (i) and DDR1-/- (ii) female mice. (Image taken 
from Vogel et al., 2001). DDR1 null mice are viable, although on 
average, had a 35% lower body weight than heterozygous mice, (b) 
Alizarin red-stained bones from DDR2 wild-type (+/+) and homozygous 
mutant (-/-) mice. DDR2-/- mice show shortening of long bones 
compared with DDR2 wild-type mice. Scale bar=2 mm. (Image taken 
from Labrador et al., 2001).
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was found to be over-expressed in glioma tissue, and resulted in increased 
adherence to collagen I coated plates. DDR1a over-expression in glioma cells 
displayed enhanced invasion and migration and stimulated activation of MMP2, 
implicating that DDR1a regulates invasion and adhesion of glioma cells by 
activating MMP2. It has been suggested that DDR2 could regulate tumour 
formation (Wall et a/., 2005). The study which sought to explore the mechanism 
by which fibrillar collagen could inhibit proliferation of tumour cells, independent 
of cytoskeletal organization and cell spreading, found that DDR2 induced 
signalling was a central mediator of fibrillar collagen induced tumour cell cycle 
arrest (Wall et a/., 2005).
DDR1 has been implicated in mesangial cell proliferation and adhesion (Curat 
and Vogel, 2002). In this study, primary mesangial cells, obtained from the 
kidney from DDR1-/- mice, showed enhanced proliferation and adhesion 
compared with WT cells. A more recent study sought to examine the function of 
DDR1 in HGF-induced branching tubulogenesis in collagen gel culture system 
(Wang et al., 2005). Using stably transfected MDCK cells over-expressing WT 
DDR1 or a dominant negative DDR1 mutant, it was shown that either over­
expressing WT DDR1 or disruption of DDR1 function by dominant negative 
DDR1 was inhibitory for branching tubulogenesis. Further experiments by these 
investigators suggested that DDR1 regulates branching tubulogenesis by 
modulating cell survival, proliferation and migration. DDR1 has also been shown 
to be required for arterial wound repair as primary vascular smooth muscle cells 
isolated from DDR1-/- mice showed decreased proliferation, collagen 
attachment, and migration in vitro (Hou et al., 2001; Hou et al., 2002). In 
addition, DDR1 signalling is essential for cerebellar granule differentiation (Bhatt 
et a/., 2000).
DDR1 upregulation has been detected in human leukocytes (such as 
neutrophils, monocytes and lymphocytes) in vitro, and it was shown that DDR1 
was responsible for leukocyte activaton, including adhesion, migration
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differentiation and cytokine/chemokine production (Yamashiro et al., 2001; 
Kamohara et al., 2001). The DDR1a isoform promotes migration of leukocytes in 
three dimensional (3D) collagen (Kamohara et al., 2001). Using the human 
monocytic leukaemia cell line, THP-1, overexpressing DDR1a or DDR1b, the 
investigators showed that the DDR1a isoform specifically enhanced migration in 
cell culture inserts and 3D collagen lattices, whilst DDR1b had no effect. 
Collagen activation of DDR1b, but not DDR1a, facilitated the differentiation of 
THP-1 cells and human monocyte derived primary macrophages (Matsuyama et 
al., 2003b). Activation of the DDR1b isoform has also been shown to promote 
differentiation of monocyte derived dendritic cells (Matsuyama et al., 2003a). In 
this study, the activation of DDR1b isoform in combination with other dendritic 
cell maturation signals, resulted in the expression of cell surface molecules 
characteristic of mature dendritic cells. Recently, DDR1b activation was shown 
to be responsible for the production of cytokines and chemokines by 
macrophages (Matsuyama et al., 2004). Using cDNA array analysis and Nothern 
blotting, the investigators showed that in the presence of collagen, a THP-1 cell 
line over-expressing DDR1b had significant upregulation of cytokine/chemokine 
mRNA compared with mock transfected cells.
The role of DDR1 in idiopathic pulmonary fibrosis (IPF), a chronic lung 
disorder,has been recently described (Matsuyam et al., 2005; Matsuyama et al., 
2006a; Matsuyama etal., 2006b). DDR1b expression was shown to be higher in 
bronchoalveolar lavage fluid (BALF) cells from IPF patients, compared with 
control samples. In addition, DDR1 activation in BALF cells from IPF patients 
induced chemokine production and MMP-9 expression, implicating DDR1 
involvement in the pathogenesis of IPF (Matsuyama et al., 2005). DDR1b was 
shown to contribute to the survival of lung fibroblast in IPF (Matsuyama et al., 
2006a). Using primary fibroblasts obtained from IPF and non-IPF patients, 
DDR1b expression was examined and found to be significantly higher in 
fibroblasts from IPF patients. In addition, DDR1 activation in IPF fibroblasts 
inhibited Fas ligand-induced apoptosis. Furthermore, a role for DDR1 in
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attenuating lung inflammation was demonstrated using RNA interference and a 
bleomycin-induced pulmonary fibrosis mouse model (Matsuyama et al., 2006b). 
Suppression of DDR1 expression in vivo reduced infiltration of inflammatory 
cells, inflammatory cell counts, certain cytokine concentrations and TGF(3 up- 
regulation in bronchoalveolar lavage fluid as well as reduction of collagen 
deposition in the lung.
DDR2 is involved in the regulation of cell proliferation of chondrocytes, hepatic 
stellar cells and fibroblasts (Labrador et al., 2001; Olaso et al., 2001; Olaso et 
al., 2002). During liver injury, DDR2 expression and signalling is induced in 
hepatic stellate cells, promoting proliferation and invasion of these cells by 
inducing the expression of MMP2, a collagenase which degrades the ECM by 
breaking down mainly collagen type IV (Olaso et al., 2001). In addition, DDR2 
plays an important role in wound healing, as revealed by delayed wound healing 
in DDR2-/- (Olaso et al., 2002). The investigators demonstrated that activation of 
DDR2 in wound fibroblasts during wound healing induced enhanced expression 
of MMP2, which in turn results in enhanced migration of these cells. In addition, 
the activation of DDR2 increases the expression of MMP1 suggesting a role for 
DDR2 in collagen-matrix recognition and remodelling (Vogel et al., 1997). 
Increased expression of DDR2 in knee cartilage of mice which developed 
osteoarthritis as a result of a heterozygous mutation in type XI collagen, 
correlated with elevated expression of MMP13 (Xu et al., 2004). Further 
experiments using cultured chondrocytes, suggested that collagen II mediated 
DDR2 activation was responsible for MMP13 expression, thereby contributing to 
cartilage damage in osteoarthritis.
Both DDRs are upregulated in smooth muscle cells in lesions of atherosclerosis
(
and lymphangioleiomyomatosis (LAM), obstructive diseases of blood vessels 
and lung, respectively (Ferri eta!., 2004). Furthermore, it was demonstrated that 
the DDR signalling in cultured human smooth muscle cells down regulates 
collagen I production and induces collagen degradation though the activation of
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MMP1 and MMP2. Both MMP levels were increased in LAM nodules, and taken 
together with the above data, the investigators suggested that collagen- 
mediated activation of the DDRs plays a role in smooth muscle cell-mediated 
collagen remodelling in lesions of artherosclerosis and LAM.
1.4.3. DDR Signalling
Little is known about the signalling pathways activated by the DDRs in response 
to collagens. The 37 amino acid insertion found in the juxtamembrane of 
DDR1b, contains the LXNPXY motif, which is required for the binding of the PTB 
domain of the adaptor protein She. It has been shown that tyrosine 
phosphorylation and activation of DDR1b recruits She (Vogel et al., 1997; Foehr 
et al., 2000; Vogel et al., 2000). Using chimaeric receptors containing the 
DDR1a juxtamembrane domain, Foehr et al. also show that FGF receptor 
substrate 2 (FRS-2) binds to the juxtamembrane region of DDR1a in vivo (Foehr 
et al., 2000). Activation of DDR2 also results in association with She; this 
interaction is thought to be mediated by Src tyrosine kinase (Ikeda et al., 2002). 
Recently, Yang et al. demonstrated that Src phosphorylates Tyr 740 in the 
activation loop of DDR2 KD, which in turn stimulates intramolecular 
autophosphorylation, leading to phosphotyrosine formation in the DDR2 
cytosolic domain and formation of She signalling complexes at the DDR2 
cytosolic domain (Yang et al., 2005).
It has was shown that DDR1b transcription and activation is induced by the p53 
tumour suppressor gene in response to DNA damage (Ongusaha et al., 2003). 
In HEK293T cells transfected with DDR1b, activation of DDR1b induces 
activation of the classical Ras/raf/MAPK pathway, therefore promoting cell 
survival. However, the Ras/MAPK pathway was not found to be activated by 
DDR1 in another study (Vogel et al., 2000). Data from this study suggested that 
there is no activation of MAPK, ERK1 or ERK2 in the human mammary tumour 
cell line T47D endogenously expressing DDR1 b.
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In addition, there is evidence for DDR1 activation of the p38 MAPK signalling 
pathway in leukocytes (Matsuyama et al., 2003a; Matsuyama et al., 2004).This 
signalling pathway was thought to be the underlying mechanism for the 
differentiation of macrophages (Matsuyama et al., 2003a) and up-regulation of 
chemokine production by these cells (Matsuyama etal., 2004). The investigators 
tested the involvement of TNF receptor-associated factor 6 (TRAF6), TGF-p- 
activated protein kinase 1-binding protein 1 (TAB1) as a mechanism to activate 
p38 MAPK in differentiated THP-1 cells. They found that activation of DDR1 b 
with collagen induced formation of a protein complex consisting of the above 
three components, followed by autophsophorylation of p38aMAPK; indicating 
the TRAF6/TAB1p/p38a cascade in DDR1b signalling. Mutational analysis and 
co-immunoprecipitation of She with phosphorylated DDR1b in differentiated 
THP-1 cells showed that She was recruited to activated DDR1b in 
macrophages. In addition, the activation of DDR1b in macrophages was shown 
to activate nuclear factor-icB (NF-kB) (Matsuyama et al., 2004). Recruitment of 
She and TRAF6 were shown to be important for signalling leading to activation 
of NF-kB. Using RNA interference, the NF-k B activator, Act1, was shown to be 
involved in IkB degradation. A schematic representation of the above described 
DDR1b signalling pathway in differentiated THP-1 cells is shown in Figure 1.11.
The potential interaction of pi integrins with DDR1 has been investigated (Vogel 
et al., 2000). The investigators demonstrated that DDR1 is fully activated in the 
presence of blocking antibodies to the pi integrins. In addition, full DDR1 
activation was detected in cells lacking p1 integrins; therefore pi integrins are 
not essential for DDR1 signalling to occur. There is evidence for the requirement 
of the Wnt5A signalling protein for DDR1 activation, as investigated in HB2 and 
MCF-7 mammary carcinoma cell lines (Jonsson and Andersson, 2001; Dejmek 
et al., 2003). In these cells, the effect of Wnt5A on DDR1 is thought to be 
mediated by the G-protein signalling pathway and suggested to regulate normal
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Figure 1.11: DDR1b signalling in differentiated THP-1 cells. Collagen 
activation of DDR1b induces the recruitment of She and transduces 
signals that lead to the activation of p38 MAPK and NF-kB. TRAF6 is an 
important signalling molecule involved in DDR1b signalling. (Figure 
adapted from Yoshimura et al., 2005).
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mammary cell adhesion. Additionally, Dejmek et al. discovered that Src tyrosine 
kinase activity is required to enable Wnt5a to effect collagen-induced activation 
of DDR1 (Dejmek et al., 2003).
1.4.4. DDR Collagen Binding
Although it was clear that the native triple-helical conformation of collagen is 
needed for DDR activation and the binding epitopes are located in the Gly-X-Y 
repeat region, until recently, the specific region/s of the collagen molecule to 
which DDRs bind to was not known. A study using atomic force microscopy and 
rotary shadowing electron microscopy to map the binding site/s of DDR2 on 
collagen I suggested that a single DDR2 complex binds to a single collagen 
molecule and that there are two sites on the collagen molecule to which DDR2 
shows preferred binding (Agarwal et al., 2002). However, these results were not 
conclusive, as the collagen preparation was heterogenous and lacked polarity.
A recent study by Leitinger et al., which sought to define DDR binding sites on 
collagen II using recombinant collagen II variants, revealed that DDR2 interacts 
specifically with the D2 period of collagen II (Leitinger etal., 2004). The D period 
is a 67 nm wide repeat structure, formed by adjacent collagen monomers 
overlapping each other by 234 amino acids within the collagen fibril. This study 
shows that DDR2 has a single high affinity binding site on collagen II and 
therefore the interaction of DDR2 with collagen has sequence specificity. This is 
in contrast to the integrins, a1p1 and a2p1, which recognise collagen I at 
multiple recognition sites (Morton et al., 1994; Xu et al., 2000), and the platelet 
GPVI receptor which is also expected to have multiple binding sites on the 
collagen triple-helix. As mentioned before, GPVI recognises the sequence G-P- 
O, which occurs with relatively high frequency within collagen I - approximately 
12% of the primary sequence (Kehrel et al., 1998).
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It has been shown that the extracellular N-terminal DS domain is required for 
collagen binding (Curat et al., 2001; Leitinger, 2003). In order to investigate 
whether the DS domain of DDR2 was sufficient for high affinity binding to 
collagen I, soluble ECD fragments of DDR deletion mutants were produced and 
tested for collagen I binding using a solid phase binding assay (Leitinger, 2003). 
An ECD fragment containing the DDR2 DS domain with the domain X missing, 
bound to collagen I with high affinity. In addition, when a DDR2 mutant lacking 
the domain X was expressed on the cell surface and stimulated with collagens, it 
was observed that autophosphorylation of this mutant occurred in a manner 
similar to WT DDR2, demonstrating that the collagen binding site on DDR2 is 
contained within the DS domain.
The DDR DS domain contains four potential surface exposed loops (Leitinger, 
2003). Homologous loop regions found in other DS domains, such as the factor 
V and VIII, are critical for ligand binding (Fuentes-Prior et al., 2002). In a study 
which looked at DDR-collagen binding sites in more detail, the DDR2 DS 
domain loops were replaced with loops from a functionally unrelated DS domain 
(Leitinger, 2003).Three of the four loop chimeras lost the ability to bind collagen 
I, and were not activated upon stimulation with collagen I. Thus three potential 
loops of the DS domain of DDR2 are critical for collagen binding and signalling. 
Subsequently, a very similar study was carried out for DDR1 (Abdulhussein et 
al., 2004). A three-dimensional model of DDR1 DS domain, based on the related 
domains of factor V and VIII was created. Individual amino acids were mutated 
or short sequences were deleted within four neighbouring cell surface exposed 
loops of the DS domain, in context of full-length DDR1. Collagen binding ELSA 
using these loop mutants showed that loops 1 and 3 were required for DDR1- 
collagen recognition.
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1.4.5. Mechanism of DDR Activation
Recent studies using soluble ECDs showed that the DDRs need to be dimerised 
in order to bind ligand (Leitinger, 2003). Chemical cross-linking analysis and gel 
filtration results of soluble N-terminally His-tagged DDR2 ECD showed His- 
DDR2 to exist mainly as a dimer while His-DDR1 forms monomers. Thus there 
is a difference in the DDRs in their ability to dimerise. In contrast to His-DDR2 
which bound collagen I with high affinity, His-DDR1 showed no recognition of 
collagen. DDR1 bound collagen with high affinity only when fused to a 
dimerising Fc tag, indicating that DDR dimerisation is required for collagen 
binding. Another study by Agarwal et al. reported that a DDR2-Fc fusion protein 
needed to be clustered or multimerised by antibodies in order to bind collagen I 
(Agarwal et al., 2002).
DDR1 and DDR2 differ in the contribution of receptor domains needed for 
activation and dimerisation (Leitinger, 2003). DDR1 and DDR2 deletion mutants 
were constructed and studied for their ability to be activated by collagen I. DDR1 
deletion mutants lacking the domain X, both domain X and the P/G rich region, 
or the DS domain, did not show autophosphorylation in response to collagen I. 
In the case of DDR2 deletion mutants, a mutant lacking the DS domain was not 
activated upon collagen stimulation, although a mutant lacking the domain X 
was able to respond to collagen as WT DDR2. Thus, DDR1 needs the entire 
extracellular region whilst DDR2 needs only the DS domain for collagen binding 
and receptor activation. Therefore, despite the close similarity between DDR1 
and DDR2 protein sequence, it appears that the two receptors use different 
mechanisms for receptor dimerisation and/or conformational change 
propagation.
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HYPOTHESIS
As the DDR ECDs bind collagen only when dimerised, we hypothesise that the 
DDRs exist as preformed oligomers on the cell surface, in the absence of ligand. 
In addition, there might be a difference between DDR1 and DDR2 in the 
contribution of receptor domains needed for dimerisation.
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PROJECT AIMS
The overall aim of this project is to investigate the mechanism of activation of 
DDR1 and DDR2. In order to do so, this study looks at two specific areas of 
interest:
1) The above described studies using the ECD of DDRs give insight into the 
oligomerisation state of these receptors; however, the presence of other 
domains such as the TM, cytoplasmic and juxtamembrane domain can influence 
the oligomeric state of DDRs on the cell surface. Therefore, the first aim is to 
investigate the oligomeric state of WT, full-length DDRs on the cell surface in the 
absence of ligand.
2) The second aim is to investigate the DDR domains required for receptor 
oligomerisation.
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Materials and Methods
Chapter 2
2.1. Materials
2.1.1. Chemicals, reagents and buffers
2.1.1.1. Mammalian cell culture and transfection
Human embryonic kidney 293 cells (HEK293 and HEK293 TSA 201 cells: 
obtained from the American tissue culture collection, Manassas, VA.
MCF-7 cells: were obtained from Dr. Maffucci (UCL).
Rat-1 cells: were obtained from Dr. Michel Faure (SUGEN Inc., San 
Francisco, CA).
Dulbecco's modified Eagle's medium/F-12 nutrient mixture, Dulbecco's 
modified Eagle's medium (without sodium pyruvate), Trypsin-EDTA and 
Zeocin (100 mg/ml): Invitrogen, Paisley, UK.
100x P/S (1000 U/ml penicillin and 1000 jug/ml streptomycin in PBS) and 
100x Glutamine (1000 U/ml): Gibco Life Technologies, Paisley, UK.
FuGENE 6: Roche Diagnostics, Indianapolis, IN.
Di-methyl-sulfonylfluoride (DMSO): Sigma-Aldrich Inc., Dorset, UK.
2x HBS: 290 mM NaCI, 50 mM HEPES buffer, 1.5 mM Na2H P 04, pH 7.1. 
ddH20: distilled, autoclaved H20.
2.1.1.2. Receptor assays, mammalian cell lysis, immunoprecipitation 
and carbohydrate analysis
Aprotonin and collagen I (acid-soluble from rat tail, C-7661): Sigma-Aldrich, 
Saint Louis, MO.
Bis(sulfosuccinimidyl) suberate (BS3): Perbio Science,Tattenhall, UK. 
Sulfosuccinimidyl-6-(biotin-amido)-6-hexanoate(Sulfo-NHS-LC-Biotin):Pierce, 
Rockford, Illinois.
Protein A, protein G sepharose beads and streptavidin sepharose beads: 
Amersham Biosciences, Buckinghamshire, UK.
Protease inhibitor cocktail: Roche Diagnostics, Indianapolis, IN. 
Endoglycosidase H (Endo H) and Peptide: N-Glycosidase F (PNGaseF): 
500,000 units/ml, New England Biolabs (Hitchin, UK).
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Endoglycosidase reaction buffer pack: New England Biolabs, Hitchin, UK -  
description of components as follows:
1x G7 reaction buffer (forPNGase F): 50 mM sodium phosphate, pH 7.5.
1x G5 reaction buffer (forEndo H): 50 mM sodium citrate, pH 5.5.
1x glycoprotein denaturing buffer: 0.5% SDS, 1% /?-mercaptoethanol. 
Neuraminidase (1 unit/ml) and O-glycosidase (0.5 units/ml): Roche 
Diagnostics, Indianapolis, IN.
2.1.1.4. SDS-PAGE and Western blotting
Pre-stained protein marker (moleculer weight range: 175, 83, 62, 47.5, 32.5, 
25, 16.5 and 6.5 kDa) and broad range protein marker (molecular weight 
range: 212, 158, 116, 97, 66, 56, 43, 35, 27, 20, 14, 6.5, 2.4 kDa): New 
England Biolabs, Hitchin, UK.
2x SDS sample buffer: 125 mM Tris-HCI (pH 6.8), 4% SDS, 10 % glycerol, 
0.1%, bromophenol blue and 1% p-mercaptoethanol for reduced sample 
buffer.
5x SDS sample buffer: 300 mM Tris-HCI pH 6.8, 10% SDS, 10% glycerol, 
0.1% bromophenol blue and 10% p-mercaptoethanol for reduced sample 
buffer.
30% acrylamide/0.8% bisacrylamide: Amresco, Solon, Ohio. 
Tetraethylmethylenediamine (TEMED): Fluka BioChemika (Buchs,
Switzerland)
Nitrocellulose (NitroBlind, 0.22 micon): Satouris Ltd, Epson, UK.
DE81 DEAE paper: Whatman
SDS running buffer (1X): 25 mM Tris base, 250 mM glycine, 0.1% SDS, pH
8.3.
SDS blotting buffer (1X): 25 mM Tris base, 192 mM glycine, 20% methanol, 
0.01% SDS, pH 7.5.
PBS (1x): 1.4 M NaCI, 0.018 M KH2P 0 4, 0.027 M KCI, 0.08 M Na2H P 04
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Tween 20, ponceau-S solution (0.1% ponceau-S, 1% acetic acid), SDS 
(electrophoresis-grade), Triton X-100, fi-mercaptoethanol, CaCI2, N ad , 
Na2HP04, NaH2P04, methanol, ethanol, isopropanol, acetic acid, ammonium 
persulphate, Tris base (electrophoresis grade), glycine (electrophoresis 
grade) and HEPES: Sigma-Aldrich, Saint Louis, MO.
Enhanced chemi-luminescent (ECL) western blotting detection reagents 1 
and 2: Amersham Pharmacia Biotech, Little Chalfont, UK.
Stripping buffer: 62.5 mM Tris, pH 6.8, 2% SDS, 100 mM p-mercaptoethanol. 
Antibody stripping solution: Alpha Diagnostic International, San Antonio, TX.
2.1.1.5. Antibodies and sources
Primary Antibodies
Rabbit anti-DDR1 Ig, sc-532 and goat anti-DDR2 Ig, sc-7554 (recognises C- 
terminal DDR1 and DDR2 epitope, respectively): Santa Cruz Biotechnology, 
Rabbit anti-DDR1 Ig, 74A: obtained from Dr. Michel Faure, SUGEN Inc., San 
Francisco, CA (recognises N-terminal DDR1 epitope).
Mouse anti-MYC tag, clone 9E10 and anti-phophotyrosine, clone 4G10: 
Upstate Biotechnology, Lake Placid, NY.
Rabbit anti-MYC tag, sc-789: Santa Cruz Biotechnology, Santa Cruz, CA. 
Mouse anti-FLAG, M2 and rabbit anti-FLAG polyclonal, F7425: Sigma- 
Aldrich, Saint Louis, MO.
Goat anti-ERK2, sc1549 and rabbit anti-Rho-GDI, A-20: Santa Cruz 
Biotechnology, Santa Cruz, CA.
Secondary Antibodies
Goat anti-mouse Ig-HRP: Amersham Biosciences UK, Little Chalfont, UK. 
Goat anti-rabbit Ig-HRP: Dako, Ely, UK.
Rabbit anti-goat IgG-HRP: ZYMED Laboratories Inc. San Francisco, CA.
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2.1.1.6. PCR, sub-cloning and DNA gel electrophoresis
PCR primers (PAGE purified, 0.05 jug scale): Sigma Genosys or Invitrogen 
Ltd, Paisley, UK.
Restriction enzymes (BamHI, EcoRI, A/of/, Ncol, Narl, Xhol, Xbal) and 
respective reactions buffers, bovine serum albumin (BSA, 10 mg/ml): 
Promega, Southampton, UK.
Pfu DNA polymerase (1 un'it/ml) and 10x Pfu buffer (10 mM (NH4)2S 0 4, 10 
mM KCI, 2 mM M gS04, 0.1% Triton X-100, 20 mM Tri-HCI, pH 8.8): 
Stratagene, Amsterdam, The Netherlands.
Taq DNA polymerase (5 units/jil) and 10x Tag buffer (1.5 mM MgCI2, 50 mM 
KCI, 0.1% Triton X-100, 10 mM Tris-HCI, pH 9.0): Promega, Southampton, 
UK.
dNTP mix: 10 mM, contains dATP, dTTP, dCTP and dGTP (2.5 mM each), 
New England Biolabs, Hitchin, UK.
T4 DNA ligase and 5x T4 ligase buffer (10 mM MgCI2, 1 mM ATP, 10 mM 
dithiothreitol, 25 pg/ml BSA, 50 mM Tris-HCI, pH 7.5): Invitrogen, Paisley, 
UK.
PCR-grade mineral oil, Ampicillin (1 mg/ml) and Ethidium Bromide: Sigma- 
Aldrich, Saint Louis, MO.
Plasmid mini-, midi- and maxi-prep kits: QIAGEN, Crawley, UK.
Luria Bertani (LB) and LB-agar: Sigma-Aldrich, Saint Louis, MO.
DH5a competent E.coli: Invitrogen Ltd, Paisley, UK.
DNA ladder, 1 kb (molecular weight markers: 10, 8, 6, 5, 4, 3, 2, 1.5, 1, and 
0.5 kb) and DNA ladder, 100 bp (molecular weight markers: 1500, 1000, 900, 
800, 700, 600, 500, 400, 300, 100 bp): Promega, Southampton, UK.
Orange DNA loading buffer (6x): 20% ficoll, 0.25% Orange G, 0.1 M  EDTA, 
pH 8.0)
TE Buffer: 10 mM Tris-HCI (pH 7.5), 1 mM EDTA.
Solution I: 30 mM KOAc, 50 mM MnCI, 100 mM KCI, 10 mM CaCI2, 15 % 
glycerol, pH to 5.8.
Solution II: 10 mM MOPS pH 7.0, 75 mM CaCI2, 10 mM KCI, 15% glycerol.
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2.2. Methods
The table below lists the names of plasmid vectors and constructs used:
Plasmid vectors Obtained from/made by
pSP72 Invitrogen
pcDNA3.1/Zeo Invitrogen
pS-DDR1 b B. Leitinger
pc-DDR1 b B.Leitinger
pc-DDR1-MYC N.Noordeen
pc-DDR1-FLAG N.Noordeen
pRK-DDR1a Dr. Michel Faure (SUGEN Inc., 
San Francisco, CA)
pRK-DDR1b Dr. Michel Faure (SUGEN Inc., 
San Francisco, CA)
pRK-MDN Dr. Michel Faure (SUGEN Inc., 
San Francisco, CA)
pc-DS-DDR1 B.Leitinger
pc-DS-DDR1 -MYC N.Noordeen
pc-DS-DDR1 -FLAG N.Noordeen
pc-DS-DDR1-2 B.Leitinger
pc-DS-DDR1 -2-MYC N.Noordeen
pc-DS-DDR1-2-FLAG N.Noordeen
pc-ADS-DDR1 B.Leitinger
pc-ADS-DDR1 -MYC N.Noordeen
pc-ADS-DDR1 -FLAG N.Noordeen
pc-APG-DDRI B.Leitinger
pc-APG-DDR1 -MYC N.Noordeen
pc-APG-DDR1 -FLAG N.Noordeen
pc-DDR1-ECTM B.Leitinger
pc-DDR1 -ECTM-MYC N.Noordeen
pc-DDR1 -ECTM-FLAG N.Noordeen
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pc-DDR1-TM1 B. Leitinger
pc-DDR1 -TM1 -MYC N.Noordeen
pc-DDR1-TM1-FLAG N.Noordeen
pc-DDR1-TM2 B.Leitinger
pc-DDR1 -TM2-MYC N.Noordeen
pc-DDR1 -TM2-FLAG N.Noordeen
pc-DDR1-TM3 B.Leitinger
pc-DDR1 -TM3-MYC N.Noordeen
pc-DDR1 -TM3-FLAG N.Noordeen
pc-DSTM 1-DDR1 -MYC N.Noordeen
pc-DSTM 1-DDR1 -FLAG N.Noordeen
pc-ADSTM 1-DDR1 -MYC N.Noordeen
pc-ADSTM 1-DDR1 -FLAG N.Noordeen
pc-DSACYT0-DDR1 -MYC N.Noordeen
pc-DSACYTO-DDR1 -FLAG N.Noordeen
pc-ADSACYTO-DDR1 -MYC N.Noordeen
pc-ADSACYTO-DDR1 -FLAG N.Noordeen
pc-DSTM 1ACYTO-DDR1 -MYC N.Noordeen
pc-DSTM 1ACYT 0-DDR1 -FLAG N.Noordeen
pc-ADSTM 1ACYTO-DDR1 -MYC N.Noordeen
pc-ADSTM 1ACYTO-DDR1 -FLAG N.Noordeen
pc-DDR1-TA P.Bhattia
pS-DDR2 N.Noordeen
pBSTyrolO Dr. Michel Faure (SUGEN Inc., 
San Francisco, CA)
pc-DDR2 B.Leitinger
pc-DDR2-MYC N.Noordeen
pc-DDR2-FLAG N.Noordeen
pc-DS-DDR2 B.Leitinger
pc-DS-DDR2-MYC N.Noordeen
pc-DS-DDR2-FLAG N.Noordeen
pc-ADS-DDR2 B.Leitinger
65
Chapter 2
PC-ADS-DDR2-MYC N.Noordeen
pc-ADS-DDR2-FLAG N.Noordeen
pc-DDR2-ECTM-MYC N.Noordeen
Pc-DDR2-ECTM-FLAG N.Noordeen
pc-DDR2-TM1 N.Noordeen
pc-DDR2-TM1-MYC N.Noordeen
pc-DDR2-TM 1 -FLAG N.Noordeen
pc-DDR2-TM2 N.Noordeen
pc-DDR2-TM3 N.Noordeen
pc-DSTM-DDR2-MYC N.Noordeen
pc-DSTM-DDR2-FLAG N.Noordeen
pc-ADSTM-DDR2-MYC N.Noordeen
pc-ADSTM-DDR2-FLAG N.Noordeen
pMIRB/mFGFR2c-MYC K.Yu (Washington University 
Medical School, St. Louis, MO)
Table 2.1: Plasmid vectors, constructs and sources
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2.2.1. Sul>cloning
2.2.1.1. Preparation of competent XL-1 Blue E.coli
XL-1 Blue cells were scraped from a glycerol stock, streaked onto LB-agar 
plates and incubated at 37°C overnight. A single colony was picked the next 
day and grown in 100 ml of LB broth at 37°C. The growth of the culture was 
monitored by measuring the absorbance at 590 nm. After the optical density 
reached 0.5, the cells were collected by centrifugation at 3500 rpm (GS-6R 
Centrifuge, Beckman) for 5 minutes at RT and the pellet re-suspended in 20 
ml Solution I (30 mM KOAc, 50 mM MnCI2, 100 mM KCI, 10 mM CaCI2, 15 % 
glycerol, pH to 5.8) and placed on ice for 30 minutes. The cells were spun 
again at 3500 rpm for 5 minutes (GS-6R Centrifuge, Beckman), 4°C and 
resuspended in 2 ml Solution II (10 mM MOPS pH 7.0, 75 mM CaCI2, 10 mM 
KCI, 15% glycerol) and stored at 4°C overnight. The next day the cells were 
aliquoted and frozen at -80°C.
2.2.1.2. Extraction and purification of plasmid DNA
DNA mini-, midi- or maxi-preps were carried out in order to obtain purified 
plasmid DNA from bacterial cultures. Ampicillin resistant colonies were grown 
in 4 ml (mini-preps) or 50 ml (midi-preps) or 100 ml (maxi-preps) of LB broth 
containing ampicillin (80 jig/ml), overnight at 37°C with shaking. The next day 
the culture was spun [1 minute at 13 000 rpm for mini-preps (Heraeus 
Biofuge); 10 minutes at 3500 rpm for midi- and maxi-preps (GS-6R 
Centrifuge, Beckman) to pellet the cells. The extractions were carried out 
using the QIAGEN Plasmid Mini (or Midi) Prep Kit (QIAGEN) according to the 
manufacturer’s protocol.
2 2.1.3. Determination of DNA concentration
DNA purified from mini- and maxi-preps was quantified by UV absorbance at 
260 nm using 1 cm quartz cuvettes and a DU 530 Life Science UVA/is™
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spectrophotometer (Beckman). The concentration was calculated using 
formula 1.
Formula 1:
DNA concentration = OD26o x 50 x dilution factor
Alternatively, DNA concentrations were estimated by agarose gel 
electrophoresis by comparison to a DNA ladder (1 kb or 100 bp) of known 
concentration.
2.2.1.4. Restriction digestion analysis
Restriction digestion analysis was carried out on 1 pg of purified midi- or 
maxi-prep DNA to verify the concentration and assess the presence of the 
DNA of interest. For DNA obtained from mini-preps, 3 pi of DNA was 
analysed by restriction digestion to assess the presence of the DNA of 
interest. The digested samples were run on a 1, 1.5 or 2% agarose gel 
depending on the size of the DNA to be assessed.
2.2.1.5. Agarose gel preparation and electrophoresis
Agarose was added to 1x TAE buffer to give a final concentration of 1-2% 
(e.g. 1% agarose: 1.0 g agarose powder in 100 ml 1x TAE). The mixture was 
- dissolved by heating in a microwave for 2-3 minutes, with intermittent stirring. 
Ethidium bromide was added to the dissolved agarose to a final 
concentration of 0.5 pg/ml, under a fume-hood and stirred until mixed. Gels 
were cast in cleaned agarose gel-trays containing well combs and allowed to 
set for 15-30 minutes in a fume-hood. Samples were loaded in 1x orange 
DNA loading buffer. DNA marker (1 pg of 1 kb or 100 bp DNA ladder) was 
also loaded. The gels were run in electrophoresis tanks (BioRad, 
Hertfordshire), containing 1x TAE buffer, at a constant voltage of 60-90 V for 
30-40 minutes. Gels were visualised and photographed using an UV 
transluminator (UVP, Cambridge).
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2.2.1.6. Purification of DNA from agarose geis
The appropriate DNA band was excised from the agarose gel using clean 
scalpels, under low intensity UV light. The gel slice was placed in an 
Eppendorf tube, weighed and purified using the QIAquick Gel Extraction Kit 
(QIAGEN) according to the manufacturer’s instructions.
2.2.1.7. Bacterial cell transformation
XL-1 Blue competent E.coli (90 pi) or DH5a competent E.coli (50 pi, 
Invitrogen) were incubated with DNA (10 pi of ligation mix) for 30 minutes on 
ice. The XL-1 Blue cells were heat shocked at 42°C for 2 minutes, and the 
DH5a were heat shocked at 37°C for 20 seconds, and the tubes were placed 
on ice. The mixture (50 pi) was plated onto LB-agar plates containing 80 
pg/ml ampicillin. The plates were incubated at 37°C overnight.
2.2.1.8. Ligations
For each ligation, 1 pi of T4 DNA Ligase (1 unit/pl, Promega or Invitrogen) 
and 2 pi of 10x Ligase buffer (Promega) or 4 pi of 5x Ligase buffer 
(Invitrogen) were mixed along with 50 ng of vector and insert DNA, the 
amount of which was calculated using formula 2 and the insert:vector ratio (a 
3:1 insert:vector molar ratio was used for each ligation). Control reactions 
containing vector DNA without insert were also prepared. Ligations were 
performed in a total volume of 20 pi, for 1 hour at RT. The DNA was then 
transformed into XL-1 Blue or DH5a competent cells, plated on LB-ampicillin 
plates and incubated overnight at 37°C.
Formula 2:
Insert (ng) = vector (ncO x size of insert (kb) x (insert:vector molar ratio)
vector size (kb)
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2.2.2. Polymerase chain reaction (PCR)
PCR reactions used 1 unit of Pfu (Invitrogen) or Vent (NEB) DNA 
polymerase. The reaction mixtures contained: 1x Pfu or Vent reaction buffer 
(Invitrogen or NEB, respectively), 250 pM dNTPs (Promega), 1 ng/pl 
template DNA, 2.5 ng/pl each forward and reverse primer (Sigma Genosys or 
Invitrogen), made up to a total volume of 100 pi with ddH20. PCR reactions 
were carried out in a DNA Thermal Cycler™ (Perkin-Elmer) - which required 
overlay of reactions with 30 pi of PCR-grade mineral oil (Sigma) or 
alternatively GeneAmp PCR System 9700 (PE Applied Biosystems). PCR 
reactions were carried out using the programme shown below:
Initial denaturation: 94°C, 5 minutes 
Denaturation: 94°C, 45 seconds
Annealing: (temperature varies by primer pair used), 45 seconds
Extension: 72°C, 1 minute
Final extension: 72°C, 10 minutes
Soak: 4°C
> 2 5  cycles
PCR products (10 pi aliquot) were visualised by electrophoresis on 1.5% or 
2% agarose gels stained with ethidium bromide (see section 2.2.1.5). DNA 
product sizes were measured against a 100 bp DNA ladder (Promega). PCR 
products were purified either by agarose gel electrophoresis and purification 
of DNA from gel (section 2.2.1.6) or without running on a gel (using the 
QIAquick PCR purification kit).
2.2.2.1. Colony PCR
Colonies obtained after ligation were screened either by restriction enzyme 
digestion of mini-prep DNA or by PCR. PCR was performed in order to 
screen a large number of colonies. Forward and reverse primers which flank 
the insertion site were used, to detect whether ligation has occurred. A 
master mix containing 2.5 ng/pl primers, 1.5 mM MgCh (Promega), 250 pM 
dNTP mix (Promega), 1x Taq polymerase buffer and 1 unit Taq polymerase
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(Promega) was made in ddhhO. Individual colonies were picked and dipped 
into separate reaction tubes containing 25 pi of the PCR mix. The PCR 
reaction was carried out as follows:
Denaturation: 94°C, 45 seconds 
Annealing: 50°C, 30 seconds 
Extension: 72°C, 45 seconds 
Soak: 4°C
>■ 25 cycles
The products were separated on a 2% agarose gel. Colonies which were 
positive for the correct insert were re-picked and plasmid DNA isolated by 
mini-prep.
2.2.2.2. DNA sequencing
Sequencing of PCR amplified DNA was carried out by the Wolfson Institute 
of Biomedical Research (University College London). 1000-500 ng of DNA in 
6 pi of ddH20 was sent with 2 pmols/pl of primer. Sequencing was also 
carried out by the Advanced Biotechnology Centre (Imperial College, 
London). Each sequencing reaction contained 1 pg of template DNA and 
12.8 pmols primer in 12 pi ddH20. Sequences were checked against 
published sequences of DDR1 and DDR2, obtained from 
www.ncbi.nlm.nih.gov. Sequence alignment was carried out using Clustalw 
(www.ebi.ac.uk/clutalw) and re-checked with Chromas (version 1.45).
2.2.3. C-terminally MYC- and FLAG-tagged DDR constructs
C-terminally MYC- and FLAG-tagged DDR1 and DDR2 constructs were 
made using Overlap Extension PCR (Horton et al., 1993). Using this method, 
two cDNA fragments can be amplified using specific primers such that the 3’ 
end of fragment A overlaps with the 5’ end of fragment B. The overlaps serve 
as primers for extension by DNA polymerase to produce a single PCR 
product with the desired insertion, deletion or mutation. Figure 2.1 outlines
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5’.
3’
PCR 1
PCR 1
Fragment A
Mix, denature, re-anneal. 3’ 
overlapping strands act as 
primers.
3’
5’ :
i
Fragment B
3’
3’
DNA polymerase extends 
overlap, and PCR is carried 
out using primers a and d. I PCR 2
Product AB with insertion
Figure 2.1: Schematic representation of Overlap Extension PCR.
72
Chapter 2
how a DNA sequence with a desired insertion can be made by this method. 
Two primary PCR products are first made using primers a and b (gives 
fragment A) and primers c and d (gives fragment B). Primers b and c are 
mutagenic. As the 3’ end of fragment A overlaps with the 5’ end of fragment 
B (red region), the two fragments can base pair, and the overlapping 3’ ends 
can serve as primers for extension by DNA polymerase to give a secondary 
PCR product (product AB). Using this method cDNA sequences encoding for 
the amino acids AAAEQKLISEEDL (MYC epitope) and AAADYKDDDDK 
(FLAG epitope) were inserted into the DDR cDNA sequences, just before the 
stop codon.
All PCR amplification reactions were performed with either Pfu (Strategene) 
or Vent (New England Biolabs) DNA polymerase according to the 
manufacturer’s instructions. All PCR products were purified either by gel 
electrophoresis using the QIA-quick Gel extraction kit (QIAGEN) or without 
running on a gel and using the QIA-quick PCR purification kit (QIAGEN). All 
PCR derived sequences in the final construct were sequenced using relevant 
primers in order to check for potential PCR mutations.
2.2.3.1. DDR2-MYC and DDR2-FLAG constructs
Primary PCR products (A and B) were created using the primer pairs a-b and 
c-d respectively (shown below). Restriction enzyme sites introduced are in 
bold and the sequence of primes are depicted 5’ to 3’:
DDR2-MYC, DDR2-FLAG
primer a: CT CAAGG ACCCAAACAT CAT CCA
DDR2-MYC
Prim erb : Aloti
CT CT G AGAT GAGCTT CT GTT CT GCGGCCGCCT CGT CGCCTT GTT GAAGGAGCA 
DDR2-MYC
primer c: CAGAACAGAAGCT CAT CT CAGAGG AGGAT CT GT GATGCT GT CAGTGCCTGG
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DDR2-MYC, DDR2-FLAG
primer d: CGTTAGAACGCGGCTACAATTAATACA 
DDR2-FLAG
Notl
primer b: CGTCATCGTCCTTATAGTCTGCGGCCGCCTCGTCGCCTTGTTGAAGGAGCA 
DDR2-FLAG
primer c: CGCAGACTATAAGGACGATGACGATAAGTGATGCTGTCAGTGCCTGG
The pS-DDR2 vector (pSP72 vector containing DDR2 cDNA insert) was used 
as the template. PCR programme: 95°C for 5 minutes, 95°C for 45 seconds,
56°C (Tm) for 45 seconds, 72°C for 1 minute and (DNA Thermo Cycler 480, 
Perkin-Elmer). Both fragments were purified by gel electrophoresis (using 
QIA-quick Gel Extraction kit). A second PCR reaction was set up to fuse the 
two primary products using the primer pair a-d. PCR programme used: 95°C 
for 5 minutes, 95°C for 45 seconds, 56°C (Tm) for 45 seconds, 72°C for 1 
minute 30 seconds.
The amplified fused PCR product AB was digested with restriction enzymes 
Bell and Xhol and ligated into the vector pS-DDR2 cut with Bell and Xhol. For 
expression in eukaryotic cells, the full-length C-terminally tagged DDR2- 
FLAG or DDR2-MYC cDNAs were cloned into pcDNA3.1/Zeo vector by 
cutting with EcoRI-Xhol.
The DDR2 MYC- and FLAG-tagged constructs were designed with a Notl site 
just before the epitope tag and stop codon in order that the ‘vector’ containing 
epitope tag from these two constructs can be used to create DDR1 and DDR 
mutant MYC- and FLAG-tagged constructs.
2.2.3.2. DDR1-MYC and DDR1-FLAG constructs
A three-piece ligation of A, B and C DNA fragments was carried out to give the 
constructs pc-DDR1-MYC and pc-DDR1-FLAG. The production of these constructs 
are described below and represented schematically in Figure 2.2.
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Narl
EcoRI
BamHI
pS-DDR1b
^  Cut EcoRI-Nar I■Narl
EcoRI
pS-DDR1b
*Primer a
*  Primer b (has Notl 
site)
STOP 
BamHI
EcoRI:
Insert A
Narl
DDR2cDNA
EcoRI
pc-DDR2-MYC or 
pc-DDR2-FLAG
^  Cut EcoRI-i■Notl
EcoRI
Fragment C
Notl
1) PCR reaction
2) Cut PCR 
product Narl-Notl
Narl Notl
Insert B
-► A + B + c (3 piece ligation)
I
Notl
EcoRI
pc-DDR1-MYC
or
pc-DDR1-FLAG
Figure 2.2: Schematic representation of the production of DDR1-MYC and 
DDR1-FLAG constructs.
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Insert A:
pS-DDR1a vector was cut with EcoRI and Narl to give a fragment 
encompassing most of the DDR1 sequence.
Insert B:
The PCR product was created using primers a and b as shown below. The 
sequence of primes are depicted 5’ to 3’:
primer a: CT AT CCT CAT CAAC AACCGC 
Notl
primer b: AT GT GCGGCCGCCACCGT GTT G AGTGCAT CCT CT
The vector pS-DDR1a (pSP72 vector containing DDR1b cDNA insert) was 
used as the PCR template. The PCR product ends just before the stop codon 
(the primer b introduces a Notl site, shown in bold).
PCR programme used: 95°C for 5 minutes for 1 cycle then 95°C for 45 
seconds, 52°C (Tm) for 45 seconds, 72°C for 1 minute for 25 cycles followed 
by 72°C for 10 minutes and 4°C soak.
The product was digested with Narl and Notl in order to be used for the 
three-piece ligation.
Fragment C: The pc-DDR2-MYC and pc-DDR2-FLAG vectors were cut with 
EcoRI and Notl, to give a ‘vector’ containing the MYC and FLAG tags with all 
of the DDR2 coding sequences removed. The sequence of the PCR 
amplified region was verified by sequencing.
2.2.3.3. DDR2 TM mutant constructs, TM1, TM2 and TM3
These mutants were made by the overlap extension PCR method described 
in section 2.2.3. For each construct, the primary PCR products A and B, 
using the primer pairs a-b and c-d respectively are shown below. Primers are 
depicted 5’ to 3’ and the mutagenic sequences are in red bold:
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DDR2 TM1, TM2, TM3
primer a: GTTTCTGCAGATTGACTTGCAC
DDR2 TM1
primer b: TGATGGCCGGGCCGATAAAGATGATGGCCACCAA 
DDR2TM1
primer c: CTTT ATCGGCCCGGCCAT CATT GT CAT CAT C
DDR2 TM2, TM2, TM3
primer d: GAACTCCTCCACAGCCACAT
DDR2 TM2
primer b: GATGACAGGGCCGGCCAGGAGGATAAAGATGA 
DDR2 TM2
primer c: CTGGCCGGCCCTGTCATCATCCTCTGGAGGCA 
DDR2TM 3
primer b: GAT GAT G ACCACC AAGCAGCC AAT CAGG AT 
DDR2 TM3
primer c: GCTGCTTGGTGGT CAT CAT CTTT AT CCT CCTGGC
DDR2 TM1 primers b and c contain the mutagenic sequence which codes for 
a glycine and proline residue instead of two leucine residues present in WT 
DDR2. For DDR2 TM2 primers b and c contain the mutagenic sequence 
which codes for a glycine and proline residue instead of two isoleucine 
residues present in WT DDR2. For DDR2 TM3, primers b and c contain a 
mutated codon which encodes for a valine instead of an alanine residue 
present in WT DDR2.
The pS-DDR2 vector was used as the template for the synthesis of the 
primary PCR products for all three mutant constructs. For DDR2 TM1, the 
PCR programme was as follows: 95°C for 5 minutes for 1 cycle then 95°C for 
45 seconds, 52°C (Tm) for 45 seconds, 72°C for 1 minute for 25 cycles 
followed by 72°C for 10 minutes and 4°C soak. For DDR2 TM2 and TM3 the
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PCR programme was as above except the primer annealing temperature 
(Tm) was changed to 53°C.
PCR products were purified by gel electrophoresis using QIA-quick Gel 
Extraction kit. A second PCR reaction was set up to fuse the two primary 
products using the primer pair a-d. PCR programme used: 95°C for 5 
minutes, 95°C for 45 seconds, 50°C (Tm) for 45 seconds, 72°C for 1 minute 
30 seconds and 4°C soak.
The amplified fused PCR product was purified using the Qia-quick PCR 
purification kit, follwed by digestion with restriction enzymes Narl and Ncol. 
The product was ligated into the vector pS-DDR2 cut with Narl and Ncol. 
These constructs were sequenced using relevant primers in order to verify 
the presence of the site-directed mutation and check for potential PCR 
mutations. For expression in eukaryotic cells, the full-length DDR2 TM 1, TM2 
and TM3 cDNAs were cut with EcoRI and Xhol and cloned into 
pcDNA3.1/Zeo vector cut with EcoRI and Xhol.
2.2.3.4. DDR2 cytosolic domain deletion construct, DDR2 ECTM
To delete the entire cytosolic region of DDR2, a PCR reaction was carried 
out using the primers shown below. Restriction enzyme sites introduced are 
in bold and primers are depicted 5’ to 3’:
EcoRI
primer a: CGGAATTCACAGAGAATGCTCTGCACCCGTT 
Notl
primer b: ATGTGCGGCCGCTTTCTGCCAGAACTGCCTCCAGAG
The forward primer a, contains an EcoRI site, which is for sub-cloning of the 
PCR product. The reverse primer d anneals to the DDR2 sequence coding 
for part of the TM domain and cytosolic juxtamembrane region and has a 
Notl site just before the stop codon. This produces a final PCR product which 
encodes for only six amino acids after the DDR2 TM domain.
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A PCR reaction was carried out using pSDDR2 as a template and the above 
two primers. The PCR programme was as follows: 95°C for 5 minutes for 1 
cycle then 95°C for 45 seconds, 59°C (Tm) for 45 seconds, 72°C for 1 minute 
and 30 seconds for 25 cycles followed by 72°C for 10 minutes and 4°C soak.
PCR products were digested with restriction enzymes EcoRI and Notl. The 
products were ligated into the vector pc-DDR2-MYC or pc-DDR2-FLAG cut 
with EcoRI and Notl to give pc-DDR2-ECTM-MYC and pc-DDR2-ECTM- 
FLAG.
2.2.3.5. DDR2 double deletion mutant constructs, DS2TM and ADS2TM
To obtain a DDR2 construct which has either the DS domain deleted, or the 
domain X, in addition to deletion of the entire cytosolic region, a PCR 
reaction was carried out using the constructs pc-DS-DDR2 and pc-ADS- 
DDR2 as templates and primer pair described in section 2.2.3.4. Restriction 
enzyme sites introduced are in bold and primer sequences are depicted 5’ to 
3’. The PCR programme is was carried out as described in section 2.2.3.4. 
PCR products were digested with restriction enzymes EcoRI and Notl. The 
products were ligated into the vector pc-DDR2-MYC or pc-DDR2-FLAG cut 
with EcoRI and Notl to give pc-DS-DDR2-MYC, pc-ADS-DDR2-MYC, pc-DS- 
DDR2-FLAG and pc-ADS-DDR2-FLAG.
2.2.3.6. DDR1 double mutant constructs, DS1TM1 and ADS1TM1
To obtain a DDR1 construct which has either the DS domain or domain X 
and P/G rich region deleted in addition to the TM1 mutation in the TM 
domain, overlap extension PCR was carried out. Primary PCR products A 
and B, were created using the primer pairs a-b and c-d, respectively, as 
shown below. Primers are depicted 5’ to 3’ and the mutagenic sequences, 
corresponding to the DDR1 TM1 mutation, are in shown in red bold:
DS1TM1
primer a: ATGGTTGCCCGACTGGTT
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primer b: AT GAGCGGCCCGAGCAGG AT GAT GGCCAC 
primer c: ATCCTGCTCGGGCCGCTCATCATTGCCCT 
primer d: GCATAATGGGGGACGCTGT
The pc-DS-DDR1-2 vector was used as the template for the synthesis of the 
primary PCR products. The PCR programme was as follows: 95°C for 5 
minutes for 1 cycle then 95°C for 45 seconds, 52°C (Tm) for 45 seconds, 
72°C for 1 minute for 25 cycles followed by 72°C for 10 minutes and 4°C 
soak. A second PCR reaction was set up to fuse the two primary products 
using the primer pair a-d. PCR programme used: 95°C for 5 minutes, 95°C 
for 45 seconds, 55°C (Tm) for 45 seconds, 72°C for 1 minute 30 seconds and 
4°C soak.
The amplified fused PCR product was digested with restriction enzymes S ad  
and Narl. The product was ligated into the vector pS-DDR1b (pSP72 vector 
with W T DDR1b cDNA inserted) cut with Sad  and Narl. In order to express 
the gene in eukaryotic cells and introduce C-terminal MYC- and FLAG-tags, 
the cDNA was cut with EcoRI and Narl and cloned into pc-DDR1-MYC and 
pc-DDR1-FLAG vector cut with EcoRI and Narl, to give pc-DS1TM1-MYC 
and pc-DS1TM1-FLAG.
To obtain the double mutant ADS1TM1, a three-piece ligation was carried out 
with the components obtained as follows:
Fragment A: pc-DDR1-TM1 construct cut with Ncol and Notl.
Fragment B: pc-DDR2-MYC or pc-DDR2-FLAG cut with EcoRI and Notl.
Fragment C: pc-ADS-DDR1 cut with EcoRI and Ncol.
The three fragments A, B and C were ligated in a single reaction to give pc- 
ADS1TM1-MYC and pc-ADS 1 TM 1 -FLAG.
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2.2.3.7. DDR1 double deletion mutants, DS1ACYTO, ADS1ACYTO, and 
triple mutants, DS1TM1ACYTO and ADS1TM1ACYTO
DDR1 double deletion mutant constructs which have either the DS domain or 
the domain X and the P/G rich region deleted, in addition to the deletion of 
the entire cytosolic region, were made. DDR1 triple mutants were made, both 
of which contain the TM1 mutation in the TM domain in addition to the 
deletion of the cytosolic region, with either the DS domain or the domain X 
plus the P/G rich region deleted. PCR reactions were carried out using the 
constructs pc-DS-DDR1 and pc-ADS-DDR1 as templates for the double 
deletion mutants and pc-DS1TM1-DDR1 and pc-ADS1TM1-DDR1 as 
templates for the triple mutants, respectively.
The primer pair used for these constructs is shown below. Restriction 
enzyme sites introduced are in bold and primer sequences are depicted 5’- 
3’:
EcoRI
primer a: CGGAATTCAGAGATGCTGCCCCCACCCCCT 
Notl
primer b: ATGTGCGGCCGCCCTGCGCCAGTGCAGCCGCCAG
The PCR programme was as follows: 95°C for 5 minutes for 1 cycle then 
95°C for 45 seconds, 54°C (Tm) for 45 seconds, 72°C for 1 minute and 30 
seconds for 25 cycles followed by 72°C for 10 minutes and 4°C soak.
PCR products were digested with restriction enzymes EcoRI and Notl. The 
products were ligated into the vector pc-DDR1-MYC or pc-DDR1-FLAG cut 
with EcoRI and Notl to give the epitope-tagged double deletion mutants and 
triple mutants as follows:
Double deletion mutants: pc-DSlACYTO-DDR1-MYC, pc-ADS1ACYTO- 
DDR2-MYC, pc-DSlACYTO-DDR1-FLAG and pc-ADS1 ACYT0-DDR1 -FLAG
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Triple mutants: pc-DS1TM1ACYT0-DDR1-MYC, pc-ADS1TM1ACYT0-
DDR1-MYC, pc-DS 1 TM 1ACYT0-DDR1 -FLAG and pc-ADS1TM1ACYT0- 
DDR1-FLAG.
2.2.3.8. MYC- and FLAG-tagged DDR1 TM mutants, TM1, TM2 and TM3
pc-DDR1-TM1, pc-DDR1-TM2 and pc-DDR1-TM3 were digested with EcoRI 
and Narl, and the resulting cDNA fragments were sub-cloned into pc-DDR1- 
MYC and pc-DDR1-FLAG cut with EcoRI and Narl. This produces pc-DDR1- 
TM1-MYC, pc-DDR1-TM1-FLAG and the corresponding TM2 and TM3 
constructs. The resulting clones were sequenced in order to verify the 
presence of the specific TM mutations.
2.2.3.9. MYC- and FLAG-tagged DDR1 deletion constructs, DS1-1, DS1- 
2, ADS1, APG and ECTM1
pc-DS-DDR1, pc-DS-DDR1-2, pc-ADS-DDR1 and pc-APG-DDR1 were 
digested with EcoRI and Narl and sub-cloned into pc-DDR1-MYC and pc- 
DDR1-FLAG digested with EcoRI and Narl, to give corresponding MYC- and 
FLAG-tagged constructs.
2.2.3.10. MYC- and FLAG-tagged DDR2 TM1 constructs
pS-DDR2-TM1 was digested with Narl and Ncol and sub-cloned into pS- 
DDR2-MYC and pS-DDR2-FLAG cut with Narl and Ncol, to give pS-DDR2- 
TM1-MYC and pS-DDR2-TM1-FLAG. The latter constructs were digested 
with EcoRI and Notl and sub-cloned into pc-DDR2-MYC and pc-DDR2-FLAG 
to obtain pc-DDR2-TM1-MYC and pc-DDR2-TM1-FLAG. The final constructs 
were sequenced in order to verify the presence of the TM mutation.
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2.2.3.11. MYC- and FLAG-tagged DDR2 deletion constructs, DS2 and 
ADS2
The constructs, pc-DS-DDR2 and pc-ADS-DDR2 were digested with EcoRI 
and Ncol and sub-cloned into pS-DDR2-MYC and pS-DDR2-FLAG vectors 
cut with Narl and Ncol, to give pS-DS-DDR2-MYC, pS-ADS-DDR2-MYC and 
corresponding FLAG tagged constructs. These constructs were digested with 
EcoRI and Xhol and sub-cloned into pc-DDR2-MYC and pc-DDR2-FLAG 
vectors digested with EcoRI and Xhol.
2.2.4. Mammalian cell culture and protein methods
2.2.4.1. Mammalian cell lines and culture medium
Human embryonic kidney 293 cells (HEK293), HEK293 TSA 201 cells, Rat-1 
cells, HEK293 TSA DDR1 and HEK293 TSA DDR2 cells were cultured in 
Dulbecco’s modified Eagle medium, Invitrogen) containing 10% foetal bovine 
serum. 100 jug/ml zeocin (for the latter two cell lines) in order to maintain 
episomal expression of the DDR genes. 100 pg/ml puromycin was added to 
the culture medium to selectively maintain the Rat-1 cell line. MCF-7 cells 
were cultured in Dulbecco’s modified Eagle medium (without sodium 
pyruvate, Invitrogen) containing 10% foetal bovine serum.
2.2.4.2. Trypsinisation and passaging of cells
All cell lines were cultured in T25 or T75 tissue culture flasks (Nunc) at 37°C 
in a 5% C 0 2 incubator. Cell lines were sub-cultured every third day. Culture 
medium was aspirated and the adherent cells growing in tissue culture flask 
were washed in PBS. Trypsin/EDTA (Gibco) at RT was added to the cells 
(0.5 ml per T25) for 1 minute at RT. The cells were dislodged by tapping of 
the flask after which a suitable volume of medium containing 10% FCS was 
added to inactivate the trypsin. The cells were then split into a tissue culture
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flask for maintenance or culture plate in order to perform an experiment, and 
incubated at 37°C, 5% CO2 .
2.2.4.3. Freezing and storage of cells
Cells grown to sub-confluency in T75 flasks were trypsinised, washed into 15 
ml complete medium (RT) and centrifuged at 1000 rpm for 5 minutes (GS-6R 
Centrifuge, Beckman). The pellet was re-suspended in 2 ml complete 
medium containg 10% DMSO. Aliquots (0.5 ml) were put into Nunc vials and 
placed at -80°C overnight. The cells were then transferred to liquid nitrogen 
for storage.
2.2A.4. Thawing of cells
Cells frozen in liquid nitrogen were thawed in a 37°C water bath and 
immediately added to 10 ml of culture medium in order to dilute out the 
DMSO. The cells were spun down at 1000 rpm for 5 minutes (GS-6R 
Centrifuge, Beckman) and re-suspended in 5 ml medium containing FCS, 
transferred to a T25 and incubated at 37°C, 5% CO2 .
2.2.4.5. Cell transfection
Calcium phosphate precipitation method: Cells were grown to -50%  
confluency in tissue culture plates and the medium was changed 2-3 hours 
prior to transfection. For 12 well tissue culture plates, 2.5 pg of DNA/ well 
was used; for 6 well plates 5 pg of DNA /well was used. DNA/CaCh mixture 
was prepared by adding CaC^ to a final concentration of 0.25 M to DNA-H2O 
mixture and vortexing briefly (volume of the DNA/CaCI2 mixture = volume of 
2X HBS). The DNA/CaCfe was added slowly, drop-wise, to 100 pi 2X HBS 
solution (50 mM HEPES pH 7.1, 280 mM NaCI, 1.5 M Na2H P 04) per 12 well 
or 200 pi per 6 well, while gently vortexing the tube containing HBS. The mix 
was incubated at RT for 30 minutes, vortexed, and added drop-wise to the
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wells. The cells were incubated at 37°C, 5% C 0 2. 18 hours later the culture 
medium was changed to fresh complete medium.
FuGENE 6 method: Cells were grown to ~50% confluency. The medium was 
changed to complete medium just before transfecting. FuGENE (3 pi) was 
added to 97 pi of serum free medium and incubated at RT for 5 minutes. 
DNA (1 pg) was added to a second tube. The diluted FuGENE was added 
drop-wise to the DNA and incubated at RT for 15 minutes. The mixture was 
added to the cells drop-wise and incubated at 37°C, 5% C 0 2.
2.2.4.6. DDR2-positive stable cell line
A DDR2 expressing HEK293 stable cell line was created using the HEK293 
TSA cells, which contain the SV40 large T antigen, which enables episomal 
replication of transfected vectors. HEK293 TSA 201 cells were grown to 50% 
in a T25 flask and transfected with 1 pg DNA vector containing the DDR2 
gene (pcDDR2) using the FuGENE method of transfection. 24 hours later, 
the medium was aspirated and replaced with complete medium containing 
100 pg/ml zeocin, in order to select for DDR2 positive cells. The medium was 
changed every third day to eliminate dead cells and debris; after about two 
weeks colonies of zeocin resistant cells were visible and these cells were 
propagated in the presence of zeocin.
2.2.4.7. Activation of sodium orthovanadate
Activated sodium orthovanadate is required for maximal inhibition of protein 
tyrosine phosphatases. A 200 mM solution of sodium orthovanadate (Sigma) 
was prepared and adjusted to pH 10.0. The yellow solution obtained was 
boiled for approximately 10 minutes, until colourless, and cooled to RT. The 
temperature was re-adjusted to pH 10.0. The solution was re-boiled and 
cooled to RT; this step was repeated until the solution remained colourless 
and the pH stabilized at 10.0. The activated sodium orthovanadate was 
stored at -20°C
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2.2.4.8. Preparation of whole cell lysate
The culture medium was removed and cells were washed x1 in cold PBS. A 
suitable volume of ice cold NP40 lysis buffer (1% NP40, 150 mM NaCI, 50 
mM Tris, pH 7.4, 1 mM EDTA) containing proteinase inhibitors [1 mM 
phenylmethylsulfonyl fluoride (PMSF) and 50 pg/ml aprotonin], was added to 
the cells and plates were placed on ice on a shaker for 20 minutes. The cells 
were then scraped off into Eppendorf tubes and lysed on ice for 1 hour; then 
spun at 13 000 rpm for 10 minutes (Heraeus Biofuge) to recover the 
detergent soluble fraction. Cell lysates were stored frozen at -20°C or directly 
processed for SDS-PAGE.
2.2A.9. SDS-PAGE
Mini-gels were prepared using the mini-protean 3 gel cast with 0.75 mm 
spacers (BioRad, Hertfordshire). 7.5% SDS-PAGE resolving gels were made 
as follows: 7.5% acrylamide/0.2% bisacrylamide, 375 mM Tris-HCI pH 8.8, 
0.1% SDS, 0.04% APS and 0.2% TEMED. 5% or 10% gels were made by 
varying the percentage of acrylamide/bisacrylamide accordingly. 4% stacking 
gels were used through out and contained 4% acrylamide/0.1% bisacrylamide, 
125 mM Tris-HCI pH 6.8, 0.1% SDS, 0.2% TEMED and 0.04% APS. Protein 
loading buffer was added to the lysates or immunoprecipitates and the 
samples were boiled at 100°C for 3 minutes. 15 pi of each sample was 
loaded on a 7.5%, 5% or 10% gel, along with pre-stained MW markers (6 pi, 
NEB). Broad range markers (10 pi, NEB), was additionally loaded when a 
more accurate estimation of protein MW was required. The proteins were 
separated using a Mini Protean 3 Cell tank (BioRad), containing SDS running 
buffer. The gels were run at a constant voltage of 50-100 V initially until the 
samples entered the resolving gel, after which the voltage was increased to 
120-150 V.
86
Chapter 2
2.2.4.10. Western blotting
After SDS-PAGE, proteins were blotted onto nitrocellulose membrane using 
a wet transfer Mini-Trans blot apparatus (BioRad). Blotting was carried out at 
4°C for 1 hour at 200 mA constant current in SDS blotting buffer. Following 
transfer, the nitrocellulose membrane was stained with Ponceau-S solution 
(0.1% Ponceau-S, 1% acetic acid) and de-stained with H20 , in order to 
visualise the blotted proteins. The membrane was incubated in blocking 
solution (3% Marvel milk powder, in PBS) for 1 hour at RT on a rotating 
platform or overnight at 4°C. The membrane was briefly washed in PBS and 
incubated with the primary Ab (diluted in PBST to the required 
concentration), either for 2 hours at RT or 4°C overnight, on a roller-shaker. 
The blots were washed x3 in PBST (1X PBS containing 0.05% Tween 20), 
for 10 minutes each and incubated with the relevant secondary Ab (diluted in 
PBST to the required concentration) for 1 hour at RT, on a roller-shaker. The 
blots were washed x5, for 5 minutes per wash, and incubated with enhanced 
chemiluminescence (ECL) detection reagents as specified by the 
manufacturer (Amersham). The blots were exposed to film (KODAK BIOMAX 
LIGHT) and developed using a Compact X4 film developer (Xograph imaging 
systems).
2.2.4.11. Chemical cross-linking
Cross-linking was carried out for 30 minutes at RT or 30 minutes at 37°C or 1 
hour at 4°C using the homobifunctional cross-linking reagent bis(sulfosuccinimidyl) 
suberate (BS3). Different concentrations of BS3 in a final volume of 500 pi 
PBS were added to confluent cells in 12 well tissue culture plates. The 
reaction was quenched by addition of 20 mM Tris pH 7.4 and incubating at 
RT for 15 minutes followed by cell lysis.
2.2.4.12. Molecular weight analysis
Molecular weight (MW) analysis of proteins was carried out in order to 
estimate the MWs of DDR oligomers obtained in cross-linking experiments.
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As 5% gels give a better resolution of large proteins than the 7.5% gels 
usually used to separate the DDR proteins, 5% gels were run for MW 
analysis of large protein complexes.
Broad range protein markers (NEB) containing MW range 212, 158, 116, 97, 
66, 56, 43, 35, 27, 20, 14, 6.5, 2.4 kDa, were used to obtain a standard curve 
from which the MWs of the DDR complexes could be obtained. The distance 
migrated was measured for each marker band from a fixed line on the blot 
and a graph plotted of distance migrated (mm) versus Log MW (kDa). The 
distances migrated of the DDR complexes were measured from the same 
fixed line on the blot and the corresponding MWs were obtained from the 
standard curve.
2.2.4.13. Collagen activation assay
HEK293 cells in 12 well tissue culture plates were transfected by calcium 
phosphate precipitation with the relevant DDR expression vectors and 24 
hours later, the cells were incubated in serum free medium for 16 hours. 
Cells were then stimulated with 10 fig/ml collagen I or 1 mM sodium 
orthovanadate for 90 minutes at 37°C. After washing with PBS cells were 
lysed in 1% NP40, 150 mM NaCI, 50 mM Tris, pH 7.4, 1 mM EDTA, 1 mM 
PMSF, 50 jig/ml aprotonin, 1 mM sodium orthovanadate, 5 mM NaF.
The detergent soluble fraction was recovered by centrifugation and aliquots 
were analysed by SDS-PAGE on 7.5% polyacrylamide gels followed by 
blotting onto nitrocellulose membranes at 200 mA for 1 hour. The blots were 
blocked overnight in 3% milk-PBS and probed with mouse anti- 
phosphotyrosine mAbs (1:666) for 2 hours. After washing x3 with PBST, the 
blots were incubated with goat anti-mouse HRP (1:10 000) secondary Ab for 
1 hour followed by washing x5 with PBST. The signals were detected by ECL 
(Amersham).
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To re-probe the blots, the membrane was stripped in 62.5 mM Tris, pH 6.8, 
2% SDS, 100 mM p-mercaptoethanol at 55°C for 30 minutes or in Antibody 
stripping solution (Alpha Diagnostic International) for 10 minutes. The blots 
were re-probed with rabbit anti-DDR1 (1:200) or goat anti-DDR2 (1:200) Abs 
followed by goat anti-rabbit Ig-HRP (1:4000) or rabbit anti-goat IgG-HRP 
(1:20,000), respectively.
2.2.4.14. Co-immunoprecipitation
HEK293 cells at -50%  confluency were transfected by calcium phosphate 
precipitation. Cells were co-transfected with plasmid vectors containing MYC- 
and FLAG-tagged W T or mutant DDR1 and DDR2 cDNA. Single 
transfectants, with either one of the plasmids alone, were also carried out as 
controls.
48 hours later, cells were lysed in NP40 lysis buffer and centrifuged for 10 
minutes at 13,000 rpm (Heraeus Biofuge) to recover the detergent soluble 
fraction. Anti-MYC or anti-FLAG antibody were added to aliquots of lysate at 
2 pg Ab (rabbit anti-MYC) or 3 pg Ab (mouse anti-FLAG M2 mAb, mouse 
anti-MYC mAb) per 500 pi lysate and incubated on a rotating wheel at 4°C 
over night. 16 hours later 20 pi (40 pi 1:1 mix of beads to PBS buffer) of 
protein A beads (for samples containing rabbit anti-MYC Ab) or protein G 
beads (for samples containing mouse anti-FLAG mAb, mouse anti-MYC 
mAb) were added and incubated for 1.5 hours on a rotating wheel at 4°C.
The samples were spun for 1 minute at 13,000 rpm (Heraeus Biofuge) to 
precipitate the beads, and the supernatants were aspirated followed by 
washing each sample four times with 1 ml NP40 lysis buffer. After the final 
wash and spin, all of the supernatant was removed followed by addition of 18 
pi of 2x reducing sample buffer. The samples were boiled for 5 minutes to 
release bound antibody and antigen from the beads.
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Samples were run on SDS-PAGE and blotted and then blocked as described 
above. The blots were probed with primary Abs; rabbit anti-MYC (1:200) or 
mouse anti-FLAG M2 mAbs (1:200) for 2 hours. After washing x3 with PBS 
containing 0.05% Tween 20 (PBST) the blots were incubated with goat anti­
rabbit HRP (1:4000) or goat anti-mouse HRP (1:8000) secondary Ab, for 1 
hour, followed by washing x5 with PBST. The signals were detected by 
enhanced chemiluminescence (Amersham Biosciences UK).
2.2.4.15. Cell surface biotinylatlon
HEK293 cells at -50%  confluency were transiently transfected with plasmid 
constructs containing WT or mutant DDR1 or DDR2 cDNA and 48 hours later 
the cells were washed once with ice cold PBS and incubated with Sulfo-NHS- 
LC-Biotin in PBS for 30 minutes on ice. The reaction was quenched by 
washing twice with 100 mM glycine in cold PBS. The cells were lysed in 
NP40 lysis buffer as described previously. Streptavidin sepharose beads 
were washed x3 in PBS and a 1:1 mixture of beads:PBS was prepared. 500 
jul of cell lysates was incubated for 2 hours with 30 pi streptavidin sepharose 
beads in PBS, to pull down biotinylated cell surface receptors. The mixture 
was centrifuged for 1 minute at 4°C to pellet the beads. Streptavidin 
sepharose beads in PBS (30 pi) was added to the recovered supernatant 
and the mixture incubated for 2 hours at 4°C, in order to remove any 
remaining biotinylated cell surface receptors. The mixture was centrifuged for 
1 minute at 4°C to pellet the beads. The beads from the first and second pull 
down were pooled and washed x4 in NP40 lysis buffer then boiled in 18 pi of 
2x reduced SB for 5 minutes to release bound protein. The supernatant from 
the second pull down was recovered and incubated with anti-DDR Ab, to 
immunoprecipitate the intracellular DDR receptor pool. To analyze the total 
DDR protein in the sample, 500 pi of starting lysate was incubated with anti- 
DDR Ab. Immunoprecipitations were carried out as described in 2.2.4.14. All 
samples were run reduced on 7.5% SDS-PAGE and analysed by Western 
blot.
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2.2.4.16. Enzymatic deglycosyiation
HEK293 cells at 50% confluency were transfected with cDNA of W T or 
mutant DDR construct, and 48 hours later the cells were lysed and the 
lysates immunoprecipitated with anti-DDR Ab. Immunoprecipitations were 
carried out as described in 2.2.4.14. The beads were washed x2 in NP40 
lysis buffer and x2 in 50 mM sodium phosphate buffer, pH 7.0, to remove 
ions which may inhibit enzyme activity.
The precipitated material was denatured in 1x glycoprotein denaturing buffer 
(0.5 % SDS and 1% p-mercaptoethanol) and 15-20 jul of immunoprecipitated 
sample was incubated with various endo- and exo-glycosidases as follows:
Endo H: Denatured immunoprecipitates were incubated with 1x Endo H 
reaction buffer and 5 units Endo H. Incubated 3 hours at 37°C.
PNGase F: Denatured immunoprecipitates were incubated with 1x PNGase 
reaction buffer, 1% NP40 and 5 units PNGase F. Incubated 3 hours or 20 
hours at 37°C.
Neuraminidase: Denatured immunoprecipitates were incubated with 1 mil of 
enzyme. Incubated 3 hours at 37°C.
Neuraminidase and O-glycosidase double digest: Denatured
immunoprecipitates were incubated with 1 mil of Neuraminidase for 1 hour at 
37°C, then 1 m il of O-glycosidase was added for the final 2 hours.
Neuraminidase, Olgycosidase and PNGase F triple digest: Denatured 
immunoprecipitates were incubated with 1 mil of neuraminidase and 5 units 
of PNGase F, 1x PNGase reaction buffer and 1% NP40 for 1 hour at 37°C, 
then O-glycosidase was added for the final 2 hours.
Control sample with no enzyme. Denatured immunoprecipitates were 
incubated for 3 hours at 37°C.
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All sample volumes were made equal by addition of 50 mM sodium 
phosphate buffer, pH 7.0. Sample buffer was added (5x) and samples were 
boiled and separated by SDS-PAGE until the gel front was run off. Samples 
were run on 7.5% gels until the 62 kDa marker was run off the gel bottom. 
This was done in order to detect shifts in protein MW, that are produced by 
deglycosylation. The gels were analysed by Western blotting as described in
2.2.4.10.
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Investigating the oligomerisation state of the DDRs in
the absence of ligand
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3.1. Introduction
The DDRs are activated upon collagen stimulation, which leads to 
autophosphorylation of conserved cytosolic tyrosine residues and further 
activation of the KD. The phosphorylated tyrosines can be detected by SDS- 
PAGE and Western blotting with an anti-phosphotyrosine mAb. As seen in 
Figure 3.1 (upper panel), both DDR1 (DDR1b isoform) and DDR2 are 
phosphorylated in response to collagen I in HEK293 cells. The corresponding 
DDR1 and DDR2 proteins are shown in the lower panel. In the case of 
DDR1, two MW forms are present, whereas for DDR2 three MW forms can 
be seen. W e wanted to know which DDR protein forms were on the cell 
surface and which protein forms were intracellularly localised. In addition, we 
reasoned that the lower forms were different biosynthetic intermediates and 
therefore we investigated post-translational modifications which could 
account for the differences between the various DDR forms. To this end, we 
performed cell surface biotinylation and enzymatic deglycosylation 
experiments.
So far, DDR oligomerisation has been studied in vitro using soluble ECD 
constructs (Leitinger, 2003). In this study, it was shown that a His-tagged 
ECD construct of DDR2, His-DDR2, existed as a non-covalent dimer in 
solution, whilst His-tagged ECD of DDR1, His-DDR1, was a monomer. His- 
DDR2 recognised collagen, but the ECD of DDR1 recognised collagen only 
as a dimeric DDR1-Fc construct, not as the monomeric His-DDR1, proving 
that the DDRs need to be dimerised in order to bind collagen. In addition to 
the ECD, full-length DDRs contain a TM domain, juxtamembrane domain and 
a KD. We wanted to know if the DDRs formed dimers in the context of the 
full-length receptor and therefore we performed chemical cross-linking 
analysis of full-length DDRs on the cell surface. Co-immunoprecipitation 
studies were carried out to verify the cross-linking results and to demonstrate 
a physical association between DDR monomers in vivo.
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Figure 3.1: Collagen l-induced autophosphorylation of WT DDR1 and 
DDR2 in HEK293 cells. DDR1 (a) or DDR2 (b) were transiently expressed 
in HEK293 cells. After stimulation with 10 jug/ml collagen I (C) or 1 mM 
sodium orthovanandate (V), cell lysates were analysed by SDS-PAGE and 
Western blotting. The blots were probed with anti-phosphotyrosine mAb 
4G10 to visualize phosphorylated receptors (a and b, upper panels). The 
blots were stripped and re-probed with anti-DDR1 Ab or anti-DDR2 Ab to 
detect total DDR protein levels (a and b, lower panels). The position and 
sizes (in kDa) of MW markers are indicated.
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3.2. Results 
3.2.1. Biochemical characterisation of WT DDRs
3.2.1.1. Cell surface biotinylation of WT DDRs
Biotinylation of cell surface receptors was carried out in order to find out if the 
lower forms of the DDRs are intracellular. DDR1 or DDR2 transfected 
HEK293 cells were incubated with Sulfo-NHS-LC-Biotin on ice to label cell 
surface receptors, and biotinylated receptors were pulled down with 
streptavidin-sepharose beads. The supernatant after pull-down was 
immunoprecipitated with anti-DDR Abs, and this represents the intracellular 
pool of receptors. In order to detect the total DDRs present in the lysate, an 
equivalent lysate volume was immunoprecipitated with anti DDR Ab. In 
addition, the above experiment was carried out in the presence of collagen I, 
in order to detect a potential downregulation of the DDRs which might occur 
upon collagen stimulation. Receptor down regulation has been shown to 
occur for other cell surface receptors upon ligand stimulation. For example, 
EGFR has been shown to intracellularly re-localise via clathrin-coated 
vesicle-mediated endocytosis mechanism upon stimulation with EGF (Haigler 
et a/., 1979; Wiley et al., 1991). DDR transfected HEK293 cells were 
incubated with 10 pg/ml collagen I for 90 minutes followed by cell surface 
biotinylation and processing as described above.
As shown in Figure 3.2 (a) the lower form of DDR1 is present only in the 
intracellular pool (lane I) whereas the upper form is present both in the cell 
surface as well as in the intracellular pool. For DDR2, only the two upper 
forms are present in the cell surface pool, and all three forms present in the 
intracellular pool (Figure 3.2, b). A control experiment was carried out where 
an intracellular protein, ERK2, was subjected to the same procedure, 
showing no intracellular protein in the cell surface pool (c). Taken together, 
these results suggest that the upper forms of the DDRs are present on the 
cell surface as well as in intracellular compartments. In the presence of
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Figure 3.2: Cell surface biotinylation of WT DDR1 and DDR2. HEK293 
cells transiently expressing DDR1 (a) or DDR2 (b) were incubated with 10 
p,g/ml collagen I or left untreated. After washing twice with cold PBS the 
cells were incubated with 3.5 mM Sulfo-NHS-LC-Biotin in PBS for 30 
minutes on ice. The reaction was quenched by the addition of 100 mM 
glycine. The cell lysates were incubated with streptavidin sepharose beads 
and the bound and free protein was separated by centrifugation to a pellet 
(containing cell surface receptors) and supernatant (containing intracellular 
receptors) fraction. The supernatant was immunoprecipitated with anti- 
DDR1 Ab (a) or anti-DDR2 Ab (b). An equivalent lysate volume was 
incubated with anti-DDR1 Ab to analyze the total DDR protein in the 
sample. All samples were analysed by SDS-PAGE and Western blot. Blots
(a) and (b) were first probed with anti-phosphotyrosine mAb, 4G10 (a and 
b, lower panels), then stripped and re-probed with anti-DDR1 or anti-DDR2 
Ab (a and b, upper panels). A control experiment was carried out for the 
intracellular protein ERK2 (c). T-total protein present in 0.5 ml lysate, S- 
cell surface receptors, l-intracellular receptors. The position and sizes (in 
kDa) of MW markers are indicated.
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collagen, there is no change in the levels of DDR protein in the cell surface 
pool versus intracellular pool, when compared with unstimulated levels. 
(Figure 3.2, a and b, upper panels). This indicates that the DDRs are not 
internalised after ligand stimulation.
Most of the phosphorylated DDRs are found in the cell surface pool as seen 
in Figure 3.2, (a) and (b). Furthermore, the phosphorylation signal of the 
intracellular pool of DDRs in the presence of collagen, is similar to the level of 
the signal produced by non-stimulated DDRs (Figure 3.2, a and b, lower 
panel). Therefore there is no phosphorylated DDR protein internalisation from 
the cell surface to the intracellular pool after stimulating with collagen I for 90 
minutes. The significance of the above findings is discussed in section 3.3.
3.2.1.2. Enzymatic deglycosylation of WT DDRs
Both DDRs are predicted to contain asparagine-linked (N-linked) 
glycosylation sites on the ECD. The DDRs contain four NXS/T motifs (the 
consensus motif for N-linked glycosylation, where X is not specified) - two of 
these motifs are within domain X and two are in the N-terminal 
juxtamembrane region (shown schematically in Figure 3.3). It is therefore 
likely that the differences in MW of the DDR forms are due to N-linked 
glycosylation. To confirm this hypothesis, we carried out enzymatic digestion 
with PNGase F, an endoglycosidase which cleaves all N-linked complex, 
hybrid or high mannose oligosaccharides which are accessible on the protein. 
To investigate whether the intracellular form was a biosynthetic precursor, 
digestion with Endo H was carried out. Endo H is an endoglycosidase which 
cleaves only high mannose oligosaccharides, which are present only on 
proteins which are in-between the ER and cis-Golgi biosynthetic pathway.
Digestion analysis was carried out on immunoprecipitated WT DDR1. For WT 
DDR2 however, we had technical difficulties in carrying out 
immunoprecipitations using an anti-DDR2 Ab. We instead expressed a C- 
terminal MYC-tagged DDR2 construct (this construct is described in section
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3.2.3) and carried out immunoprecipitation of DDR2-MYC protein with an 
anti-MYC Ab. Immunoprecipitates of WT DDR1 and DDR2-MYC were 
denatured and incubated with Endo H or PNGase F for 3 hours at 37°C or 
left untreated. The digests were run on SDS-PAGE and analysed by Western 
blot. As seen in Figure 3.3 (a), lane 1, only the lower form of DDR1 is Endo H 
sensitive, whilst the upper form is Endo H resistant, indicating that the lower 
form carries high mannose oligosaccharides and is a biosynthetic form. If the 
difference between the two forms was only due to N-linked glycosylation one 
would expect a single MW species after digestion with PNGase F. However, 
in the presence of PNGase F, DDR1 is still present as two forms (lane 3), 
with the lower form corresponding in MW to the deglycosylated high 
mannose species (approximately 100 kDa; lane 1 versus lane 3).
A similar enzymatic digestion analysis was carried out for DDR2, as shown in 
Figure 3.3 (b). As DDR2 consists of three MW species, the analysis is less 
straight-forward. As seen in lane 1, only the lower band is Endo H sensitive 
and therefore a biosynthetic form of DDR2. With PNGase F, however, three 
different MW species are present (lane 3). Even upon digesting for 20 hours 
with excess enzyme, there is no further reduction in the complexity of the 
observed pattern of bands (lane 4).
To further investigate the reason for heterogeneity, we tested for the 
presence of serine- or threonine-linked (O-linked) glycans. Unlike for N- 
glycosylation, there is no consensus motif for O-glycosylation and this type of 
glycosylation is therefore difficult to predict. We used NetOGIyc 3.1 software 
(Julenius et al., 2005), which identifies O-glycosylation motifs. This predicts a 
putative threonine O-glycosylation site in the DDR ECD, in the extracellular 
juxtamembrane region near the TM domain which is conserved between 
DDR1 and DDR2 (Thr 361 and Thr 358, in DDR1 and DDR2, respectively; 
see Figure 3.4, c). Deglycosylation using O-glycosidase, which cleaves 
serine or threonine-linked, unsubstituted Gal-p(1-3)-GalNAc-a- (O-linked core) 
was carried out. O-glycosidase cannot cleave the O-linked core structure if 
the O-linked core is modified, usually with mono, di ortrisialylation.
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Figure 3.3: Enzymatic deglycosylation of WT DDR1 and DDR2-MYC. (a) 
and (b), Schematic diagram showing putative N-linked (black arrows) and 
O-linked (red arrows) glycosylation sites on DDR1 and DDR2 ECDs. 
Lysates of HEK293 cells transiently expressing DDR1 (a) or DDR2-MYC
(b) were immunoprecipitated with anti-DDR1 Ab (a) or anti-MYC Ab (b). 
The precipitated material was denatured and incubated with either Endo H 
(H), PNGase F (F and F1), no enzyme (-), and for 3 hours at 37°C. In 
addition, DDR2-MYC im mu noprecipitate was incubated with PNGase F for 
20 hours at 37°C (F2). The samples were separated by SDS-PAGE, 
blotted onto nitrocellulose and probed with anti-DDR1 or anti-MYC Ab.
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Figure 3.4: DDR1 and DDR2 are O-glycosylated. (a) and (b), O- 
glycosidase digestion of DDR1 WT and DDR2-MYC, respectively, (c) 
DNA sequence alignment of WT DDRs with DDRTA mutants. Bases 
coding for the conserved threonine residue (T361 in DDR1 and T358 in 
DDR2), predicted to be O-glycosylated, are in blue and the bases coding 
for the alanine residue in the corresponding mutant sequence are in red. 
The amino acids coding for WT DDR1 (358-364) and WT DDR2 (355-361) 
are shown, (d) Endo H and PNGase F digestion of WT DDR1 and 
DDR1TA mutant. Lysates of HEK293 cells transiently expressing WT 
DDR1 (a and d), DDR1TA (d) or DDR2-MYC (b) were immunoprecipitated 
with anti-DDR1 Ab (a and d) or anti-MYC Ab (b). The precipitated material 
was denatured and incubated with either Endo H (H), PNGase F (F), 
Neuraminidase (N), Neuraminidase, O-glycosidase (NO) or 
Neuraminidase, O-glycosidase and PNGase F (NOF) or no enzyme (-) for 
3 hours at 37°C, then separated by SDS-PAGE, blotted onto nitrocellulose 
and probed with anti-DDR1 (a and d) or anti-MYC Ab (b). The position and 
sizes (in kDa) of MW markers are indicated.
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Neuraminidase, an exoglycosidase which cleaves all non-reducing terminal 
branched and unbranched sialic acids, is required to enable O-glycosidase to 
function.
Immunoprecipitates of W T DDR1 and DDR2-MYC were denatured and 
incubated with Endo H, PNGase F, Neuraminidase, both Neuraminidase and 
O-glycosidase or a combination of Neuraminidase, O-glycosidase and 
PNGase F for 3 hours at 37°C. The digests were run on SDS-PAGE and 
analysed by Western blot. As seen in Figure 3.4 (a) lane 3 and 4, only the 
upper form is sensitive to Neuraminidase, shifting slightly compared with the 
untreated protein. A further potential shift produced in the presence of O- 
glycosidase is not apparent in the sample treated with Neuraminidase and O- 
glycosidase (lane 4). However, when PNGase F, Neuraminidase and O- 
glycosidase are added together, a single MW species is formed, indicating 
that the difference between the two DDR1 forms is due to N-glycosylation 
and O-glycosylation.
As seen in Figure 3.4 (b), there is a slight shift in the upper form of DDR2 
upon Neuraminidase, and both Neuraminidase and O-glycosidase addition 
(lane 5 and 6), compared with the untreated sample (lane 4). Upon addition 
of PNGase F, Neuraminidase and O-glycosidase there is a slight shift in the 
upper form (lane 2) compared with sample treated with only PNGase F (lane 
3), but all three MW forms are still present. This indicates that the uppermost 
form is O-glycosylated and that another post-translational modification, 
besides glycosylation, is responsible for the difference between the different 
forms of DDR2.
To confirm the above results, a point mutation was introduced in the DDR1 
amino acid sequence, which resulted in the conversion of the conserved 
threonine which is predicted to be O-glycosylated (Thr 361), to an alanine, in 
order to prevent O-glycosylation. This mutant was digested with Endo H and 
PNGase F (in a similar manner as described for W T DDR) and analysed by 
SDS-PAGE and Western blot (Figure 3.4, d). Lanes 1 and 4 show untreated
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controls and lanes 2 and 5 show Endo H treated samples, of WT DDR1 and 
mutant DDR1 (DDR1TA), respectively. Endo H treatment produces the 
expected shift in the lower MW form, however in this particular experiment 
the Endo H shift is observed as a fuzzy band. This might be due to the very 
low amounts of this species present in the samples.
Digestion with PNGase F produces the two forms of W T DDR1 that we 
normally observe (compare to Figure 3.4, a). However, digestion of DDR1TA 
with PNGase F produces a band which has the same MW as the fully 
deglycosylated receptor (-100 kDa, Figure 3.4, d; lane 3 versus lane 6). This 
result suggests that Thr 361 in DDR1 is a site for O-glycosylation. This result, 
taken together with the result obtained from deglycosylation using O- 
glycosidase, strongly indicates that the difference between the two DDR1 
forms is due to N-linked and O-linked glycosylation. Experiments to confirm 
that DDR2 is O-glycosylated, using the DDR2 O-glycosylation mutant, are 
currently ongoing in the laboratory. However it is likely that for DDR2, there is 
another type of post-translational modification apart from glycosylation, which 
is responsible for the three different MW forms. The different types of 
potential modification are described in section 3.3.
3.2.2. Chemical cross-linking analysis of WT DDRs using BS3
In order to investigate DDR oligomerisation in the context of the full-length 
receptor, chemical cross-linking of DDRs on the cell surface was carried out. 
A membrane impermeable, homobifunctional cross-linker, BS3, was used to 
cross-link the cell surface receptors only. Full-length, W T DDRs were 
transiently over-expressed in HEK293 cells and 48 hours later varying 
concentrations of BS3 were added to the cells and incubated at 37°C for 30 
minutes. Whole cell lysates were run reduced on SDS-PAGE and blotted 
onto nitrocellulose. The blots were probed with anti-DDR1 or anti-DDR2 
antibodies.
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Figure 3.5 (a) shows that in the absence of cross-linker, the DDR1 protein 
migrates around 120 kDa (upper MW form); however, in the presence of BS3, 
additional bands can be seen which migrate at higher MW. Lysates from 
cross-linker treated and untreated cells were run on 5% gels and MW 
analyses of DDR1 protein bands were carried out, as described in Methods. 
By this method, we calculated the size of the higher MW bands for DDR1 to 
be approximately 240 kDa, which correspond to DDR1 dimers. Cross-linking 
analysis was also performed at 4°C for 1 hour, as the low temperature would 
reduce potential receptor internalization. The experiment was carried out 
along with cross-linking at 37°C and the results were compared. There was 
no difference in the amount of cross-linked DDR1 between the two different 
temperatures (data not shown). The ability of DDR1 to oligomerise in the 
absence of ligand was seen in another cell line, MCF-7, a mammary 
carcinoma cell line containing endogenous DDR1 protein. In the presence of 
cross-linker a similar pattern of higher MW bands was visible (Figure 3.5, c). 
Similar results were also observed in a HEK293T cell line stably over­
expressing DDR1 (data not shown) and in a Rat-1 cell line also stably over­
expressing DDR1 (Figure 3.5, d).
DDR2 oligomerisation was studied in transiently transfected in HEK293 cells 
(Figure 3.5, b) and in HEK293T cells stably expressing DDR2 (data not 
shown). In the absence of BS3 there was no cross-linked band, and the 
DDR2 protein migrated at approximately 130 kDa (upper MW form). However, 
on addition of increasing concentrations of cross-linker higher MW bands 
appeared of approximately 250 kDa, as obtained by MW analysis. This value 
corresponds to the MW of DDR2 dimers.
3.2.3. Co-immunoprecipitation studies of WT DDRs
Co-immunoprecipitation experiments were carried out to confirm that DDR1 
and DDR2 dimerise in the absence of collagen. For these experiments, 
initially, N-terminal HA- and MYC-tagged cDNAs of DDR1 and DDR2 were 
made. However, these constructs showed defective expression patterns of
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Figure 3.5: DDR1 and DDR2 form ligand-independent dimers on the cell 
surface, (a) and (b), chemical cross-linking analysis of WT DDR1 (a) and 
WT DDR2 (b) transiently over-expressed in HEK293 cells, (c) and (d), 
chemical cross-linking analysis of endogenous DDR1 in MCF-7 cells (c) 
and Rat-1 cells stably over-expressing WT DDR1 (d). The cells were 
washed once with cold PBS and incubated with BS3 in PBS for 30 minutes 
at 37°C at the concentrations indicated. The reaction was quenched with 
10 mM Tris pH 7.4, followed by cell lysis. Cell lysates were analysed by 
SDS-PAGE and Western blotting. The blots were probed with anti-DDR1 
(a), (c) and (d) or anti-DDR2 (b) Abs. The position and sizes (in kDa) of 
MW markers are indicated.
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DDR protein - the upper form being expressed to a significantly lower extent 
when compared with W T DDRs. Therefore, in response to collagen I, the 
autophosphorylation level of these constructs were significantly decreased 
compared with W T DDRs (data not shown). Subsequently, cDNAs encoding 
C-terminally MYC- and FLAG-tagged DDRs were constructed (see Methods). 
These tagged constructs were tested for their ability to be 
autophosphorylated in response to collagen I. Figure 3.6 (a) shows that the 
expression level and phosphorylation signal for DDR1-MYC and DDR1-FLAG 
is very similar to W T DDR1. Figure 3.6 (b) gives the result for the DDR2 
constructs, which were tested in a similar manner. As for the DDR1 
constructs, the DDR2 constructs are very similar to WT DDR2.
For co-immunoprecipitation assays, DDR-MYC and DDR-FLAG were either 
co-transfected or singly transfected into HEK293 cells. 48 hours later, the 
cells were lysed and the lysates immunoprecipitated with anti-MYC Ab or 
with anti-FLAG mAb and the precipitated material was analyzed by Western 
blotting using the anti-FLAG mAb and anti-MYC Abs. Figure 3.7 (a) shows 
that DDR1-FLAG co-precipitates with anti-MYC Ab and Figure 3.8 (a) shows 
DDR1-MYC co-precipitates with anti-FLAG mAb, when cells were co­
transfected with both tagged constructs. To ensure that the anti-MYC Ab 
does not recognize the FLAG epitope and vice versa, controls were carried 
out where the lysate of cells singly transfected with one epitope-tagged 
receptor, e.g. DDR-FLAG, were immunopreciptated with anti-MYC Ab. When 
blotted with anti-FLAG mAb, no immunoprecipitated DDR-FLAG was seen 
(Figure 3.7, a and b, lower panels, lane 4) indicating that the anti-MYC 
antibody does not recognize the FLAG epitope. The anti-FLAG mAb was also 
tested and the results show that it does not react with the MYC epitope 
(Figure 3.8, a and b, lower panels, lane 1). In vitro mixing controls were 
carried out where lysates of cells singly transfected with DDR-MYC or DDR- 
Flag were mixed together and immunoprecipitated with one Ab and blotted 
with the other Ab (indicated by an asterisk in Figure 3.7 and 3.8). The mixing 
controls showed a negative result as no co-precipitation of two differently
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Figure 3.6: DDR-FLAG and DDR-MYC show normal autophosphorylation, 
similar to WT DDR. WT DDR1, DDR1-MYC or DDR1-FLAG (a), and WT 
DDR2, DDR2-MYC or DDR2-FLAG (b), were transiently over-expressed in 
HEK293 cells. After stimulation with 10 pg/ml collagen I (C) or 1 mM 
sodium orthovanadate (V) cell lysates were analysed by SDS-PAGE and 
Western blotting. The blots were probed with anti-phosphotyrosine mAb 
4G10 (a and b, upper panels) or probed with anti-DDR1 Ab (a and b, lower 
panels). The position and sizes (in kDa) of MW markers are indicated.
107
Chapter 3
IP: anti-MYC 
*
T: DDR1-FLAG + +
DDR1-MYC + + +
175 —
IP: anti-MYC 
*
T: DDR2-FLAG -  + + +
DDR2-MYC + + +
175 __
m m wm
83 — 83 __
Blot: Anti-MYC
175 —
Blot: Anti-MYC
175 __
83 __ 83 —
Blot: Anti-FLAG
Blot: Anti-FLAG
Figure 3.7: Co-immunoprecipitation of DDR-FLAG with DDR-MYC. 
HEK293 cells were transfected with DDR1-FLAG or DDR1-MYC or co­
transfected with both types of constructs (a). The same procedure was 
carried out for DDR2-MYC and DDR2-FLAG (b). (a) and (b), The cells 
were lysed and the lysates immunoprecipitated with anti-MYC mAb. The 
precipitated material was separated by SDS-PAGE, blotted onto 
nitrocellulose and probed with anti-FLAG mAb. The blots were stripped 
and re-probed with anti-MYC Ab. *denotes mixing control where lysates of 
cells singly transfected with DDR-MYC or DDR-FLAG were mixed 
together. T-transfection, IP-immunoprecipitation. The position and sizes (in 
kDa) of MW markers are indicated.
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Figure 3.8: Co-immunoprecipitation of DDR-MYC with DDR-FLAG. 
HEK293 cells were transfected with DDR1-FLAG or DDR1-MYC or co­
transfected with both types of constructs (a). The same procedure was 
carried out for DDR2-FLAG and DDR2-MYC constructs, (a) and (b), The 
cells were lysed and the lysates immunoprecipitated with anti-FLAG mAb. 
The precipitated material was separated by SDS-PAGE, blotted onto 
nitrocellulose and probed with anti-FLAG mAb. The blots were stripped 
and re-probed with anti-MYC Ab. *denotes mixing control where lysates of 
cells singly transfected with DDR-MYC or DDR-FLAG were mixed 
together. T-transfection, IP-immunoprecipitation. The position and sizes (in 
kDa) of MW markers are indicated.
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tagged DDRs were seen, indicating that the tagged receptors need to be 
expressed in the same cell membrane for co-immunoprecipitation to occur.
A similar result was obtained for DDR2. As seen in Figure 3.7 (b), when 
DDR2-MYC and DDR2-FLAG are co-transfected and cell lysates 
immunoprecipitated with the anti-MYC Ab and probed with the anti-FLAG 
mAb, DDR2-FLAG co-immunoprecipitates with DDR2-MYC. Our results also 
show that DDR2-MYC in turn co-immunoprecipitates with DDR2-FLAG 
(Figure 3.8, b) thus confirming that DDR2-FLAG and DDR2-MYC interact 
with one another.
For both DDRs, the lower MW forms of the receptor co-precipitate in addition 
to higher MW receptor, indicating that the biosynthetic precursor forms of the 
DDRs also interact with one another. Furthermore, a higher co-precipitation 
signal of the biosynthetic form of DDR2 was obtained compared with the 
mature DDR2 forms present on the cell surface, suggesting that the 
biosynthetic form may oligomerise to a greater extent than the mature forms. 
As the DDRs are over-expressed in HEK293 cells, this may be due to the 
greater concentration of the precursor form present in the ER.
We next used the co-immunoprecipitation assay to investigate the effect of 
collagen on DDR oligomerisation. HEK293 cells, co-transfected with MYC- 
and FLAG-tagged DDRs, were treated for 90 minutes with collagen I and 
processed as described above. The lysates were immunprecipitated with the 
anti-MYC Ab (for DDR1) or anti-FLAG mAb (for DDR2) and the 
immunoprecipitates were subjected to SDS-PAGE and Western blotting. For 
both DDR1 and DDR2, the blots were first probed with anti-FLAG mAb. As 
seen in Figure 3.9 (a), the levels of DDR1-FLAG co-precipitated with the anti- 
MYC Ab after stimulation with collagen I is very similar to the levels in 
collagen untreated samples. The blot was stripped and re-probed with anti- 
MYC Ab to check the levels of DDR1-MYC, which was found to be similar in 
both stimulated and non-stimulated samples. For DDR2, a similar result was 
seen. The levels of DDR2-MYC co-precipitating with the anti-FLAG mAb was
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Figure 3.9: Collagen stimulation does not increase the levels of DDR 
oligomerisation, (a) Co-immunoprecipitation of DDR1-FLAG with DDR1- 
MYC in the presence of collagen I. (b) Co-immunoprecipitation of DDR2- 
MYC with DDR2-FLAG in the presence of collagen I. For both (a) and (b), 
HEK293 cells were co-transfected with plasmids encoding DDR-MYC and 
DDR-FLAG. Serum-starved cells were incubated with 10 jug/ml collagen I 
for 90 minutes. Cell lysates were immunoprecipitated with anti-MYC Ab 
(a) or anti-FLAG mAb (b), run on SDS-PAGE and blotting onto 
nitrocellulose. The blots were probed with anti-FLAG mAb, stripped and 
re-probed with anti-MYC Ab. The right panels show the corresponding 
activation levels of DDRs in co-immunoprecipitated samples. Aliquots of 
cell lysates were taken out prior to diluting the samples for 
immunoprecipitation, run on SDS-PAGE, blotted onto nitrocellulose and 
probed with anti-phosphotyrosine mAb, 4G10. The blots were stripped 
and re-probed with anti-DDR1 (a) or anti-DDR2 (b) Abs.
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similar for collagen treated versus untreated samples (Figure 3.9, b). This 
result indicates that collagen does not increase the level of DDR dimerisation 
and supports our result that DDRs exist as dimers during biosynthesis.
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3.3. Discussion
In the first part of this study, we have carried out basic biochemical 
characterisation of DDR1 and DDR2. We suspected that the lowest MW 
forms of the DDRs correspond to precursor forms of DDR1 and DDR2. Using 
cell surface biotinylation and digestion with Endo H, we have shown that the 
lowest MW weight forms of both DDRs are intracellularly localised, and 
represent an incompletely glycosylated, high mannose precursor form of the 
DDRs.
In addition, we wanted to know if the intermediate MW form of DDR2 was a 
precursor or a mature form of the receptor. Cell surface biotinylation showed 
that this form is present on the cell surface. In addition, this form is Endo H 
resistant and therefore corresponds to a mature, complex glycosylated form 
of DDR2 protein. Cell surface biotinylation after stimulating the receptors with 
collagen I revealed that whilst the highest MW form the DDRs show ligand- 
dependent activation, the intermediate MW form of DDR2 shows a highly 
reduced level of ligand-dependent autophosphorylation - suggesting that this 
form is in some way inhibited from autophosphorylation. To find out how the 
precursor forms differ from the mature forms, PNGase F digestion was 
carried out, which revealed that N-glycosylation is only partially responsible 
for the difference between the DDR MW forms. As the DDRs contain a 
putative O-glycosylation site in the ECD, we performed digestion analysis 
with neuraminidase and O-glycosidase, which suggested that the DDRs have 
an O-linked sugar modification. Furthermore, mutation of the potential O- 
glycosylation site in DDR1, followed by PNGase F digestion analysis 
confirmed that DDR1 is O-glycosylated.
Cell surface biotinylation in the presence of collagen I revealed that there is 
no change in total protein levels on the cell surface in the absence of 
collagen versus when collagen is present. This indicates that there is very 
little or no internalisation of DDRs upon collagen stimulation for 90 minutes. 
For most RTKs, the receptors are rapidly internalised after ligand stimulation
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thus downregulating cellular responses (Mukherjee et al., 1997). Most of the 
phosphorylated DDRs are found in the cell surface pool and there is no 
enhanced phosphorylation of DDRs located in the intracellular pool, after 
stimulation with collagen (Figure 3.2, a and b). This most likely means that 
the receptors are not endocytosed in an active form; and therefore are not 
signalling from within endosomes - a phenomenon that has been suggested 
for other RTKs such as EGFR and the insulin receptor (reviewed in Baass et 
al., 1995). A plausible explanation for this result could be that, since the 
DDRs function as cell-matrix adhesion receptors, they therefore remain on 
the cell surface for a longer time than most other RTKs, transducing signals 
to the intracellular environment while maintaining adhesion with the ECM.
Although it is clear that in the case of DDR1, both N-linked and O-linked 
glycosylation is required to convert the precursor form to the mature receptor, 
for DDR2, the sugar modifications are not sufficient to convert the precursor 
to the intermediate MW form and subsequently to the highest MW form. The 
pattern of bands seen in HEK293 cells are also observed in primary hepatic 
stellate cells naturally expressing DDR2 (Olaso et al., 2001). In addition, a 
constant ratio of upper versus intermediate form is obtained thus eliminating 
proteolytic degradation to cause this difference. Other potential post- 
translational modifications found on the DDR2 mature form could be, 
palmitoylation, ubiquitinylation or sumoylation. Palmitoylation is the covalent 
attachment of the lipid moiety, palmitic acid and is found on many proteins 
(reviewed in Bijlmakers and Marsh, 2003). For example, transmembrane 
proteins such as the T-cell receptor co-receptor CD8 p (Kennedy and Limbird, 
1994) and the GPCRs such as the a2A and p-2 adrenergic receptors 
(Belanger et al., 2001) are modified by palmitoylation. Integral membrane 
proteins are palmitoylated on cysteines that are either close to the TM 
domain-cytosolic domain boundry, or located in the cytosolic domain itself, 
however a clear consensus sequence for palmitoylation of TM proteins has 
not been discovered (Kennedy and Limbird, 1994; Belanger et al., 2001). In 
addition, not much is known about the function of palmitoylation in TM 
proteins, but there is emerging evidence that palmitoylation could be involved
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in receptor trafficking, as shown by mutagenesis studies on the GPCR, 
CCR5 (Blanpain et al., 2001) and localisation of TM proteins to lipid rafts 
(Webb et al., 2000). However, it is unlikely that DDR2 is palmitoylated as 
there is no suitably localized cysteine residue within the TM domain or TM- 
cytosolic domain boundry.
Another type of post-translational modification is ubiquitination. Upon ligand 
binding, RTKs such as PDGFRp (Mori et al., 1995) and MET (Jeffers et al., 
1997) are modified by the covalent attachment of ubiquitin chains 
(polyubiquitination), which initiates targeting of these receptors to the 
proteasome or lysosome for degradation. In contrast, attachment of a single 
ubiquitin molecule (monoubiquitination) at multiple sites has been shown to 
play a role in receptor endocytosis and trafficking (reviewed in Hicke, 2001). 
Cell surface proteins which are polyubiquitinated or multi-monoubiquitinated, 
show a dense smearing at the higher MW region of the gel, in the presence 
of ligand, as demonstrated for PDGFp and ErbB receptors (Mori et al., 1992; 
Haglund et al., 2003b). We have not observed such smearing in the Western 
blots of DDR immunoprecipitates, therefore it is unlikely that DDR2 is 
polyubiquitinylated or multi-monoubiquitinated. However it cannot be 
excluded that DDR2 is monoubiquitinated at a single site. Monoubiquitination 
at a single lysine residue has been found on other cell surface receptors 
which results in the addition of a single ubiquitin unit of approximately 8  kDa 
thus produces a shift in MW of the protein of interest (reviewed in Haglund et 
al., 2003a). It is therefore possible that the addition of monoubiquitin could 
account for the difference between the intermediate and upper forms of 
DDR2.
However, as monoubiquitinylation is found to be induced upon ligand binding, 
it is likely that DDR2 contains a different type of post-translational 
modification, such as ‘SUMO’ modification. Post-translational modification of 
proteins by the small ubiquitin-like modifier (SUMO) was discovered relatively 
recently, and shown to regulate nuclear transport, stress response, signal 
transduction and cell cycle progression (Matunis et al., 1996, Okura et al.,
115
Chapter 3
1996). Like ubiquitin modification, covalent attachment of SUMO to protein 
targets occurs on lysine residues. Sequence analysis of DDR2 predicts a 
lysine residue in the cytosolic domain to be available for SUMO modification 
(www.abgent.com/doc/sumoploty SUMO modification is reversible, and does 
not appear to target proteins for degradation. It rather alters the target protein 
function through changes in cellular localization, biochemical activation, or 
through protection from ubiquitin-dependent degradation (reviewed in Yeh et 
al., 2000). Most of the known SUMO modified proteins are localized in the 
nucleus (such as p53, PML Ring Finger, RANGAP1) and the cytoplasm 
(IkBoc). More recently the glucose transporters, GLUT 1 which is localised on 
the cell membrane, and GLUT4, were shown to be substrates for 
sumoylation (Giorgino et al., 2000). Future work would involve experimentally 
addressing the possibility of DDR2 to contain monoubiquitin or SUMO 
modification.
In the second part of this study, we investigated whether the DDRs exist as 
dimers on the cell surface, in the absence of ligand. Two different methods 
have been used to show that both DDR1 and DDR2 exist as preformed 
oligomers on the cell surface. Firstly, chemical cross-linking analysis of WT 
DDRs shows that at least a proportion of these receptors exist as ligand- 
independent dimers. This method enables the sizes of the DDR complexes to 
be obtained by MW analysis. In addition, we were able to use this method to 
observe endogenous DDR1 dimerisation in the MCF-7 cell line, and therefore 
a more natural environment for DDR1 than transient over-expression in 
HEK293 cells. Although the sizes of the higher MW bands produced by 
cross-linking correspond to dimers of DDR1 or DDR2, this does not 
necessarily point to the existence of oligomers since some other cellular 
protein of a similar size might be associated with the receptors. Therefore 
another method, co-immunoprecipitation, was used to demonstrate that 
DDRs form oligomers in the absence of ligand. Co-immunoprecipitation 
studies using two differently epitope-tagged DDRs confirmed the cross- 
linking results and demonstrated an association between DDR monomers.
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As shown by experiments using ECD recombinant DDRs in vitro, the DDRs 
need to be dimerised in order to bind collagen - DDR1 only bound collagen 
with high affinity when fused to a dimerising Fc tag (Leitinger, 2003). The 
DDR2 ECD was shown to exist as dimers by chemical cross-linking, while 
DDR1 was a monomer, suggesting that cell surface DDR2 might be expected 
to form dimers in the absence of ligand. Another study using atomic force 
microscopy to investigate the DDR binding site on collagen reported that 
DDR2 needed to be dimerised via an Fc tag, and clustered, in order to bind 
collagen efficiently (Agarwal etal., 2002).
The existence of preformed receptor oligomers in the absence of ligand have 
been reported for the RTKs, EGFR (Gadella and Jovin, 1995; Moriki et al.,
2001). The fibroblast growth factor receptor (FGFR) has also been implicated 
to exist as preformed dimers (Raffioni et al., 1998). Upon studying a KD 
mutant of this receptor, the investigators found that the precursor form of the 
mutant receptor exhibits ligand-independent activation, which is not seen for 
the mature form of the receptor. Based on this, a model was proposed for the 
signalling of this receptor, which implies that normal FGFRs on the cell 
surface are likely to be dimerised in the absence of ligand. In addition, a 
number of cytokine receptors such as transforming growth factor-p (TGFp) 
receptors I and II (Gilboa et al., 1998), the Epo receptor (Constantinescu et 
al., 2001) and the GH receptor (Gent et al., 2002; Brown et al., 2005) have 
been shown to exhibit ligand-independent dimerisation on the cell surface.
As shown by co-precipitation studies, the precursor receptor forms are able 
to interact, suggesting that the DDRs are already oligomerised during 
biosynthesis and remain associated during transport to the cell surface. It is 
likely that dimerisation is required for either DDR biosynthesis and/or 
transport of DDR protein to the cell surface. Oligomerisation of the GH 
receptor in the ER has been shown by co-immunoprecipitation (Gent et al.,
2002). Type I and II TGFp receptors have been shown to form homodimers 
in the ER, as shown by sedimentation velocity of metabolically labelled 
receptors on sucrose gradients (Gilboa etal., 1998).
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Upon establishing that DDRs are predimerised in the absence of ligand, the 
next step was to investigate the effects of collagen on DDR dimerisation. 
Chemical cross-linking studies of DDRs upon stimulation with collagen I, did 
not produce a conclusive result, due to the problem of large MW of trimeric 
collagen-receptor complex (of approximately 500 KDa), which is stabilised 
upon cross-linking. These large complexes most likely do not enter SDS- 
PAGE gels efficiently (data not shown). We used co-immunoprecipitation to 
obtain a preliminary idea of the effect of collagen in DDR dimerisation. As 
shown in Figure 3.9, we did not see a difference in co-precipitation of 
epitope-tagged DDRs after stimulation with collagen I for 90 minutes, when 
compared with co-precipitation levels in unstimulated cells, indicating that 
collagen does not alter the abundance of preformed DDR dimers. This result 
is supported by our finding that the DDRs exist as dimers from the time of 
their synthesis in the ER.
It is therefore likely that collagen binding to DDR dimers results in a 
conformational change within dimeric receptors and not an increase in 
receptor dimers. However other types of experiments need to be carried to 
confirm this; such as fluorescence resonance energy transfer (FRET). FRET 
is a biophysical method which has been used to investigate the effect of 
ligand binding to other cell surface receptors such as the GH receptor (Brown 
et al., 2005); and is a popular method for investigating oligomerisation of a 
number of receptors which belong to the GPCR family (Rocheville et al., 
2000; Cornea et al., 2001; Floyd et al., 2003; Overton et al., 2003).
In summary, the results presented in this chapter suggest that the DDRs are 
dimerised in the ER during biosynthesis and are transported to the cell 
surface as dimers. This dimerised receptor complex is inactive by virtue of 
the cytoplasmic KDs being held in an inhibitory conformation. Collagen 
binding most likely induces a re-orientation of receptor monomers within the 
dimer, allowing the KDs to become activated.
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Analysis of receptor domains responsible for DDR 
oligomerisation and/or activation
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4.1. Introduction
Both DDR1 and DDR2 are composed of an N-terminal discoidin domain 
(DS), followed by a region of no known homology (domain X), a TM domain, 
a juxtamembrane domain and a C-terminal catalytic tyrosine KD. DDR1 
contains an additional region rich in proline and glycine situated between the 
domain X and the TM domain (see Introduction and Figure 1.9).
Studies with DDR1 and DDR2 deletion mutants (Leitinger, 2003) revealed a 
difference between DDR1 and DDR2 in the contribution of protein domains 
for collagen-induced DDR activation. DDR1 needed the whole ECD for 
collagen binding and receptor activation, whereas for DDR2 a large part of 
the ECD was not required. For DDR2 the DS domain seemed sufficient for 
both collagen binding and receptor activation. Therefore, DDR1 and DDR2 
might show significant differences in the context of receptor domains involved 
in dimer formation. Chemical cross-linking of cell surface-expressed DDR1 
and DDR2 deletion mutants were carried out in order to define which parts of 
the ECD was involved in dimerisation and to investigate the importance of 
the TM domain, cytoplasmic juxtamembrane domain and KD for DDR 
dimerisation. In addition, to confirm cross-linking results, co- 
immunoprecipitation studies of epitope-tagged DDR1 and DDR2 mutants 
were carried out.
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4.2 Results
4.2.1. Chemical cross-linking analysis of DDR1 deletion mutants
Various DDR1 deletion mutants were tested for their ability to be cross-linked 
by BS3. Figure 4.1 shows schematic drawings of full-length W T DDR1 and 
DDR1 deletion mutants. For these experiments the mutants were transiently 
over-expressed in HEK293 cells along with the W T DDR1. The cells were 
incubated with BS3, followed by cell lysis, SDS-PAGE and Western blotting 
using the anti-DDR1 Ab.
So far, all studies have been carried out with the DDR1b isoform. An 
experiment was carried out to compare the cross-linking of two different 
isoforms of DDR1, DDR1a and DDR1b, with each other. The difference 
between the two isoforms is that DDR1 b has a 37 amino acid insertion in the 
juxtamembrane region, and we wanted to investigate if the lack of this 
insertion in DDR1a would affect its ability to be cross-linked by BS3. In the 
same manner, a DDR1 deletion mutant, MDN, which lacks the KD, was 
tested. For this experiment DDR1a, DDR1b and MDN cDNAs were 
expressed from a different vector, pRK5 (obtained from Sugen Inc, San 
Francisco, CA). The expression level from this vector is higher than that of 
DDR1 expressed from the pcDNA3.1 vector which was used to express all 
other DDR1 cDNAs. Both DDR1a and DDR1b isoforms show a very similar 
pattern of higher oligomer bands in the presence of BS3 (Figure 4.2). The 
MDN mutant, which lacks the KD, showed oligomers which correspond to 
dimers. As this mutant is known to be dominant negative, it is expected to be 
able to dimerise, and the cross-linking result confirms this.
Subsequently a DDR1 mutant lacking the entire cytosolic region (DDR1 
ECTM) was tested to investigate if the cytosolic juxtamembrane region was 
needed for DDR1 dimerisation (Figure 4.3, a and b). The blots were probed 
with anti-DDR1 Ab, 74A, which recognises an epitope at the N-terminus of 
DDR1. This Ab does not recognise WT DDR1 as strongly as the C-terminal 
anti-DDR1 Ab used in most other blots to detect DDR1 with intact
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Figure 4.1: Schematic representation of WT DDR1 and DDR1 deletion 
mutants. The mutant ADS1 lacks the DS domain whilst DS1-1 lacks the 
region between the DS domain and P/G rich region (domain X), DS1-2 
lacks most of the region between the DS domain and the TM domain (i.e. 
the domain X and P/G rich region). The APG mutant has the P/G rich 
region deleted. The two cytoplasmic deletion mutants are ECTM (which 
lacks the entire cytoplasmic domain) and MDN (which lacks only the 
tyrosine KD). The double deletion mutant, DS1TM, contains deletion of the 
domain X, P/G rich region and the entire cytoplasmic domain, whilst the 
double mutant ADS1TM, has the DS domain and the entire cytoplasmic 
domain deleted. The numbers below each mutant refer to the deleted 
amino acids.
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Figure 4.2: The KD is not necessary for DDR1 dimer formation. HEK293 
cells were transfected with DDR1 KD deletion mutant, MDN, and two 
different isoforms of WT DDR1, DDR1a and DDR1b. 48 hours later, the 
cells were washed once with cold PBS and incubated with the indicated 
concentrations of BS3 in PBS for 30 minutes at RT. The reaction was 
quenched with 10 mM Tris pH 7.4. The cells were lysed and cell lysates 
were were run reduced on 7.5% SDS-PAGE and blotted onto 
nitrocellulose. The blots were probed with anti-DDR1 (74A) Ab which 
recognises an N-terminal epitope of DDR1. Boxed areas show dimer 
bands. The position and sizes (in kDa) of MW markers are indicated. The 
above three cDNAs were expressed from a different vector, pRK5, which 
gives strong expression of DDRs, hence the signal for the WT DDR 
oligomer bands are greater than that obtained in Figure 4.3 (PTO), even 
though both blots were probed with the 74A Ab, which gives a weaker 
signal than the anti-DDR1 Ab against the C-terminus.
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Figure 4.3: The cytoplasmic domain is not required for DDR1 dimerisation.
(a) HEK293 cells were transiently transfected with the DDR1 deletion 
mutants MDN, ECTM or WT DDR1. 48 hours later, the cells were washed 
once with cold PBS and incubated with 0.3 mM BS3 in PBS for 30 minutes, 
RT. The reaction was quenched with 10 mM Tris pH 7.4. The cells were 
lysed and cell lysates were were run reduced on 7.5% SDS-PAGE and 
blotted onto nitrocellulose. Black arrows point to the dimer bands, (b) Cell 
lysates of MDN and ECTM samples were loaded onto 5% SDS-PAGE and 
immunoblotted as described above. Black arrows point to the position of 
monomers (M) - which runs with the gel front - and dimers (D). The 
position and sizes (in kDa) of MW markers are shown.
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cytoplasmic domains. Hence a longer exposure blot for WT DDR1 is shown 
separately (a, left panel), in order to clearly visualize the dimer band. Higher 
oligomer bands are seen for DDR1 ECTM mutant, and DDR1 MDN, proving 
that the cytoplasmic domain is not required for DDR1 dimerisation. In the 
presence of 0.1 mM cross-linker, dimers are clearly visible of molecular 
weights approximately 160 kDa and 140 kDa (as estimated by MW analysis 
on 5% SDS-PAGE, see Figure 4.3, b) for DDR1 MDN and DDR1 ECTM, 
respectively.
Having established that the cytoplasmic domain is not required for DDR1 
dimerisation, the involvement of different subdomains of the ECDs was 
tested by chemical cross-linking analysis of four extracellular deletion 
mutants, DS1-1, DS1-2, ADS1 and APG (schematically shown in Figure 4.1). 
Figure 4.4 shows the results of the chemical cross-linking analysis. As seen 
in Figure 4.4 (a), ADS1, which lacks the DS domain, shows a higher MW 
band in the presence of BS3 (of approximately 200 kDa) which corresponds 
to ADS1 dimers. However, the DDR1 deletion mutant APG, which lacks the 
P/G rich region, does not show a higher MW weight band which might 
correspond to dimers of APG. Furthermore, as seen in Figure 4.4 (b), the 
DS1-1 mutant, which lacks the domain X, and DS1-2 mutant, which lacks the 
domain X plus the P/G rich region, do not show any corresponding dimer 
bands.
A reason for the lack of cross-linking of APG, DS1-1 and DS1-2 could be that 
these proteins are not expressed on the cell surface, therefore the mutants 
were tested for cell surface expression.
4.2.2. Test for cell surface expression of DDR1 deletion mutants APG, 
and DS1-1 and DS1-2
The DDR1 deletion mutants, DS1-1, DS1-2 and ADS1 were previously tested 
for collagen-dependent autophosphorylation (Leitinger, 2003), and found to 
be defective in this process. Subsequently, the APG mutant was made and
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Figure 4.4: The ECD is not required for DDR1 dimerisation. HEK293 cells 
were transfected with each of the above DDR1 deletion mutants and WT 
DDR1. 48 hours later, the cells were washed once with cold PBS and 
incubated with 0.3 mM BS3 in PBS for 30 minutes at RT. The reaction was 
quenched with 10 mM Tris pH 7.4. The cells were lysed and cell lysates 
were were run reduced on 7.5% SDS-PAGE and blotted onto 
nitrocellulose. The blots were probed with anti-DDR1 Ab. A black arrow 
points to ADS1 dimers. The position and sizes (in kDa) of MW markers are 
indicated.
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tested for collagen-induced autophosphorylation. As seen in Figure 4.5, WT 
DDR1 produced a clear phosphorylation signal in response to collagen I 
whilst the APG mutant was negative for collagen-dependent 
autophosphorylation.
We carried out cell surface biotinylation and digestion with Endo H and 
PNGase F enzymes on APG, DS1-1 and DS1-2 mutants to investigate 
whether these proteins were on the cell surface. For cell surface biotinylation, 
these mutants were transiently expressed in HEK293 cells, and incubated 
with 3.5 mM Sulfo-NHS-LC-Biotin for 30 minutes on ice. The reaction was 
quenched with 100 mM glycine, followed by cell lysis. The cell lysates were 
incubated with streptavidin sepharose beads to pull-down biotinylated cell 
surface receptors. The supernatant was immunoprecipitated with anti-DDR1 
Ab to recover the intracellular DDR1 receptor pool. Figure 4.6 (a) shows that 
both DS1-2 and APG mutants are not present in the cell surface pool (lane S) 
and are instead intracellularly localised (lane I). Figure 4.6 (c) shows a 
control experiment with an intracellular protein Rho-GDI, carried out at the 
same time, showing no intracellular protein on the cell surface. To confirm 
the biotinylation results, digestion with Endo H and PNGase F were carried 
out (Figure 4.6, c). Immunoprecipitates of APG, DS1-1 and DS1-2, were 
denatured and incubated with 5 units of Endo F or PNGase F enzyme for 
three hours at 37°C, subjected to SDS-PAGE and Western blotting. The APG 
and DS1-1 proteins were both sensitive to Endo H, indicated by the shift to a 
lower MW form in the presence of this enzyme. Thus the APG and DS1-1 
proteins contain high mannose sugars and therefore all of the protein for 
these two mutants are most likely present as intracellular biosynthetic forms. 
For DS1-2, there is no shift upon Endo H or PNGase F digestion. The amino 
acid sequence of this mutant contains no potential N-linked glycosylation 
sites and therefore one cannot infer from Endo H digestion whether DS1-2 is 
present only as a biosynthetic precursor form.
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Figure 4.5: DDR1 APG is defective in collagen-induced
autophosphorylation. WT DDR1 or DDR1 APG were transiently expressed 
in HEK293 cells. After stimulation with 10 jag/ml collagen 1 (C) or 1 mM 
sodium orthovanadate (V) cell lysates were analysed by SDS-PAGE and 
Western blotting. The blots were probed with anti-phosphotyrosine mAb 
4G10 (upper panel) or probed with anti-DDR1 Ab (lower panel). The 
position and sizes (in kDa) of MW markers are indicated.
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Figure 4.6: Cell surface expression of APG, DS1-1 and DS1-2. (a) 
HEK293 cells transfected with cDNA of APG or DS1-2 were incubated 
with 3.5 mM Sulfo-NHS-LC-Biotin in PBS for 30 minutes at 4°C. The 
reaction was terminated with 100 mM glycine. The cell lysates were 
incubated with streptavidin sepharose beads and bound and free protein 
was separated by centrifugation to pellet (containing cell surface 
receptors) and supernatant (containing intracellular receptors) fraction. 
The supernatant was immunoprecipitated with anti-DDR1 Ab (a) or Rho- 
GDI Ab (b). An equivalent lysate volume was incubated with anti-DDR1 Ab 
to analyze the total DDR protein in the sample. All samples were run 
reduced on 7.5% SDS-PAGE and blotted onto nitrocellulose and probed 
with anti-DDR1 Ab (a) or Rho-GDI (b). Blue arrow points to DS1-2 protein. 
T-total protein present in 0.5 ml lysate, S-cell surface receptors, I- 
intracellular receptors, (c) Enzymatic deglycosylation of APG, DS1-1 and 
DS1-2. HEK293 cells were transfected with cDNAs of each of the 
constructs. 48 hours later the cells were lysed and the lysates 
immunoprecipitated with anti-DDR1 Ab. The precipitated material was 
denatured and incubated with either Endo H (H), PNGase F (F) or no 
enzyme (-) for 3 hours at 37°C, then separated by 7.5% SDS-PAGE, 
blotted onto nitrocellulose and probed with anti-DDR1 Ab. The position 
and sizes (in kDa) of MW markers are indicated.
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Table 4.1 summarises the results of the various DDR1 mutants’ ability to be 
activated by collagen I (results for DS1-1, DS1-2 and ADS2 mutants are 
taken from Leitinger, 2003) and their ability to be cross-linked by BS3.
4.2.3. Chemical cross-linking analysis of DDR2 deletion mutants
In the case of DDR2, ECD mutants and mutants lacking the cytosolic domain 
were made and tested for their ability to be cross-linked by BS3. The two 
DDR2 ECD deletion mutants DS2, which lacks most of the region between 
the DS domain and the TM region, and ADS2, which lacks the DS domain, 
are schematically represented in Figure 4.7.
Figure 4.8 shows the results of the chemical cross-linking analysis of the 
DDR2 mutant lacking the cytosolic domain (DDR2-ECTM-MYC). A MYC tag 
at the C-terminal end of the construct was introduced as there is no antibody 
which can recognise the ECD of DDR2. Dimers corresponding to a MW 
weight of 170 kDa were seen upon cross-linking with 0.3 mM BS3 and 1.0 
mM BS3. Therefore the cytosolic domain is not necessary for DDR2 
dimerisation.
To test whether a subdomain of the ECD was involved instead, we analysed 
cross-linking of the two DDR2 deletion mutants ADS2 and DS2 (Figure 4.9). 
For DS2, the monomeric protein has a MW of about 110 kDa and forms 
dimers which co-migrate with the marker of 212 kDa upon cross-linking. The 
dimer bands for ADS2, which appear around 220 kDa, are at low intensity 
due to the low expression of this mutant compared to WT DDR2 and ADS2 
expression. Taken together, neither the DS domain nor the domain X are 
necessary for DDR2 dimerisation. Collagen-dependent activation assays of 
ADS2 and DS2 were carried out previously (Leitinger, 2003) and the results 
are summarised in Table 4.2, along with the cross-linking data.
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WTDDR1 DS1 DS1-2 ADS1 APG MDN ECTM1
Collagen-dependent
autophosphorylation +  - - - - - -
Ability to be cross- 
linked by BS3
DS1TM
Table 4.1: Summary of the ability of DDR1 deletion mutants to
activate in response to collagen I and to be cross-linked by BS3
Chapter 4
WT DDR2 ADS2 DS2 ECTM2 DS2TM ADS2TM
Collagen-dependent
autophosphorylation
Ability to be cross-
linked by BS3 +  +  +  +  +
Table 4.2: Summary of the ability of DDR2 deletion 
mutants to activate in response to collagen I and to be 
cross-linked by BS3
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Figure 4.7: Schematic representation of WT DDR2 and DDR2 deletion 
mutants. The mutant ADS2 lacks the DS domain only and the mutant DS2 
lacks most of the region between the DS domain and the TM domain. The 
ECTM2 mutant lacks the entire cytoslic region. The double mutants 
ADS2TM and DS2TM lack the DS domain and the cytosolic domain 
(ADS2TM) and the domain X and the cytoslic domain (DS2TM). The 
amino acids deleted are given below each mutant.
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Figure 4.8: The cytosolic domain is not necessary for DDR2 dimerisation. 
HEK293 cells were transfected with DDR2 ECTM-MYC (ECTM2-MYC) or 
WT DDR2-MYC. 48 hours later, the cells were washed once with cold PBS 
and incubated with the indicated concentrations of BS3 in PBS for 30 
minutes at RT. The reaction was quenched with of 10 mM Tris pH 7.4. The 
cells were lysed and cell lysates were run reduced on 7.5% SDS-PAGE 
and blotted onto nitrocellulose. The blots were probed with anti-MYC Ab. 
The position and sizes (in kDa) of MW markers are indicated.
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Figure 4.9: Most of the ECD of DDR2 is not necessary for DDR2 dimer 
formation. HEK293 cells were transfected with each of the above DDR2 
deletion mutants, DS2, ADS2 or WT DDR2. 48 hours later, the cells were 
washed once with cold PBS and incubated with the indicated 
concentrations of BS3 in PBS for 30 minutes at RT. The reaction was 
terminated by the addition of 10 mM Tris pH 7.4. The cells were lysed and 
cell lysates were were run reduced on 7.5% SDS-PAGE and blotted onto 
nitrocellulose. The blots were probed with anti-DDR2 mAb. The position 
and sizes (in kDa) of MW markers are indicated. Black arrows point to 
bands corresponding to dimers of DS2 and ADS2. The blot showing ADS2 
had to be over-exposed as the expression level of this mutant is low.
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4.2.4. Co-immunoprecipitation studies of epitope-tagged DDR1 deletion 
mutants
In order to verify the results of cross-linking analysis of DDR1 and DDR2 
deletion mutants, C-terminal MYC- and FLAG-tagged DDR1 and DDR2 
deletion mutants were made and used for co-immunoprecipitation 
experiments.
DDR1 deletion constructs, epitope-tagged with MYC or FLAG, were either 
co-transfected or singly transfected into HEK293 cells. The cells were lysed 
48 hours later, and the lysates immunoprecipitated with anti-MYC Ab or with 
anti-FLAG mAb and the precipitated material was analyzed by Western 
blotting using the anti-FLAG mAb or anti-MYC Ab. As expected from the 
cross-linking results, the DDR1 cytoplasmic deletion mutant shows co­
precipitation of FLAG-tagged protein with the anti-MYC Ab (Figure 4.10). The 
same experiment carried out with DDR1 ECD mutants gave a similar, 
positive result (Figure 4.11). As seen in Figure 4.11 (a), in cells co­
transfected with ADS1-MYC and ADS1-FLAG, ADS1-FLAG co-precipitates 
with the anti-MYC Ab. The same experiment was carried out with the two 
ECD mutants, DS1-1 and DS1-2, which gave a negative result in the cross- 
linking assay and were shown to be most likely intracellulary localised. Both 
DS1-1-FLAG and DS1 -2-FLAG co-precipitate with the respective MYC- 
tagged proteins, DS1-1-MYC and DS1-2-MYC (Figure 4.11, b and c). In 
addition, the intracellularly localised mutant, APG, also shows co-precipitation 
of FLAG-tagged protein with the anti-MYC Ab. These results show that the 
above mentioned subdomains of the ECD of DDR1 are not required for 
DDR1 interaction. Furthermore, the intracellular DDR1 mutants can interact, 
which is similar to the result obtained for the lower forms of the WT DDRs.
To rule out that DDR1 dimerisation is due to multiple interactions along the 
entire ECD (in which case individual domain deletions within a homodimer 
might be tolerated), we co-expressed two different ECD deletion mutants that 
are not expected to be able to interact via their ECD. The DS1-2 construct 
retains the DDR1 DS domain, but places it in an unnatural position close to
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Figure 4.10: Co-immunoprecipitation of epitope-tagged DDR1 cytosolic 
domain deletion mutant. HEK293 cells were singly transfected with 
epitope-tagged cDNA of the deletion construct or co-transfected with both 
FLAG- and MYC-tagged cDNA. The cells were lysed and the lysates 
immunoprecipitated with anti-MYC Ab. The precipitated material was 
separated by 10% SDS-PAGE, blotted onto nitrocellulose and probed with 
anti-MYC or anti-FLAG mAb. *denotes mixing control where lysates of 
cells singly transfected with MYC- or FLAG-tagged mutants were mixed 
together. T-transfection; IP-immunoprecipitation. The blue arrow points to 
ECTM1-MYC, which is expressed only as a precursor form and runs just 
above Ig bands. Red arrows point to ECTM1-FLAG, of which both mature 
and precursor forms are expressed. The ECTM1 protein runs just above 
the Ig bands. The position and sizes (in kDa) of MW markers are indicated.
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Figure 4.11: Co-immunoprecipitation of MYC- and FLAG-tagged DDR1 
ECD deletion mutants. For each deletion mutant, HEK293 cells were 
singly transfected with epitope-tagged cDNA of the deletion construct or 
co-transfected with both FLAG- and MYC-tagged cDNA. The cells were 
lysed and the lysates immunoprecipitated with anti-MYC Ab. The 
precipitated material was separated by 7.5% SDS-PAGE, blotted onto 
nitrocellulose and probed with anti-MYC or anti-FLAG mAb. Blue arrows 
point to FLAG-tagged mutants. Black arrows point to Ig bands. *denotes 
mixing control where lysates of cells singly transfected with MYC- or 
FLAG-tagged mutants were mixed together. T-transfection; IP- 
immunoprecipitation. The position and sizes (in kDa) of MW markers are 
indicated.
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the TM domain. The co-expressed ADS1 construct, on the other hand, is 
missing the DS domain, and retains the rest of the DDR1 ECD. Co- 
immunoprecipitation studies (Figure 4.12) indicated no impairment in the 
ability of these proteins to associate, showing that the entire DDR1 ECD is 
dispensable for DDR1 dimerisation.
We subsequently made two double deletion mutants of DDR1: DS1TM 
(lacking domain X, P/G rich and cytosolic regions) and ADS1TM (which lacks 
the DS domain and cytosolic region); both MYC- and FLAG-tagged for 
carrying out co-immunoprecipitation studies. The epitope-tagged ADS1TM 
mutants were not expressed by transiently transfected HEK293 cells 
however, and therefore we could only examine co-immunoprecipitation of 
DS1TM-MYC and DS1TM-FLAG. As seen in Figure 4.13, MYC-tagged 
DS1TM co-precipitates with DS1TM-FLAG, indicating that, in the absence of 
the cytoplasmic domain, both the DS domain and the TM domain are 
sufficient for DDR1 dimerisation.
A control experiment was carried out to establish that the interactions 
observed were not due to non-specific hydrophobic interactions between 
DDR1 mutant proteins. We used another RTK, fibroblast growth factor 
receptor 2 (FGFR2), tagged with six MYC epitopes at the C-terminus 
(FGFR2-6MYC), and co-transfected this receptor with DDR1-FLAG. As seen 
in Figure 4.14 (a), upon immunoprecipitation with the anti-MYC Ab and 
blotting with the anti-FLAG mAb, there is no DDR1-FLAG protein co- 
precipitating with FGFR-6 MYC protein. The experiment was performed vice 
versa (Figure 4.14, b). Immunoprecipitating with the anti-FLAG mAb and 
blotting with anti-MYC Ab does not show FGFR-6 MYC protein co- 
precipitating with DDR1-FLAG. A positive control for co-precipitation was 
carried out in the same experiment using DDR1-MYC and DDR1-FLAG, 
where DDR1-FLAG co-precipitates with the anti-MYC Ab.
Another control experiment was carried out where cells were lysed in RIPA 
buffer containing 0.1% SDS. RIPA buffer has been used in co-
139
Chapter 4
IP: anti-MYC 
*
T: DS1-2-FLAG - + + +
ADS1-MYC + + + -
175 —
62—  ~  ,,
Blot: anti-MYC
83 —
6 2 -
Blot: anti-FLAG
Figure 4.12: Co-immunoprecipitation of DDR1 ECD mutants, DS1-2- 
FLAG with ADS1-MYC. HEK293 cells were singly transfected with MYC- 
or FLAG-tagged cDNA of the deletion construct or co-transfected with 
both FLAG- and MYC-tagged constructs. The cells were lysed and the 
lysates immunoprecipitated with anti-FLAG mAb. The precipitated 
material was separated by 7.5% SDS-PAGE, blotted onto nitrocellulose 
and probed with the anti-MYC mAb. The blot was stripped and re-probed 
with the anti-FLAG mAb. *denotes mixing control where lysates of cells 
singly transfected with MYC- or FLAG-tagged mutants were mixed 
together. T-transfection; IP-immunoprecipitation. The position and sizes 
(in kDa) of MW markers are indicated.
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Figure 4.13: Co-immunoprecipitation of epitope-tagged DDR1 double 
deletion mutant, DS1TM-FLAG with DS1TM-MYC. HEK293 cells were 
singly transfected with MYC- or FLAG-tagged cDNA of the deletion 
construct or co-transfected with both FLAG- and MYC-tagged constructs. 
The cells were lysed and the lysates immunoprecipitated with anti-FLAG 
mAb. The precipitated material was separated by 10% SDS-PAGE, 
blotted onto nitrocellulose and probed with anti-FLAG mAb. The blot was 
stripped and re-probed with the anti-MYC Ab. *denotes mixing control 
where lysates of cells singly transfected with MYC- or FLAG-tagged 
mutants were mixed together. The red arrow points to DS1TM-FLAG 
protein which runs just below the Ig band. T-transfection; IP- 
immunoprecipitation. The position and sizes (in kDa) of MW markers are 
indicated.
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Figure 4.14: DDR1 does not interact with FGFR2 in vivo, (a) DDR1- 
FLAG does not co-precipitate with MYC-tagged FGFR2 (FGFR2-6MYC).
(b) FGFR2-6MYC does not co-precipitate with WT DDR1-FLAG. For both 
(a) and (b), HEK293 cells were singly transfected with FGFR2-6MYC, 
DDR1-FLAG and DDR1-MYC cDNA or co-transfected with FGFR2-6MYC 
and DDR1-FLAG or DDR1-MYC or DDR1-FLAG cDNA. The cells were 
lysed and the lysates immunoprecipitated with anti-MYC Ab (a) or anti- 
FLAG mAb (b). The precipitated material was separated by 7.5% SDS- 
PAGE, blotted onto nitrocellulose and probed with anti-FLAG mAb. The 
blots were stripped and re-probed with anti-MYC Ab. *denotes mixing 
control where lysates of cells singly transfected with MYC- or FLAG- 
tagged constructs were mixed together. T-transfection; IP- 
immunoprecipitation. The position and sizes (in kDa) of MW markers are 
indicated.
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immunoprecipitation studies of GPCRs, as the presence of SDS disrupts 
hydrophobic protein interactions (McVey et al., 2000). The experiment was 
carried out with epitope-tagged DDR1 deletion mutant, DS1-1. This mutant 
was used as it showed a negative result for cross-linking. As seen in Figure 
4.15 (a), even upon lysing in RIPA buffer, both DDR1-MYC and DS1-FLAG 
still co-precipitates with their respective FLAG-tagged (for WT DDR1) or 
MYC-tagged (for DS1-1 and WT DDR1) counterparts. There is no reduction 
in the levels of co-precipitation when compared with a parallel experiment 
performed using NP40 lysis buffer (Figure 4.15, b). These results indicate 
that the interactions between DDR1 are not non-specific hydrophobic 
interactions but due to specific domain contacts.
4.2.5. Co-immunoprecipitation studies of epitope-tagged DDR2 deletion 
mutants
In the case of DDR2, a very similar result was obtained for co- 
immunoprecipitation of domain deletion mutants. The cytosolic deletion 
mutant, DDR2 ECTM-FLAG, co-precipitates with DDR2-ECTM-MYC protein 
as seen Figure 4.16. In addition, when the epitope-tagged ECD mutants of 
DDR2 are co-transfected and cell lysates immunoprecipitated with the anti- 
MYC Ab and immunoblotted with the anti-FLAG mAb, DS2-FLAG co- 
immunoprecipitates with DS2-MYC (Figure 4.17, a) and ADS2-FLAG co­
precipitates with ADS2-MYC (Figure 4.17, b), thus confirming that both the 
DS domain and the domain X, on their own, are not required for DDR2 to 
oligomerise.
Since neither of the single deletion mutants showed an inability to interact, 
double deletion mutants of DDR2 were made. The double mutant DS2TM 
has both the domain X and the cytosolic domain deleted while ADS2TM has 
both the discoidin domain and cytosolic domain deleted. The mutants contain 
C-terminal MYC/FLAG epitope tags in order to be used in co- 
immunoprecipitation experiments. Cross-linking studies have shown that 
these mutants are able to form oligomers, albeit at a low level (data not
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Figure 4.15: Co-immunoprecipitation of epitope-tagged DS1 mutant and 
WT DDR1 in RIPA lysis buffer versus NP40 lysis buffer, (a) Co- 
immunoprecipitation of DS1 mutant in RIPA versus NP40 lysis buffer, (b) 
Co-immunoprecipitation of WT DDR1 in RIPA versus NP40 lysis buffer. 
For both (a) and (b), HEK293 cells were singly transfected with epitope- 
tagged cDNA of the deletion construct or co-transfected with both FLAG- 
and MYC-tagged cDNA. The cells were lysed and the lysates 
immunoprecipitated with anti-MYC Ab (a) or anti-FLAG mAb (b). The 
precipitated material was separated by SDS-PAGE, blotted onto 
nitrocellulose and probed with anti-MYC Ab (a) or anti-FLAG mAb (b). The 
blots were stripped and re-probed with either anti-FLAG mAb (a) or anti- 
MYC Ab (b). *denotes mixing control where lysates of cells singly 
transfected with MYC or FLAG-tagged mutants were mixed together. T- 
transfection; IP-immunoprecipitation. The position and sizes (in kDa) of 
the MW markers are indicated.
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Figure 4.16: Co-immunoprecipitation of DDR2 cytosolic deletion mutant, 
ECTM2-MYC with ECTM2-FLAG. HEK293 cells were singly transfected 
with MYC- and FLAG-tagged cDNA of DDR2 ECTM (ECTM2) construct or 
co-transfected with both MYC- and FLAG-tagged cDNA. The cells were 
lysed and the lysates immunoprecipitated with anti-FLAG Ab. The 
precipitated material was separated by 7.5% SDS-PAGE, blotted onto 
nitrocellulose and probed with anti-MYC or anti-FLAG Ab. *denotes mixing 
control where lysates of cellssingly transfected with MYC- or FLAG-tagged 
mutants were mixed together. T-transfection; IP-immunoprecipitation. The 
position and sizes (in kDa) of MW markers are indicated.
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Figure 4.17: Co-immunoprecipitation of epitope-tagged DDR2 ECD 
deletion mutants. For each deletion mutant shown above, HEK293 cells 
were singly transfected with epitope-tagged cDNA of the deletion construct 
or co-transfected with both FLAG- and MYC-tagged cDNA. The cells were 
lysed and the lysates immunoprecipitated with anti-MYC Ab. The 
precipitated material was separated by SDS-PAGE, blotted onto 
nitrocellulose and probed with anti-MYC or anti-FLAG Ab. *denotes mixing 
control where lysates of cells singly transfected with MYC- or FLAG-tagged 
mutants were mixed together. T-transfection; IP-immunoprecipitation. The 
position and sizes (in kDa) of MW markers are indicated.
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shown). Therefore, they are expressed on the cell surface to a certain extent. 
The MW of the cross-linked bands correspond to dinners of the upper, and 
most likely, fully glycosylated forms of both DS2TM, (which has an expected 
MW around 40 kDa) and ADS2TM (expected MW around 56 kDa).
Figure 4.18 (a) shows that DS2TM-MYC can co-immunoprecipitate with the 
anti-FLAG mAb, and in a similar manner, Figure 4.18 (b) shows ADS2TM- 
MYC co-immunoprecipitating with the anti-FLAG mAb. Again, as for the other 
DDR2 deletion mutants and WT DDR2, the lower MW, precursor forms of 
both double deletion mutants co-precipitate more strongly than the mature, 
cell surface forms. These results show that the combined deletion of both the 
DS domain and the cytosolic domain or the domain X and the cytosolic 
domain are not sufficient to disrupt DDR2 dimerisation.
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Figure 4.18: Co-immunoprecipitation of epitope-tagged DDR2 double 
deletion mutants, DS2TM and ADS2TM. For each double deletion mutant 
shown above, HEK293 cells were singly transfected with epitope-tagged 
cDNA of the construct or co-transfected with both FLAG- and MYC-tagged 
cDNA. The cells were lysed and the lysates immunoprecipitated with anti- 
FLAG mAb. The precipitated material was separated by SDS-PAGE, 
blotted onto nitrocellulose and probed with anti-MYC or anti-FLAG Ab. 
Panel (a) and (b) show the result for DS2TM and ADS2TM, respectively. 
*denotes mixing control where lysates of cells singly transfected with MYC 
or FLAG-tagged mutants were mixed together. Blue arrows point to FLAG- 
tagged mutants, and the red arrows point to the corresponding, co­
precipitated MYC-tagged mutant. Black arrows point to Ig bands. T- 
transfection; IP-immunoprecipitation. The position and sizes (in kDa) of 
MW markers are indicated.
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4.3. Discussion
In this chapter we have attempted to define the domain/s involved in DDR 
dimerisation. Chemical cross-linking studies carried out on DDR1 
cytoplasmic deletion mutants, DDR1 MDN and DDR1 ECTM, showed clearly 
these mutants’ ability to form ligand-independent dimers. Therefore both the 
KD and the intracellular juxtamembrane region are not required for DDR1 
dimer formation in the absence of ligand. This result is confirmed by co- 
immunoprecipitation studies of epitope-tagged DDR1 ECTM. There has been 
little evidence for the involvement of the cytosolic domain in the dimerisation 
of other RTKs. A role for the cytosolic domain in RTK dimerisation has been 
implied for the ErbB family member, ErbB2 (Penuel et a/., 2002). ErbB2, 
unlike the other ErbB receptors, can be activated by ligand-independent 
mechanisms. One mechanism is by ErbB2 self-association, which is thought 
to be due to receptor over-expression (Di Fiore et al., 1987). By chemical 
cross-linking analysis, Penuel et al., have shown that a region within the 
intracellular domain consisting of three hydrophobic amino acids is necessary 
for homomeric association of ErbB2 monomers in the absence of ligand. 
Furthermore, a molecular modelling study (Bagossi et al., 2005), based on 
the crystal structure of the KD of ErbB1 (Stamos et al., 2002) predicts 
favourable dimerisation interactions for between the KDs of adjacent, 
membrane bound, ErbB2 monomers.
Having established that the entire cytosolic region of DDR1 is dispensable for 
receptor dimerisation, the effect of the ECD was next investigated. As 
mentioned before, the DDR1 ECD is composed of three subdomains - the 
DS domain at the N-terminus, followed by domain X and P/G rich region. 
DDR1 mutants with each of these domains deleted, in the context of the full- 
length receptor, and a double deletion mutant deleting the domain X and P/G 
rich region, were analysed by chemical cross-linking, to determine which of 
these domain/s were involved in dimer formation. Out of the four deletion 
mutants, only the DS domain deleted mutant, ADS1, showed ligand- 
independent dimers upon cross-linking. Co-precipitation of epitope-tagged 
ADS1, confirmed this result. However, the other three mutants, DS1-1, APG
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and DS1-2 did not produce higher oligomer bands upon cross-linking 
analysis, but co-immunoprecipitation studies showed that these mutants are 
able to oligomerise. Two likely explanations for the discrepancy between the 
two methods are that the reactive lysines on the protein that are required for 
covalent-bond formation with the cross-linker are not available or that these 
mutants are not present on the cell surface. Cell surface biotinylation and 
Endo H/F digestion showed that the major proportion of each of the three 
mutants are in fact intracellularly localised and represent a biosynthetic 
precursor species. Co-immunoprecipitation studies show that these mutants 
are present as preformed dimers. These mutants are most likely degraded 
before they are converted to a mature, fully glycosylated form. Therefore both 
the domain X and the P/G rich region are required for formation of the mature, 
fully glycosylated proteins, as well as targeting DDR1 to the cell surface. 
Furthermore, most of the ECD is dispensable for DDR1 dimerisation, as the 
deletion of either the DS domain, the domain X, the APG region or the 
domain X in combination with the APG region, does not disrupt dimer 
formation. Furthermore, the entire ECD is dispensable for DDR1 dimerisation, 
as shown by the ability of the deletion mutants, DS1-2 and ADS1, to 
associate.Therefore neither the ECD nor the cytoplasmic domain is required 
for DDR1 dimerisation.
As with the DDR1 cytosolic domain deletion mutant, the analogous DDR2 
mutant showed clear dimer formation upon cross-linking. Therefore, DDR2 
and DDR1 are similar in this aspect of not requiring the intracellular region for 
ligand-independent dimerisation. To investigate the ECD involvement in the 
case of DDR2 oligomerisation, two deletion mutants, one with the DS domain 
and the other with the domain X deleted, were investigated by both cross- 
linking and co-immunoprecipitation.
In contrast to the DDR1 deletion mutant DS1-1, the analogous DDR2 
deletion mutant, DS2, which has most of the region between the DS domain 
and TM domains deleted, is able to dimerise in the absence of collagen, as 
shown by cross-linking and co-immunoprecipitation studies. In addition, 
previous studies have shown this mutant to be activated by collagen
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(Leitinger, 2003). This result shows that the DS2 mutant is present on the cell 
surface and indicates that the domain X is not needed for DDR2 targeting to 
the cell surface, dimerisation, ligand binding or signalling. Furthermore, the 
deletion mutant ADS2 (which lacks the DS domain) is able to dimerise as 
shown by cross-linking analysis. Therefore this mutant is present on the cell 
surface and able to form ligand-independent dimers. However, the mature, 
cell surface targeted form of the receptor is expressed in very low amounts. 
Unlike the DS2 mutant, ADS2 does not show ligand-dependent 
autophosphorylation. This is due to the fact that the DS domain plays a 
pivotal role in collagen binding (Leitinger, 2003). Therefore the DS domain of 
DDR2 is not essential for receptor dimerisation, however, this domain could 
play a role in efficient targeting of DDR2 to the cell surface. As seen for the 
WT DDR2 mature, cell surface form, the mature (and therefore most likely 
cell surface) forms of the DDR2 mutants also co-precipitate to a much lower 
level, when compared with the respective precursor (and therefore 
intracellular) forms. This might suggest that oligomers of DDR2 are present 
at low levels on the cell surface when compared with DDR2 oligomers during 
biosynthesis. However, as these proteins are over-expressed, it is likely that 
due to the high density of proteins in the ER-Golgi biosynthetic pathway, 
there is a greater chance of forming homomeric receptor interaction.
It was shown in a previous study that a soluble ECD construct of DDR2, 
which contains the entire DDR2 ECD exists as a non-covalent dimer in 
solution (Leitinger, 2003), indicating that the DDR2 ECD contains sequences 
which mediate dimerisation. As the DS domain on its own formed monomers 
(Leitinger, 2003), and the DS domain plus domain X forms dimers (E. 
Hohenester, personal communications), this indicates that the domain X is 
responsible for dimerisation of DDR2 ECD in solution. However, dimerisation 
is not abolished for full-length DDR2 containing the domain X deletion. The 
discrepancy between the results with the DDR2 ECDs and full-length cell 
surface expressed DDR2 can be explained if one assumes that in the full- 
length receptor other sequences mediate dimerisation in addition to domain 
X. Interaction via these sequences would be sufficient for dimerisation and 
signalling in the absence of domain X. These sequences could be in the 28
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amino acid sequence of the ECD not deleted in DS2 or in the cytoplasmic or 
TM domain of the full-length DDR2.
Having found that neither of the DDR2 single deletion mutants tested were 
disrupted in dimerisation, we then analysed if more than one domain was 
required for dimerisation. The two DDR2 double mutants, with the whole 
cytosolic region deleted plus the DS domain (ADS2TM) or the domain X and 
cytosolic region deleted (DS2TM), still retain the ability to dimerise, as shown 
by co-immunoprecipitation studies. Therefore as for DDR1, the DDR2 ECD 
and cytosolic domains are dispensable for ligand-independent dimerisation, 
although they may contribute to dimer stability (see Chapter 5). It is thus 
likely that the TM domain, which is present in all constructs tested so far, 
mediates DDR dimerisation. We have studied the contribution of the TM 
domain in DDR dimerisation, described in Chapter 5.
In contrast to the DDRs, for other RTKs such as MET and PDGFRp, it was 
found that a specific domain in the ECD is required for ligand-independent 
receptor dimerisation (Kong-Beltran et al., 2004; Omura et al., 1997). 
Chemical cross-linking of MET deletion mutants in cells, revealed that the 
SEMA domain, contained in the extracellular region, was necessary for MET 
receptor dimerisation (Kong-Beltran et al., 2004). However, the authors have 
not investigated if the deletion constructs used are expressed on the cell 
surface. Furthermore, chemical cross-linking analysis and co- 
immunoprecipitation studies of PDGFRp deletion mutants and chimaeric 
receptor constructs, showed that ligand-independent PDGFpR dimerisation 
occurs via the extracellular immunoglobulin-like domain four (Omura et al., 
1997).
The ErbB family members (ErbB1, 2, 3 and 4) can homodimerise as well as 
heterodimerise, therefore defining the receptor domains responsible for 
oligomerisation is complex. Biochemical studies have shown that for ErbB2 
heteromeric association with the ErbB1 receptor, the ECD is necessary and 
sufficient to mediate heterodimerisation (Qian et al., 1999) and is thought to
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be the main driving force for ErbB2 heterodimerisation in the presence of 
ligand (Fitzpatrick et al., 1998). Crystal structures of the ECD of ErbB1, 
ErbB2 and ErbB3 shows a specific ‘dimerisation loop’ in the ECD which 
interacts to form homodimers (Cho and Leahy, 2002; Garrett et al., 2002; 
Ogiso et al., 2002; Cho et al., 2003, Ferguson et al., 2003; Garrett et al.,
2003). It should be noted that the above mentioned biochemical and 
structural studies describe ligand-dependent dimerisation. For ligand- 
independent oligomerisation of ErbB receptor family members, there is 
evidence for the requirement of the cytoplasmic domain in mediating 
homomeric receptor interactions. For ErbB1, co-immunoprecipitation studies 
have shown that the KD is required for homomeric interactions of this 
receptor in the absence of ligand (Chantry, 1995). As mentioned before, the 
ErbB2 receptor also contains a specific region in the cytosolic domain, of 
three hydrophobic amino acids, which is found to be important for ligand- 
independent homodimerisation (Penuel et al., 2002).
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Investigating the role of the transmembrane domain 
in DDR receptor dimerisation and activation
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5.1. Introduction
The TM domains of the DDRs contain two putative dimerisation sequences, 
either one of which could be involved in driving receptor dimerisation or 
contribute indirectly to receptor oligomerisation by being driven together by 
other receptor regions. The putative dimerisation motif GxxxG (Sternberg and 
Gullick, 1990; Russ and Engelman, 2000; Senes et al., 2000) and the 
potential self-interacting leucine zipper motif (Langosch and Heringa 1998; 
Gurezka et al., 1999; Gurezka and Langosch, 2001) are both found in the 
DDR1 and DDR2 TM sequences (Figure 5.1, a).
The leucine zipper heptad motif is found in the helical TM domain of a variety 
of single spanning membrane proteins and consists of hydrophobic aliphatic 
residues such as leucine and isoleucine, which form a repeated heptad 
pattern resulting in alignment of these residues on one face of an a-helix. 
This motif can therefore mediate oligomerisation of adjacent a-helices via 
hydrophobic side-chain packing interactions (Arkin et al., 1994; Simmerman 
et al., 1996; Pinto et al., 1997; Langosch and Heringa 1998; Gurezka et al., 
1999). The leucine zipper motif was shown to be important for function and 
oligomeric assembly of a number of naturally occurring, single-span TM 
proteins (Gurezka et al., 1999); for example, the Epo receptor (Kubatzky et 
al., 2001; Ruan etal., 2004) and E-cadherin (Huber etal., 1999).
The five residue GxxxG sequence motif is found frequently in TM domains of 
RTKs and other TM proteins, and was shown to promote TM helix 
dimerisation (Russ and Engelman, 2000; Senes et al 2000; Sternberg and 
Gullick, 1990). The first position of the five residue sequence requires a small 
side-chain (Gly, Ala, Ser, Thr or Pro) and position five a very small side-chain 
such as Gly or Ala. The majority of research on the GxxxG motif has been 
carried out on the human erythrocyte sialoglycoprotein, glycophorin A (GpA), 
a cell surface receptor which was found to contain the GxxxG motif as part of 
a seven residue sequence in its TM domain (Adams et al., 1996; Lemmon et 
al., 1992; MacKenzie et al., 1997). The presence of this motif was shown to 
be responsible for the strong dimerisation of GpA TM a-helices (Doura et al.,
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a
Leucine zipper (red)
Heptad pattern . g a . . d e . g a . . d e . g a . . d e  . 
DDR1 ILIGCLVAIILLLLLIIALMLW
DDR2 ILIGCLVAIIFILLAIIVIILW
GxxxG motif (underlined)
DDR1 ILIGCLVAIILLLLLIIALMLW
DDR2 ILIGCLVAIIFILLAIIVIILW
ILIGCLVAIILLLLLIIALMLW WT DDR1
ILIGCLVAIILLGPLIIALMLW DDR1 TM1
ILIGCLVAIILLLLLGPALMLW DDR1 TM2
ILIGCLWI ILLLLLI IALMLW DDR1 TM3
ILIGCLVAIIFILLAIIVIILW WT DDR2
ILIGCLVAIIFIGPAIIVIILW DDR2 TM1
ILIGCLVAIIFILLAGPVIILW DDR2 TM2
ILIGCLWI IFILLAI IVI ILW DDR2 TM3
Figure 5.1: The DDR TM mutants, TM1, TM2 and TM3. (a) The TM domain 
sequences of WT DDR1 (amino acids 418-439) and DDR2 (amino acids 
415-436). The potential leucine zipper motif is shown in red and the GxxxG 
motif (GCLVA in the DDRs) is underlined. The WT sequence conforms to the 
requirements of a leucine zipper heptad repeat pattern of (iso)leucine 
residues, as indicated above the amino acid sequence. Positions a and d of 
a seven residue helical repeat consists of apolar residues, which mediate 
interactions between two parallel a  helices, (b) Amino acid modifications of 
the DDR TM domain mutants TM1, TM2 and TM3. TM1 and TM2 contain 
mutations which interfere with the potential leucine zipper of the TM 
domains. The amino acids Leu430 and Leu431 (DDR1) and Leu427 and Leu428 
(DDR2) are mutated to Gly and Pro in the TM1 mutants and lie433 and lie434 
(DDR1) and lie424, lie425 (DDR2) to Gly and Pro in the TM2 mutants. TM3 
contains a point mutation in Ala (DDR1) and Ala422 (DDR2) to a Val, which 
interferes with the potential GxxxG motif.
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2004). As revealed by solution NMR studies, GpA TM a-helices containing 
the GxxxG motif can interact with each other in a similar pattern to the right- 
handed crossing of two straight a-helices. Specifically, bulky side-chains 
(such as valine and leucine) on one monomer, can pack against a groove 
formed on the adjacent monomer helix, in a ‘ridges into groove’ manner 
(MacKenzie etal., 1997).
Specific point mutations were introduced into DDR1 and DDR2 TM domain 
sequences which, according to previous studies on other cell surface 
receptors, were designed to disrupt the two dimerisation motifs of interest. 
For example, double point mutations (LL->GP) in the Epo receptor TM 
domain, disrupted self-assembly when analysed by the ToxR system, a 
system that measures dimerisation of isolated TM domains in bacterial 
membranes (Kubatzky et al., 2001). Subsequently, asparagine scanning 
mutagenesis studies confirmed that the mutated amino acids correspond to a 
leucine zipper motif (Ruan et al., 2004). The TM domains of the ErbB 
receptors contain the GxxxG motif. Mutagenesis of the fourth glycine of this 
motif to a valine residue, followed by analysis of these ErbB mutants using 
the TOXCAT system (which is similar to the ToxR system), showed that this 
specific mutation prevents homo-oligomerisation of isolated ErbB TM 
sequences (Mendrola et al., 2002).
As shown in Figure 5.1 (c) and (d), DDR1 and DDR2 TM1 and TM2 mutants 
contain two point mutations which should disrupt the potential leucine zipper 
motif, by mutating two leucine or two isoleucine residues to glycine and 
proline residues. A proline residue was introduced, as proline usually 
introduces kinks into the a-helices (via restricted side-chain conformations), 
thereby reducing interactions between TM segments (Huber etal., 1999).
A third DDR1 and DDR2 TM mutant, TM3, was made containing a potential 
disruption in the GxxxG motif (Figure 5.1 c and d). Mutation of the second 
glycine of this sequence to a bulky residue such as valine was shown to 
disrupt oligomerisation for members of the ErbB receptor family (Mendrola et 
al., 2002). Therefore, an analogous mutation was introduced into the DDR
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TM domain (Figure 5.1). We tested the DDR1 and DDR2 TM mutants for 
their protein expression, ability to dimerise and activate in response to 
collagen I.
Chapter 5
5.2 Results 
5.2.1. Chemical cross-linking analysis of DDR1 TM mutants
In order to investigate whether the DDR1 TM mutants were defective in their 
ability to dimerise, chemical cross-linking analysis was carried out. The three 
mutants or W T DDR1 were transiently over-expressed in HEK293 cells. The 
cells were washed and incubated with BS3, for 30 minutes at RT, followed by 
cell lysis, SDS-PAGE and Western blotting using an anti-DDR1 Ab. As seen 
in Figure 5.2, all three mutants, as well as WT DDR1, show higher MW 
bands, in the presence of BS3, which correspond to DDR1 oligomers. This 
indicates that none of the mutants are defective in dimerisation. A similar 
experiment was carried out, but with cross-linking at 4°C for 1 hour. The 
results were similiar to that seen in Figure 5.2 (data not shown).
5.2.2. Co-immunoprecipitation of DDR1 TM mutants
Co-immunoprecipitation of C-terminally MYC- and FLAG-tagged DDR1 TM 
mutants, TM1 and TM3, were carried out in order to verify the results of 
cross-linking analysis. As seen in Figure 5.3, both TM1 and TM3 FLAG- 
tagged receptors co-precipitate with the anti-MYC Ab, thus verifying the 
cross-linking results. Co-precipitation of WT DDR1-FLAG with the anti-MYC 
Ab, was carried out in parallel to estimate if there was a difference in the 
degree of co-precipitation between the TM mutants and WT DDR1. However, 
results from four different experiments indicate that there is no significant 
change in the levels of co-precipitation between WT DDR1 and TM mutants 
(data not shown). An additional protein is of MW approximately 62 kDa, is 
observed in co-precipitates of both TM1-MYC and TM3-MYC (Figure 5.3, 
lower panels, red arrows). This protein most likely corresponds to the 
membrane anchored p-subunit of DDR1, consisting of only the TM domain 
and cytosolic region, shown previously to be produced by proteolytic 
cleavage of the DDR1 ECD (Vogel, 2002). This result indicates that the entire 
DDR1 ECD is dispensable for dimerisation.
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WT DDR1 TM1 TM2 TM3
BS3 (mM) 0 0.1 0.3 0 0.1 0.3 0 0.1 0.3 0 0.1 0.3i r - r M
V  ► -  9  * Dimer
212 —
175—'
1 1 5  ! Monomer
Blot: anti-DDR1
Figure 5.2: Ligand-independent oligomerisation of DDR1 TM mutants, 
TM1, TM2 and TM3. WT DDR1 and DDR1 TM mutants TM1, TM2 and 
TM3 were transiently expressed in HEK293 cells. After washing with cold 
PBS, BS3 in PBS was added to the cells at the indicated concentrations, 
and incubated for 30 minutes, RT. The reaction was quenched with 10 mM 
Tris pH 7.4. Cell lysates were analysed by 7.5% SDS-PAGE and Western 
blotting. The blots were probed with anti-DDR1 Ab. The position and sizes 
(in kDa) of MW markers are indicated.
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IP: anti-MYC 
*
T: TM1-FLAG - + + +
TM1-MYC + + + -
175 —
IP: anti-MYC 
*
T: TM3-FLAG + + + -
TM3-MYC - + + + 
175 —
83 —
1 7 5 -
Blot: anti-MYC
83 —
Blot: anti-MYC
175 —
83 —
62—
•  •  *  •  «-
Blot: anti-FLAG
83 — 
62 —
m> m
Blot: anti-FLAG
Figure 5.3: Co-immunoprecipitation of DDR1 TM1-FLAG and DDR1 TM3- 
FLAG with the anti-MYC Ab. HEK293 cells were singly transfected with 
MYC- or FLAG-tagged cDNA of DDR1 TM1 or DDR1 TM3 or co­
transfected with both FLAG- and MYC-tagged constructs. The cells were 
lysed and the lysates immunoprecipitated with anti-MYC Ab. The 
precipitated material was separated by 7.5% SDS-PAGE, blotted onto 
nitrocellulose and probed with anti-MYC. The blots were stripped and re­
probed with anti-FLAG mAb. *denotes mixing control where lysates of 
cells singly transfected with MYC- or FLAG-tagged mutants were mixed 
together. T-transfection; IP-immunoprecipitation. Blue arrows point to 
DDR1 TM1-FLAG and DDR1 TM3-FLAG. Red arrows point to the DDR1 
p-subunit. Black arrows point to Ig bands. The position and sizes (in kDa) 
of MW markers are indicated.
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5.2.3. Collagen-dependent activation assay of DDR1 TM mutants
The mutants were tested for their ability to be activated in response to 
collagen I. Upon transient expression in HEK293 cells, the DDRs were 
activated with different concentrations of collagen I for 1.5 hours. The cells 
were lysed and the cell lysates analysed by SDS-PAGE and Western 
blotting. The phosphotyrosines on activated DDRs were detected using the 
4G10 Ab. The blots were stripped and the levels of DDR1 protein were 
detected using an anti-DDR1 Ab. Figure 5.4 (a) shows the results for the 
activation assays of TM1 and TM2. The protein expression levels for both 
TM1 and TM2 were similar to the WT DDR1 (lower panel). However, there 
was a significant decrease in the level of autophosphorylation for both TM1 
and TM2 compared to W T at all three concentrations of collagen I tested 
(upper panel), indicating that disrupting the leucine zipper motif prevents 
receptor activation. In the case of TM3, however, the autophsophorylation 
level was more similar to W T DDR1 (Figure 5.4, b). These results point to the 
leucine zipper motif, and not the GxxxG motif, in mediating DDR1 assembly 
in the presence of collagen I.
5.2.4. Expression of DDR2 TM mutants and co-immunoprecipitation of 
DDR2 TM1 mutant
As seen in Figure 5.5 (a) the DDR2 TM mutants TM1 and TM2, did not 
express in a similar manner to WT DDR2, in that the expression level of the 
upper form of both TM1 and TM2 mutants was greatly decreased, compared 
to the two lower forms. However, the DDR2 TM3 mutant was expressed in a 
normal manner. Endo H and PNGase F digestion of analysis of the TM1 
mutant showed that the higher MW form of TM1 is Endo H resistant and 
therefore represents a mature form, which is most likely expressed on the 
cell-surface (data not shown); this form most likely corresponds to the 
intermediate MW form seen in WT DDR2. Taken together, disrupting the 
leucine zipper motif prevents normal expression of the upper form of DDR2 
whilst disruption of the GXXXG motif does not. We wanted to test if the 
defective DDR2 TM1 mutant was still able to oligomerise. Therefore, a C-
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WT DDR1 DDR1 TM1 DDR1 TM2 Mock
Collagen 1 (pg/ml) 0 1 5 1 0 0 1 5 1 0 0 1 5 1 0 0  5
1 75 —  .
•*» mm * *  -
83 —
Blot: anti-PY
175 —
83 —
Blot: anti-DDR1
WT DDR1 DDR1 TM3
Collagen 1 (pg/ml) 0 1 5 10 0 1 5 10
175 —
83 —
Blot: anti-PY
175 —
83 —
Blot: anti-DDR1
Figure 5.4: The DDR1 TM mutants, TM1 and TM2, but not TM3, are 
defective in collagen-induced autophosphorylation. WT DDR1 or DDR1 
mutants TM1, TM2 or TM3 were transiently expressed in HEK293 cells. 
After stimulation with collagen I at the indicated concentrations, cell 
lysates were analysed by 7.5% SDS-PAGE and Western blotting. The 
blots were probed with anti-phosphotyrosine mAb 4G10 (upper panel) 
stripped and re-probed with anti-DDR1 Ab (lower panel). The position and 
sizes (in kDa) of MW markers are indicated.
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a b
TM1 TM2 TM3 WT IP; anti-FLAG
*
175— T: TM1-FLAG - + + +
*  ®  f ?  TM1 -MYC + + + -
83— 175 —
Blot: anti-DDR2 ®  *  3=
83 —
Blot: anti-FLAG
175 —
83 —
Blot: anti-MYC
Figure 5.5: Analysis of DDR2 TM mutants, (a) DDR2 TM mutants, TM1 
and TM2 show defective protein expression, whilst DDR2 TM3 is similar to 
WT DDR2. WT DDR2 or DDR2 mutants TM1, TM2 or TM3 were 
transiently expressed in HEK293 cells. The cells were lysed 48 hours 
later, and the lysates were analysed by SDS-PAGE and Western blotting. 
The blots were probed with anti-DDR2 Ab. (b) Co-immunoprecipitation of 
epitope-tagged DDR2 TM1 mutant. HEK293 cells were singly transfected 
with MYC- or FLAG-tagged DDR2 TM 1 or co-transfected with both MYC- 
and FLAG-tagged constructs. The cells were lysed and the lysates 
immunoprecipitated with anti-FLAG mAb. The precipitated material was 
separated by 7.5% SDS-PAGE, blotted onto nitrocellulose and probed 
with anti-FLAG mAb. The blots were stripped and re-probed with anti-MYC 
Ab. Black arrow points to DDR2TM1-FLAG, middle and lower forms. Red 
arrow points to DDR2TM1-MYC. ‘denotes mixing control where lysates of 
cells singly transfected with MYC- or FLAG-tagged mutants were mixed 
together. T-transfection; IP-immunoprecipitation. The position and sizes (in 
kDa) of MW markers are indicated.
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terminally MYC- and FLAG-tagged TM1 mutant was made and tested by co­
precipitation assay. As shown in Figure 5.5 (b), the MYC-tagged form of 
DDR2TM1 is able to co-precipitate with the anti-FLAG mAb. Therefore, the 
leucine zipper motif is not required for DDR2 oligomerisation, however it is 
needed for proper DDR2 expression.
5.2.5. Collagen-dependent activation assay of DDR2 TM mutants
All the DDR2 TM mutants were tested for collagen l-dependent receptor 
activation. HEK293 cells expressing DDR2 TM1, TM2 and TM3 were 
activated with different concentrations of collagen I for 1.5 hours. The cells 
were lysed and the cell lysates analysed by SDS-PAGE and Western 
blotting. The phosphotyrosines on activated DDRs were detected using the 
4G10 mAb. The blots were stripped and the levels of DDR2 protein were 
detected using an anti-DDR2 Ab. As shown in Figure 5.6 (upper panel) 
DDR2 TM3 mutant shows a phosphorylation signal similar to WT DDR2, 
indicating that the GxxxG motif is not required for DDR2 signalling.
There is a low level of phosphorylation seen for TM2 mutant, compared with 
TM3 and W T DDR2. This corresponds to there being a very small amount of 
the upper, mature form of TM2, which is the form that is phosphorylated upon 
stimulation with collagen I (Figure 5.6, lower panel). In the case of the TM1 
mutant, the upper form is not visibly expressed, as seen by Western blot, 
(Figure 5.6, lower panel), and the expression of the middle and lower form is 
somewhat reduced compared with W T DDR2. Therefore, there is no visible 
phosphorylation signal for this mutant. Taken together with the fact that some 
phosphorylation of the upper form of TM2 was detected and the primary 
effect of the mutation is on the DDR2 upper form, these results indicate that 
the leucine zipper is required for normal expression of DDR2.
5.2.6. Co-precipitation of DDR1 double and triple mutants
Subsequently, to further test the role of the TM domain in DDR1 
oligomerisation, double and triple DDR1 mutants were made, where more
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DDR2TM1 DDR2TM2 DDR2TM3 W T DDR2
Collagen 1 (pg/ml) 0 1 10 0 1 10 0 1 10 0 1 10
175 —
m • w ** m
83 —
Blot: anti-PY
1 7 5 _  .
83— •
Blot: anti-DDR2
Figure 5.6: DDR2 TM domain mutants TM1 and TM2, but not TM3, are 
defective collagen l-dependent autophosphorylation. WT DDR2 or DDR2 
mutants TM, TM2 or TM3, were transiently expressed in HEK293 cells. 
After stimulation with collagen I at the above concentrations, cell lysates 
were analysed by 7.5% SDS-PAGE and Western blotting. The blots were 
probed with anti-phosphotyrosine mAb 4G10 (upper panel) stripped and 
re-probed with anti-DDR2 Ab (lower panel). The position and sizes (in 
kDa) of MW markers are indicated.
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than one DDR1 domain was deleted or disrupted. These mutants were tested 
for their ability to dimerise by co-immunoprecipitation.
To investigate the role of the TM domain in DDR in the absence of the 
subdomains of the ECD, we made two DDR1 double mutants, incorporating 
the leucine zipper TM1 mutation, and with either the DS domain (named 
ADS1TM1) or the domain X plus P/G rich region deleted (named DS1TM1). 
Both mutants were made as C-terminally MYC- and FLAG-tagged constructs. 
As seen in Figure 5.7, the FLAG-tagged versions of the constructs co­
precipitate with the MYC-tagged versions, suggesting that the deletion of the 
DS domain and the disruption of the leucine zipper in the TM domain is not 
sufficient for preventing DDR1 oligomerisation. Similarly, the deletion of the 
domain X and P/G rich region together with the disruption of the leucine 
zipper motif, is not sufficient for preventing DDR1 oligomerisation.
In view of the above results, we wanted to know if an additional deletion of 
the DDR1 cytoplasmic domain would prevent receptor oligomerisation. To 
test this, two triple mutants of DDR1 were made. Both mutants had the whole 
cytoplasmic domain deleted as well as the TM1 mutation. One of the triple 
mutants contained deletion of the domain X and P/G rich region, named 
DS1TM1ACYTO, whilst the other mutant contained a deletion of the DS 
domain, named ADS1TM1ACYTO, in addition to the cytoplasmic domain 
deletion and TM mutation. Both mutants were MYC- and FLAG-tagged at the 
C-terminus. Upon checking for protein expression in HEK293 cells, it was 
observed that only the DS1TM1ACYTO mutant expressed whilst the 
ADS 1 TM 1 ACYTO mutant did not (data not shown). Co-immunoprecipitation 
was carried out to see whether the ADS1TM1ACYTO mutant was able to still 
oligomerise. As seen from Figure 5.8, the MYC-tagged mutant does co­
precipitate with the anti-FLAG mAb. Therefore the DS domain in this mutant 
is most likely mediating the majority of the interactions between the two DDR 
monomers.
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DS1TM1-MYC + + + -
175 —
83 —
t
Ev
IP: anti-FLAG 
*
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Blot: anti-FLAG
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Figure 5.7: Co-immunoprecipitation of DDR1 double mutants, DS1TM1- 
FLAG and ADS1TM1-MYC with the anti-MYC Ab and anti-FLAG mAb, 
respectively, (a) and (b), HEK293 cells were singly transfected with MYC- 
or FLAG-tagged cDNA of DS1TM1 (a) or ADS1TM1 (b) or co-transfected 
with both MYC- and FLAG-tagged cDNA of the particular construct. The 
cells were lysed and the lysates immunoprecipitated with anti-MYC Ab (a) 
or anti-FLAG mAb (b). The precipitated material was separated by 7.5% 
SDS-PAGE, blotted onto nitrocellulose and probed with the anti-MYC Ab 
(a) or anti-FLAG mAb (b). The blots were stripped and re-probed with the 
anti-FLAG mAb (a) or anti-MYC Ab (b). Blue arrows point to DS1TM1- 
FLAG and ADS1TM1-FLAG. Black arrows point to Ig bands. *denotes 
mixing control where lysates of cells singly transfected with MYC- or 
FLAG-tagged mutants were mixed together. T-transfection; IP- 
immunoprecipitation. The position and sizes (in kDa) of MW markers are 
indicated.
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IP: anti-FLAG 
*
T: DS1TM1-FLAG - + + + 
DS1TM1-MYC + + + - t
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33 _
25 —
Blot: anti-FLAG
33 —
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Figure 5.8: Co-immunoprecipitation of epitope-tagged DDR1 triple mutant 
DS1TM1ACYTO-MYC with the anti-FLAG mAb. HEK293 cells were singly 
transfected with MYC- or FLAG-tagged DS1TM1ACYTO or co-transfected 
with both MYC- and FLAG-tagged cDNA constructs. The cells were lysed 
and the lysates immunoprecipitated with anti-FLAG mAb. The precipitated 
material was separated by 10% SDS-PAGE, blotted onto nitrocellulose 
and probed with anti-FLAG mAb. The blot was stripped and re-probed 
with anti-MYC Ab. The red and blue arrows points to DS1TM1 ACYTO- 
MYC and DS 1 TM 1ACYTO-FLAG, respectively. Black arrows point to Ig 
bands, ‘denotes mixing control where lysates of cells singly transfected 
with MYC- or FLAG- tagged mutants were mixed together. T-transfection; 
IP-immunoprecipitation. The position and sizes (in kDa) of MW markers 
are indicated.
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We further tested the DDR1 triple mutant for its ability to oligomerise with full- 
length DDR1. W e reasoned that the two proteins would be unable to interact 
via the ECD by virtue that this combination would not have the respective 
extracellular subdomains aligned. To test this, we carried out co-precipitation 
experiments of DS1TM1ACYTO with DDR1-FLAG. As seen in Figure 5.9 (a), 
the amount of DS1TM1 ACYTO-MYC protein co-precipitating with DDR1- 
FLAG was greatly reduced compared with the amount of the same triple 
mutant co-precipitating with DS1TM1ACYTO-FLAG. The level of expression 
of DS1TM1 ACYTO-MYC is the same in both co-transfected samples (Figure 
5.9, b). These results indicate that the DS domain is needed for DDR1 
oligomerisation and provide an additional control for the specificity of co- 
immunoprecipitation.
A parallel study was carried out in a collaborating laboratory, to establish if 
the DDR1 TM domain mediates self-assembly. In this study, the effect of the 
three mutations, TM1, TM2 and TM3, on TM domain assembly was 
examined. The results from this study are described and discussed in section
5.3.
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Figure 5.9: Co-immunoprecipitation of epitope-tagged DDR1 triple mutant, 
DS1TM1ACYTO, with epitope-tagged WT DDR1. (a) HEK293 cells were 
singly transfected with epitope-tagged cDNA of DS1TM1ACYTO or WT 
DDR1 or co-transfected with both DS1TM1 ACYTO-MYC and WT DDR1- 
FLAG. As a comparison, cells were co-transfected with MYC- and FLAG- 
tagged cDNA of the triple mutant. The cells were lysed and the lysates 
immunoprecipitated with anti-MYC Ab. The precipitated material was 
separated by 10% SDS-PAGE, blotted onto nitrocellulose and probed with 
anti-MYC or anti-FLAG Ab. *denotes mixing control where lysates of cells 
singly transfected with MYC- or FLAG-tagged mutants were mixed 
together, (b) Aliquots of lysate from (a) was analysed by SDS-PAGE and 
Western blotting with anti-MYC Ab, to check the level of DS1TM1 ACYTO- 
MYC expression. T-transfection; IP-immunoprecipitation. Black and blue 
arrows point to the position of WT DDR1-FLAG and DS1TM1ACYTO- 
FLAG, respectively. The red arrow points to DS1TM1 ACYTO-MYC. The 
position and sizes (in kDa) of the MW markers are indicated.
171
Chapter 5
5.3. Discussion
In this study we investigated the ability of the DDR TM domain to mediate, or 
contribute to DDR dimerisation and activation. We specifically wanted to 
know if either of two potential dimerisation motifs, the leucine zipper motif or 
the GxxxG sequence, found in the DDR TM domain, was involved in ligand- 
independent DDR dimerisation. We further explored the role of each of these 
dimerisation motifs in collagen l-induced DDR signalling. In order to do so, 
we made specific mutations in the DDR TM domain, in analogy to previous 
studies.
Two mutants, TM1 and TM2, which introduce point mutations to disrupt the 
leucine zipper motif, were made for both DDR1 and DDR2, in context of the 
full-length receptor. These mutants, which contain the double mutant LL->GP 
(TM1) and ll->GP (TM2), were made according to a similar mutation made in 
the Epo receptor TM domain, which reduced Epo receptor ligand-dependent 
activation and self-assembly of Epo receptor TM domains (Kubatzky et al.,
2001). A second type of dimerisation motif, the GxxxG motif, is found in both 
DDR1 and DDR2 TM domains, which could be involved in DDR 
oligomerisation and activation, instead of the leucine zipper motif. This motif 
is found in the ErB1 receptor TM domain, and by mutation analysis, was 
shown to be required for TM domain self-association (Mendrola et al., 2002). 
We thus made the TM3 mutant to disrupt the GxxxG motif.
As shown by chemical cross-linking analysis, none of the three DDR1 TM 
domain mutants was defective in dimerisation in the absence of ligand. 
These results were confirmed by co-immunoprecipitation of epitope-tagged 
DDR1 mutants. DDR1 TM1 and TM2 mutants show only a very low level of 
receptor activation in response to collagen I compared to WT DDR1, 
indicating that the propagation of conformational change is blocked. TM3, on 
the other hand was able to autophosphorylate to a similar level as WT DDR1 
indicating that this motif is not involved in TM domain signalling. The above 
results can be interpreted as follows: the TM domain of DDR1 is not required 
for receptor dimerisation in the absence of ligand, however, when collagen is
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present and bound to the ECD, the TM domains of adjacent DDR monomers 
can self-assemble via their leucine zipper motifs.
In the case of DDR2, both TM1 and TM2 mutations showed defective protein 
expression manifested in the loss of the upper form of DDR2. This results in 
decreased collagen dependent signaling for both TM1 and TM2. The DDR2 
TM3 mutant was normal in terms of protein expression and collagen 
dependent signalling. However, the TM1 mutant can still dimerise as shown 
by co-immunoprecipitation study, indicating that the leucine zipper is not 
important for receptor dimerisation but likely plays a role in protein folding 
and targeting to the cell surface.
Further studies, on the ability of the DDR1 TM domain for self-assembly, 
were carried out by a collaborating group (Carafoli and Hohenester, Imperial 
College, London). The capacity for self-assembly of WT and mutant DDR1 
TM domains was tested using the TOXCAT system (Russ and Engleman, 
1999). This assay has been used previously for the ErbB receptors 
(Mendrola et al., 2002), integrin allb (Li et a/., 2004), GpA (Russ and 
Engleman) and EpoR (Kubatzky et al., 2001) TM domain interactions. The 
isolated W T DDR1 and mutant TM domain sequence was fused to N-terminal 
DNA binding domain of ToxR (a dimerisation dependent transcription 
activator), and a monomeric periplasmic anchor (the maltose binding 
protein). Association of the TM domains on the bacterial inner cell membrane 
would result in the ToxR mediated activation of a reporter gene encoding 
chloroamphenicol acetyltransferase (CAT). The level of CAT expression 
indicates the strength of the TM association. A construct containing the WT 
TM domain of GpA was used as a positive control for dimerisation, whilst a 
dimerisation defective GpA mutant TM domain containing construct was used 
as a negative control (Figure 5.10, A). According to the measured CAT 
activity, the W T DDR1 TM domain showed very strong dimerisation, more 
than the W T GpA TM domain (Figure 5.10, B). Both TM1 and TM2 show 
drastically reduced CAT activity compared to the WT DDR1, whilst TM3 CAT 
activity was very similar to WT DDR1 (Figure 5.10, C). These results suggest 
firstly that the DDR1 WT TM domain is able to self-associate in vivo and
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residues
GpA wt L IIF G V M A G V IG T IL  ( 7 5 - 8 9 )
GpA G83I L I IF G V M A 0 V IG T IL  ( 7 5 - 8 9 )
DDR1.1 A IL IG C L V A I IL L L L L I IA L M L W  ( 4 1 7 - 4 3 9 )
DDR1.2 IL IG C L V A I  IL L L L L I  IA LM LW  ( 4 1 8 - 4 3 9 )
DDR1.4 IG C L V A I IL L L L L I  IA LM LW  ( 4 2 0 - 4 3 9 )
UT
5 6 -
4 3 -
Figure 5.10: The DDR1 TM domain self-associates in bacterial 
membranes. (A) DDR1 TM sequences tested in the TOXCAT assay. The 
dimerising GpA sequence and the non-dimerising G83I GpA mutant were 
used as positive and negative controls, respectively. (B) Homodimerisation 
of ToxR1 chimaeric constructs, as measured by CAT enzyme activity. 
Lysates from MM39 E. coli cells expressing chimaeras with the indicated 
TM sequences were used to measure CAT activity by ELISA. CAT activity 
is represented as absorbance at 405 nm. The experiment is representative 
of three independent experiments. The lower panel shows the relative 
expression levels of the chimaeric proteins. Lysates from MM39 cells 
expressing the chimaeric constructs were separated on 10% SDS-PAGE 
and immunoblotted with an Ab against the C-terminal MBP domain. The 
asterisk denotes full-length chimaeras; the arrowhead denotes proteolysed 
GpA chimaeras. (C) Homodimerisation of ToxR1 chimaeric constructs 
containing wild-type and mutant DDR1 TM sequences, determined as in 
(B). The data are presented as mean ± standard deviation from three 
independent experiments, each performed in triplicate or quintuplicate and 
normalised to the values obtained with DDR1.1. The lower panel shows 
the relative expression levels, as in B; UT, untransformed cells.
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secondly that the leucine zipper motif, but not the GxxxG motif is responsible 
for DDR1 TM domain self-association. Importantly, these results complement 
our findings that the leucine zipper motif, but not the GxxxG motif, is required 
for DDR1 signalling.
Several studies with other cell surface receptors, such as the ErbB receptor 
and Epo receptor, have indicated that the interaction between TM a-helices 
contribute to stabilization of receptor dimers. Using chimaeric receptor 
constructs and immunofluorescence co-patching technique, it was shown 
that the Epo receptor TM domain is essential and sufficient for ligand- 
independent oligomerisation (Constantinescu et al., 2001). Similarly, the Epo 
receptor TM domain had a strong potential to self-interact in a bacterial 
reporter system (Kubatzky et al., 2001). Furthermore, this interaction was 
shown to occur via a leucine zipper motif, as the introduction of simultaneous 
mutations of two conserved leucine residues in the TM domain, LL->GP, 
reduced both self-assembly and tyrosine phosphorylation upon ligand 
stimulation.
For the members of the ErbB receptor family, there are conflicting models for 
the involvement of the TM domain in dimer formation. Isolated ECDs of ErbB 
family members, ErbB1 and ErbB4, were shown to dimerise completely upon 
ligand binding, indicating that the ECD is solely responsible for receptor 
oligomerisation, whilst the TM and cytosolic domains are not involved 
(Ferguson et al., 2000; Elleman et al., 2001;). In contrast, another model 
argues that the ErbB1 TM domain is mainly responsible for ligand-induced 
dimerisation and provides the primary driving force for receptor dimerisation 
(Tanner and Kyte, 1999). The investigators showed this by comparing the 
dissociation/association kinetics of the ErbB1 ECD on its own to ErbB1 
containing both ECD and TM domains. The latter construct showed a 
significantly lower degree of dissociation than the former construct, indicating 
that the TM domain helps ligand-induced dimerisation.
Recently, a study carried out by Bennasroune et al. revealed that specific 
hydrophobic peptides corresponding to the TM domain of ErbB1 and ErbB2
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can act as inhibitors of receptor signalling by inhibiting ligand-dependent 
receptor dimerisation (Bennasroune et al., 2004). This finding is supported by 
a study by Mendrola et al., who showed, using the TOXCAT system, that the 
isolated TM domain of ErbB1, 2, 3 and 4 self-associate strongly in bacterial 
cell membranes, and through mutagenesis studies, pointed to the GxxxG 
motif of the TM domain which might be involved in dimer formation (Mendrola 
et al., 2 0 0 2 ).
The fact that two dimerisation motifs are found in the DDR TM domain could 
be significant, in the light of recent work done on ErbB1 and ErbB2 TM 
domain interactions (Gerber et al., 2004). ErbB1 and ErbB2 contain two 
GxxxG like motifs, one on the N-terminal part and the other on the C-terminal 
part of the TM domain. The authors investigated the isolated WT and mutant 
TM domains for the ability to interact, using the ToxR system. The 
investigators showed that the N-terminal GxxxG motif was involved in ErbB1 
heterodimerisation with ErbB2 TM domain, but not homodimerisation of 
ErbB1 receptors. Previous work showed that the C-terminal GxxxG motif was 
needed for ErbB receptors to homodimerisation (Mendrola et al., 2002). 
Taken together, these results suggest that both GxxxG motifs play a role in 
ErbB1 TM domain interactions, with one motif involved in homodimerisation 
and the other GxxxG motif playing a role in heterodimerisation with ErbB2. It 
is conceivable that the GxxxG motif in the DDRs is involved in the interaction 
with another TM protein.
The GxxxG motif, though present in the DDR TM domain, does not seem to 
have a role in DDR TM assembly or signalling. The mere presence of this 
motif is not sufficient to suggest that it is responsible for TM domain 
interactions as residues surrounding the GxxxG framework have been shown 
to play an important role in determining if the GxxxG motif interactions are 
favourable for the particular protein in question (Lemmon et al., 1992; Russ 
and Engelman, 1999; Melnyk et al., 2003). Mutagenesis studies have 
suggested that other amino acids in the TM domain, besides the two glycine 
residues of the GxxxG motif, are involved in mediating GpA 
homodimerisation (Langosch et al., 1996). Another more recent study on the
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GpA TM domain, where specific TM helix interfacial residues were introduced 
into the TM domain of another protein, the M13 major coat protein (MCP), 
found that interfacial residues 12 residues apart are able to modulate TM 
helix-helix interactions (Melnyk et al., 2004).
As both TM1 and TM2 mutants were able to oligomerise in the absence of 
ligand, we made and tested two DDR1 double mutants, containing the TM1 
mutation with either the DS domain or the domain X plus the P/G rich region 
deleted. Both these mutants were able to co-precipitate and therefore homo- 
oligomerise, indicating that the KD or the region of the ECD, which is still 
present, is mediating receptor dimerisation. We then made and tested by co- 
immunoprecipitation, a DDR1 triple mutant containing the TM1 mutation plus 
the domain X plus the P/G rich region deleted. This mutant was able to 
oligomerise, indicating that the DS domain, which is still intact in this mutant, 
is mediating receptor dimerisation. This result taken together with DDR 
domain deletion analysis described in Chapter 4, suggests that the DDRs are 
able to interact with each other via both the ECD and cytosolic regions. The 
importance of each region in driving and/or stabilising receptor dimers in the 
presence of ligand would be the next step for investigation as it is expected 
that a conformation change would occur within the receptor dimers upon 
ligand binding. Receptor conformation changes upon ligand binding have 
been shown for EGFR (Moriki et al., 2001), and Neu (or ErbB2) receptor (Bell 
et al., 2000). The investigators carried out Cys-scanning mutagenesis of the 
receptor juxtamembrane region and proposed a model by which ligand 
binding to the ECD of preformed, inactive receptor dimers induced rotation of 
the extracellular juxtamembrane region and hence the TM domain, leading to 
dissociation of the dimeric, inactive form of the cytosolic region. It could be 
that a mechanism of activation of DDRs involves a similar ‘rotation model’, 
and experiments similar to that performed for EGFR and ErbB2 need to be 
carried out to determine this.
In conclusion, a mechanism of DDR1 activation is proposed as follows. 
Inactive receptors exist as preformed dimers on the cell surface via 
interactions between the ECD and TM domain and possibly the cytoplasmic
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domain, with the cytoplasmic KDs most likely in an inhibitory conformation. 
Collagen binding to the DS domain leads to a conformational change in the 
ECD, and self-assembly of the two TM a-helices allows the tyrosine KD to 
come closer together. We speculate that this causes a release of the KD 
inhibitory conformation and activation of the tyrosine kinase, enabling 
autophosphorylation of conserved tyrosine residues in the cytoplasmic 
region. A schematic diagram of DDR1 activation based this model is shown 
in Figure 5.11.
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H
+Collagen
- ►
In the absence of ligand DDR 
exists as preformed dimers on 
the cell surface. Signalling
Conformational change and self- 
assembly of the TM helices via 
the leucine zipper motif enables 
autophosphorylation.
Figure 5.11: A model for DDR1 activation. In the absence of ligand, DDR1 
exist as preformed dimers on the cell surface. The two DDR1 monomers 
interact with each other via the ECD and TM domain to give an inactive 
conformation where the KDs are too far apart to interact. Upon collagen 
binding to the DS domain, there is a conformational change in the 
extracellular region and self-assembly of TM a-helices, via the leucine 
zipper motif, which draws the two receptor monomers closer together 
enabling the KDs to phosphorylate each other on conserved tyrosine 
residues.
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General Discussion
Chapter 6
6.1. Introduction
In this thesis I have shown firstly, that full-length WT DDR1 and DDR2 exist 
as preformed dimers on the cell surface. The precursor forms of both DDRs 
exist as preformed dimers during biosynthesis. Once dimerised, the 
receptors are most likely associated during transport to the cell surface, 
suggesting that the DDRs are most likely constitutive dimers. Secondly, the 
DDR domains essential for receptor dimerisation were investigated, and it 
was found that neither the ECDs nor the cytosolic domains were required for 
dimerisation. In the third part of this thesis, the role of the TM domain in DDR 
dimerisation and activation was explored. Two potential dimerisation motifs 
are found in the DDR TM domain -  a leucine zipper and a GxxxG motif. 
Mutations to disrupt both these motifs did not effect receptor dimerisation in 
the absence of ligand. However, in the presence of ligand, it was found that 
the leucine zipper motif, but not the GxxxG motif, was required for DDR1 
signal transduction. A parallel study which looked at the potential for self­
association of the isolated DDR1 TM domain in bacterial inner membranes, 
revealed that the W T DDR1 TM domain interacts strongly. A DDR1 mutant 
TM domain containing disrupting mutations in the GxxxG motif did not affect 
self-assembly, whereas mutations in the leucine zipper motif drastically 
reduced self-association. Thus, the DDR1 TM domain self-associates in 
biological membranes via the leucine zipper motif.
The observations made in this study in relation to the literature on similar 
investigations carried out for other cell surface receptors, and the wider 
implications of the findings presented in this thesis will be discussed below.
Future directions of the research based on the constructs and information 
from the research presented in this thesis are also discussed.
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6.2. Preformed dimerisation of DDRs and other ceil surface receptors
The results of this study have shown that the DDRs exist as dimers on the 
cell surface and during receptor biosynthesis. This is a novel finding, and 
ligand-independent dimerisation has only been found for a few other RTKs. 
Our finding is consistent with the earlier report that used soluble ECD 
constructs of DDRs to investigate DDR collagen binding in vitro, which 
showed that the DDRs needed to be dimerised in order to bind collagen 
(Leitinger, 2003).
There have been a number of studies investigating the dimerisation state of 
the ErbB receptors in the absence and presence of ligand. Analysis of 
recently solved crystal structures of the ECDs of these receptors in the 
absence and presence of ligand put forward a mechanism by which ligand 
binding induces dimerisation of the ECD (Cho and Leahy, 2002; Garrett et al., 
2002; Ogiso et al., 2002; Cho et al., 2003; Ferguson et al., 2003; Garrett et 
al., 2003). However, challenges to the dogma of ligand-mediated receptor 
dimerisation have been put forward by several independent groups, whose 
research support the hypothesis that the ErbB receptors exists as preformed 
dimers (Chu et al., 1997; Gadella and Jovin, 1995; Moriki et al., 2001, Sako 
et al., 2000; Yu et al., 2002). The latter studies suggest that activation 
involves ligand-induced conformational changes within a dimeric receptor.
We have found that for DDRs, the dogma that RTKs are dimerised upon 
ligand binding may not be relevant. Our data show dimerisation of 
biosynthetic precursor receptors and therefore provide evidence of 
constitutive DDR dimers. For other cell surface receptors, the main evidence 
for ligand-induced dimerisation is based on the crystal structures of receptor 
ECD, and therefore proteins in solution. These receptors include the ErbB 
receptor family, described above, and the cytokine receptors such as the Epo 
receptor (Livinah et al., 1996) and the GH receptor (Fuh et al., 1992; de Vos 
et al., 1992). In full-length receptors, the TM or cytosolic domains likely 
influence receptor dimerisation. According to initial crystallographic evidence, 
the Epo receptor was thought dimerise upon ligand binding, but a
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subsequent structural study showed that receptor dimerisation is not sufficient 
for activation (Livinah et a/., 1998). Furthermore, recent biochemical studies 
strongly indicate these receptors to be present as ligand-independent dimers 
on the cell-surface (Constantinescu et al., 2000). This is also true for the GH 
receptor; recent evidence using biophysical studies with BRET and FRET in 
addition to co-immunoprecipitation studies have provided strong evidence for 
ligand-independent receptor dimers (Brown et al., 2005). Evidence that these 
receptors form dimers in the ER underscore the result that these receptors 
are constitutively dimerised (Gent et al., 2002)
For ErbB1 (EGFR), it has been suggested that without predimers, 
dimerisation would take longer as receptor monomers would need to diffuse 
in the PM looking for partner receptors and the existence of preformed 
dimers would enable accelerated EGFR activation and signal transduction 
(Yu et al., 2002). However, as DDRs normally take longer than other RTKs to 
be activated by their ligand, the above hypothesis is difficult to apply for these 
receptors, and other slower processes, such as receptor clustering may be 
involved in DDR activation.
6.3. The role of the ECD and cytoplasmic domain in ligand-independent 
oligomerisation of DDRs and other RTKs
The study described in Chapter 4 shows that both the ECD and cytosolic 
region are not essential for DDR dimerisation in the absence of ligand. 
However this does not imply that these regions are not involved in receptor 
monomer contacts within the preformed dimers. It is possible that there are 
interactions, as found for the ErbB receptors, in both the ECD and 
cytoplasmic domains, but these interactions are dispensable due to strong 
interactions via the DDR TM domains. The findings that the DDRs are still 
dimerised when the leucine zipper motif is disrupted, demonstrates that other 
domains contribute to receptor stability.
In RTKs such as FGFR2 and RET, disulphide bonds between cysteine 
residues in the ECD have been implicated in ligand-dependent receptor
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dimerisation (Robertson et al., 2000). In the DDR ECD, there is one unpaired 
cysteine which was hypothesized to be involved in receptor dimerisation. 
However mutation analysis of this cysteine to disrupt a potential inter­
receptor disulphide bridge did not affect receptor signalling or dimerisation 
(Leitinger and Bhattia, personal communication).
Biochemical studies with a chimaeric receptor comprising of ECD and TM of 
EGFR and cytosolic domain of Epo receptor showed that this protein did not 
dimerise in the absence of ligand, as shown by chemical cross-linking 
analysis, whilst the full-length WT EGFR did predimerise (Yu et al., 2002). 
These results indicate that the cytoplasmic domain is required for ligand- 
independent EGFR homodimerisation. Another study by Penuel et al., further 
identified specific hydrophobic amino acids in the C-terminal tail of ErbB2 that 
are required for ligand-independent receptor homodimerisation (Penual et al.,
2002). When ligand is present and bound, it seems that the ECD of EGFR 
plays a major role in dimerisation, as suggested from the crystal structures. 
However, the role of the TM domain and cytosolic domain contacts in the 
presence of bound ligand have not yet been investigated. It has been 
suggested that these receptors could exist in a monomer/dimer equilibrium 
which is stabilized upon ligand binding (Garett et al., 2002).
The therapeutic implications for finding a specific domain required for 
receptor dimerisation is shown by the discovery of the mAb pertuzumab 
(Omnitarg), which blocks ErbB2 heterodimerisation with EGFR, ErbB3 and 
ErbB4. The crystal structure of pertuzumab in complex with ErbB2 ECD 
reveals the mechanism of action of this mAb. Pertuzumab binds to a binding 
pocket in domain II of ErbB2 thus preventing the dimerisation ‘hairpin’ or 
‘arm’ of partner EGFR/ErbB3/ErbB4 receptor from fitting into the binding 
pocket (Franklin et al., 2004).
The MET RTK has also been suggested to predimerise and by deletion 
analysis it was shown that the SEMA domain in the ECD is essential for MET 
signalling (Kong-Beltran et al., 2004). The investigators showed that deletion 
of this domain prevents receptor activation both in the presence and absence
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of ligand. The study suggests that in the absence of ligand recombinant 
SEMA domain (rSEMA) most likely blocks receptor dimerisation whereas in 
the presence of ligand rSEMA binds ligand and therefore prevents MET 
activation. The study further suggests that rSEMA could be used as a 
‘biotherapeutic’ - as the treatment of MET overexpressing tumour cells with 
recombinant SEMA in the presence or absence of ligand resulted in 
decreased MET signal transduction, cell motility and migration.
6.4. The role of the TM domain in receptor oligomerisation and activation 
of DDRs and other cell surface receptors
In the third part of our study we investigated the role of the TM domain in 
DDR dimerisation and signalling. Results from a parallel study using the 
TOXCAT assay provide strong evidence for the DDR1 TM domain to self- 
interact. Therefore the TM domain must play a major role in ligand- 
independent receptor-receptor interactions. Our study shows that the TM 
domain is important for DDR1 signal transduction, revealing a critical role for 
the leucine zipper motif in DDR1 activation.
As described in Chapter 1, the DDRs are found up-regulated in a number of 
human disease and pathological conditions such liver fibrosis, idiopathic 
pulmonary fibrosis and inflammation, atherosclerosis, lymphangioleiomyomatosis, 
osteoarthritis, rheumatoid arthritis, primary biliary cirrhosis and malignant 
tumours. Based on these findings that the specific motif in the DDR1 TM 
domain is essential for transmitting the conformational change induced upon 
ligand binding, future work would be to look towards finding an effective 
method to block DDR signalling. For example, short hydrophobic TM 
peptides corresponding to the WT DDR TM domain could be designed and 
tested for the ability to block receptor dimerisation and signalling. Such a 
study was carried out for the EGFR and ErbB2 receptors where hydrophobic 
TM peptides inhibited specifically the autophosphorylation and down stream 
signalling of EGFR and ErbB2 (Bennasroune et al., 2004). In addition mutant 
DDR TM peptides could be made with mutations similar to TM1 and TM2, 
and used for confirmation of the mechanism of action of the WT TM peptides.
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In conclusion, the findings presented in this thesis strongly argue in favour of 
the important role of the TM domain in DDR function. It cannot be excluded 
that the TM interactions could act in concert with the ECD, as studies by 
Leitinger, 2003 showed that deletion of subdomains of the ECD inhibits 
DDR1 signalling (Leitinger, 2003). In the presence of ligand, the co-ordinated 
association of the TM domains could favour productive interaction of the 
intracellular KDs leading to autophosphorylation and signalling. Even though 
the cytoplasmic juxtamembrane region is not essential for DDR dimerisation 
as shown in this study, further deletion analysis needs to be carried out to 
explore the role of the cytosolic juxtamembrane region in DDR signalling, as 
this region could be important in preventing DDR activation in the absence of 
ligand.
DDR activation is a result of ligand binding to the ECD, as shown for all other 
RTKs. The data presented in this thesis suggests that in the absence of 
collagen, the DDRs exist as inactive dimers with the KDs held in an inactive 
conformation. We propose that collagen binding induces a conformational 
change that is transmitted to the cytoplasmic domain, allowing the KDs to 
become activated. We show that the leucine zipper in the DDR1 TM domain 
is critical for transmitting the conformational change imposed on the receptor 
dimer by collagen binding. Thus, self-assembly of the DDR1 TM domain, 
although not essential for dimerisation, promotes a ligand-induced 
conformational switch required for the activation of signalling. Although we do 
not know the nature of the conformational rearrangement, a possible 
mechanism would be that TM domain interactions involve relative rotation of 
receptor protomers within the dimer, as have been suggested for EGFR 
(Moriki et al., 2001), the Epo receptor (Seubert et al., 2003), or the GH 
receptor (Brown et al., 2005).
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6.5. Future work
6.5.1. Determining the nature of a possible post-translational modification 
in DDR2
As detailed in Chaper 3, we were unable to fully determine the type of post- 
translational modification that might be responsible for the presence of the 
different MW forms of DDR2. In section 3.3, we suggested that either 
monoubiquitination or SUMO modification might be responsible for the 
difference. The presence of monoubiquitin can be detected by SDS-PAGE 
and immunoblotting using a commercially available anti-ubiquitin Ab, which is 
able to distinguish between monoubiquitin and polyubiquitin structures. A 
similar approach can be used for detecting SUMO modifications.
6.5.2. Investigate the effect of collagen on DDR dimerisation in live cells
One or more of the following methods can be used to look at the effect of 
collagen on DDR dimerisation in live cells - BRET, FRET or Fluorescence 
Lifetime Imaging Microscopy (FLIM) analysis. FRET analysis is a useful 
method for measuring conformational changes and spatial proximity of a 
membrane protein of interest. These non-invasive biophysical methods do 
not require detergent solubilization (as used in co-immunoprecipitation 
studies) and therefore allow one to look at the receptor in its natural 
environment. Another advantage of FRET over BRET or co- 
immunoprecipitation studies is that it allows one to measure conformation 
changes and/or interactions of the mature, cell surface population of the 
membrane protein. For FRET analysis, the membrane protein can be N- 
terminally or C-terminally tagged with cyan fluorescent protein (CFP) and 
yellow fluorescent protein (YFP). We have made DDR constructs C- 
terminally tagged with a monomeric version of C/YFP. Four constructs 
DDR1-CFP, DDR1-YFP, DDR2-CFP and DDR2-YFP were made and 
checked for receptor expression and functionality. The presence of the 
C/YFP tag does not affect expression and collagen-dependent 
autophosphorylation when compared with WT DDRs (Leitinger and McCaine, 
personal communications). Thus these constructs will be used for FRET
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analysis to explore the oligomeric state of DDRs in situ and determine the 
effect of collagen on DDR oligomerisation in live cells.
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